Original Article
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
N Engl J Med 2004; 350:221-231January 15, 2004
- Abstract
Background
Restenosis after coronary stenting necessitates repeated percutaneous or surgical revascularization procedures. The delivery of paclitaxel to the site of vascular injury may reduce the incidence of neointimal hyperplasia and restenosis.
Methods
At 73 U.S. centers, we enrolled 1314 patients who were receiving a stent in a single, previously untreated coronary-artery stenosis (vessel diameter, 2.5 to 3.75 mm; lesion length, 10 to 28 mm) in a prospective, randomized, double-blind study. A total of 652 patients were randomly assigned to receive a bare-metal stent, and 662 to receive an identical-appearing, slow-release, polymer-based, paclitaxel-eluting stent. Angiographic follow-up was prespecified at nine months in 732 patients.
Results
In terms of base-line characteristics, the two groups were well matched. Diabetes mellitus was present in 24.2 percent of patients; the mean reference-vessel diameter was 2.75 mm, and the mean lesion length was 13.4 mm. A mean of 1.08 stents (length, 21.8 mm) were implanted per patient. The rate of ischemia-driven target-vessel revascularization at nine months was reduced from 12.0 percent with the implantation of a bare-metal stent to 4.7 percent with the implantation of a paclitaxel-eluting stent (relative risk, 0.39; 95 percent confidence interval, 0.26 to 0.59; P<0.001). Target-lesion revascularization was required in 3.0 percent of the group that received a paclitaxel-eluting stent, as compared with 11.3 percent of the group that received a bare-metal stent (relative risk, 0.27; 95 percent confidence interval, 0.16 to 0.43; P<0.001). The rate of angiographic restenosis was reduced from 26.6 percent to 7.9 percent with the paclitaxel-eluting stent (relative risk, 0.30; 95 percent confidence interval, 0.19 to 0.46; P<0.001). The nine-month composite rates of death from cardiac causes or myocardial infarction (4.7 percent and 4.3 percent, respectively) and stent thrombosis (0.6 percent and 0.8 percent, respectively) were similar in the group that received a paclitaxel-eluting stent and the group that received a bare-metal stent.
Conclusions
As compared with bare-metal stents, the slow-release, polymer-based, paclitaxel-eluting stent is safe and markedly reduces the rates of clinical and angiographic restenosis at nine months.
Media in This Article
Figure 1
Cumulative Distribution Curves (Paired-Lesion Analysis) for Percent Stenosis of the Luminal Diameter in the Group That Received a Paclitaxel-Eluting Stent and the Group That Received a Bare-Metal Stent before and Immediately after the Intervention and at Nine Months.Figure 2
Subgroup Analysis for the Nine-Month Rate of Angiographic Restenosis in the Analysis Segment among Patients Assigned to Receive a Paclitaxel-Eluting Stent as Compared with Those Assigned to Receive a Bare-Metal Stent.Article Activity
- Article
The implantation of coronary stents reduces the risk of periprocedural complications and restenosis more than does balloon angioplasty alone.1,2 Nonetheless, clinical and angiographic restenosis still occurs in a substantial proportion of patients, often necessitating repeated revascularization procedures, decreasing the quality of life, and increasing health care expenditures.3,4 The principal cause of restenosis after coronary stenting is neointimal hyperplasia resulting from the proliferation and migration of smooth-muscle cells and extracellular matrix production.5 Numerous systemic pharmacologic and adjunctive device-based approaches have been ineffective at further lowering the risk of restenosis after stenting.6 Recently, the site-specific delivery of agents capable of interrupting cellular replication has shown promise in inhibiting neointimal hyperplasia.7 In particular, the polymer-based, sirolimus-eluting stent has proved to be safe and effective in reducing the risk of restenosis in previously untreated lesions of native coronary arteries.8,9
Paclitaxel, a lipophilic molecule derived from the Pacific yew tree Taxus brevifolia, is capable of inhibiting cellular division, motility, activation, secretory processes, and signal transduction.10-15 The vascular compatibility and efficacy of paclitaxel in reducing neointimal hyperplasia after balloon- and stent-mediated injury have been shown in in vitro and in vivo studies.16-21 The potential for a slow-release, polymer-based, paclitaxel-eluting stent to reduce the risk of restenosis after the treatment of short, focal atherosclerotic lesions in humans has been demonstrated in small-to-moderate-sized studies.22,23 We therefore performed a large-scale, prospective, double-blind, randomized, multicenter trial to examine the safety and efficacy of such a stent in reducing the risk of clinical and angiographic restenosis in a broad population of patients and lesions.
Methods
Study Population and Protocol
Patients who were at least 18 years of age, had stable or unstable angina or provokable ischemia, and were undergoing percutaneous coronary intervention for a single, previously untreated lesion in a native coronary artery were considered for enrollment. Clinical exclusion criteria included previous or planned use of intravascular brachytherapy in the target vessel or of any drug-eluting stent; myocardial infarction within 72 hours before enrollment; a left ventricular ejection fraction of less than 25 percent; hemorrhagic diatheses; contraindications or allergy to aspirin, thienopyridines, paclitaxel, or stainless steel; a history of anaphylaxis in response to iodinated contrast medium; use of paclitaxel within 12 months before study entry or current use of colchicine; a serum creatinine level of more than 2.0 mg per deciliter (177 μmol per liter), a leukocyte count of less than 3500 per cubic millimeter, or a platelet count of less than 100,000 per cubic millimeter; a recent positive pregnancy test, breast-feeding, or the possibility of a future pregnancy; coexisting conditions that limited life expectancy to less than 24 months or that could affect a patient's compliance with the protocol; and current participation in other investigational trials. The study was approved by the institutional review board at each participating center, and consecutive, eligible patients provided written informed consent.
Before undergoing catheterization, patients received 325 mg of aspirin and a 300-mg oral dose of clopidogrel, a base-line electrocardiogram was obtained, and creatine kinase and isoenzyme levels were measured. Angiographic eligibility for inclusion was then assessed: patients had to have a single target lesion with a reference-vessel diameter on visual examination of 2.5 to 3.75 mm and a lesion length of 10 to 28 mm that could be covered by a single study stent. Angiographic exclusion criteria included a left main or ostial target lesion, moderate or severe calcification of the target vessel or lesion, tortuosity or angulation, bifurcation of the target lesion (defined by a side branch measuring more than 2.0 mm in diameter with more than 50 percent stenosis), an occluded target lesion (Thrombolysis in Myocardial Infarction grade 0 or 1 flow), or thrombus. Patients were also excluded if the use of atherectomy or cutting balloon was planned before stenting. Enrollment was permitted after the successful treatment of one additional nonstudy lesion in a nonstudy vessel before randomization.
Randomization and Stent Implantation
Randomization was performed by telephone and was stratified according to the presence or absence of medically treated diabetes mellitus and vessel size (less than 3.0 mm vs. 3.0 mm or more). Patients were assigned in equal proportions in a double-blind fashion with the use of random serial numbers to treatment with either the slow-release, polymer-based, paclitaxel-eluting stent (TAXUS, Boston Scientific) or a visually indistinguishable bare-metal stent (EXPRESS, Boston Scientific). Unfractionated heparin was administered according to standard practice, and the use of glycoprotein IIb/IIIa inhibitors was at the operator's discretion. After mandatory dilation with the use of a balloon:artery ratio of 1:1, an appropriate-sized stent (approximately 2 to 4 mm longer than the lesion, with a ratio of stent diameter to distal reference-vessel diameter of 1 to 1.1:1) was implanted at a pressure of at least 12 atm. Stents were available in lengths of 16, 24, and 32 mm and in diameters of 2.5, 3.0, and 3.5 mm. Additional study stents could be implanted in the event of edge dissections of types B through E or otherwise suboptimal results, and the use of dilation after stent implantation was at the operator's discretion.
A postprocedural electrocardiogram was obtained, and cardiac enzymes were measured every 8 hours for 24 hours. Patients took 325 mg of aspirin daily indefinitely and 75 mg of clopidogrel daily for six months. Clinical follow-up was scheduled at one, four, and nine months and yearly thereafter for five years.
Data Management
Independent study monitors verified 100 percent of the data on site from case-report forms. Data were maintained in a computerized data base by PAREXEL International, and the investigators had unrestricted access to the data. All major adverse cardiac events were reviewed and adjudicated by an independent committee whose members were unaware of patients' treatment allocation. A data and safety monitoring committee periodically reviewed blinded safety data, each time recommending that the study continue without modification. An independent analysis was performed at the angiographic core laboratory by a technician who was unaware of patients' clinical outcomes, using validated quantitative methods.24 Measures were reported separately within the stent, within 5 mm proximal and distal to each edge, and over the entire segment that was analyzed (the “analysis segment”). The manuscript was prepared by the principal investigator and revised after the other coauthors reviewed it.
End Points and Definitions
The primary end point was the nine-month incidence of ischemia-driven target-vessel revascularization, as adjudicated by the independent clinical-events committee. Target-vessel revascularization was considered to be driven by ischemia if the stenosis of the target vessel was at least 50 percent of the luminal diameter on the basis of a quantitative analysis, with either electrocardiographic changes while the patient was at rest or a functional study indicating ischemia in the distribution of the target vessel, or if there was stenosis of at least 70 percent in conjunction with recurrent symptoms alone. Target-lesion revascularization was defined as repeated revascularization for ischemia owing to stenosis of at least 50 percent of the luminal diameter anywhere within the stent or within the 5-mm borders proximal or distal to the stent.
Myocardial infarction after the intervention was defined as either the development of pathologic Q waves lasting at least 0.4 second in at least two contiguous leads with an elevated creatine kinase MB fraction level or, in the absence of pathologic Q waves, an elevation in creatine kinase levels to more than twice the upper limit of normal with an elevated creatine kinase MB level. A creatine kinase level more than five times the upper limit of normal was required to diagnose a myocardial infarction after bypass surgery.
Major adverse cardiac events were defined as death from cardiac causes (if the cause of death was undetermined, it was categorized as cardiac), myocardial infarction, or ischemia-driven target-vessel revascularization. Target-vessel failure was defined as death, myocardial infarction, or ischemia-driven revascularization related to the target vessel. If an adverse event could not conclusively be attributed to a non-target vessel, the event was considered a target-vessel failure.
Stent thrombosis was defined as an acute coronary syndrome with angiographic documentation of either vessel occlusion or thrombus within or adjacent to a previously successfully stented vessel or, in the absence of angiographic confirmation, either acute myocardial infarction in the distribution of the treated vessel or death from cardiac causes within 30 days. Binary restenosis was defined as stenosis of at least 50 percent of the luminal diameter of the treated lesion.
Statistical Analysis
Using a two-sided test for differences in independent binomial proportions with an alpha level of 0.05 and allowing for a 10 percent rate of attrition, we calculated that 1172 patients would have to undergo randomization for the study to have 85 percent power to detect a reduction in the primary end point of ischemia-driven target-vessel revascularization from an anticipated 15 percent after bare-metal stenting to 9 percent with the paclitaxel-eluting stent, a 40 percent relative reduction. The protocol also prespecified that a minimum of 216 patients would be randomly assigned to receive a 32-mm stent, which became available only in the latter part of the study. An additional 154 patients whose lesions were longer than 24 mm therefore underwent randomization, bringing the total number enrolled to 1326 patients.
The principal secondary end point was the extent of stenosis of the target lesion at nine months. The protocol initially prespecified that follow-up angiography be performed in the first 536 consecutive patients enrolled — a number that, assuming a 25 percent rate of attrition, afforded the study 80 percent power to demonstrate a 17 percent reduction in mean (±SD) stenosis, from 27.2 to 22.5±16.7 percent. To make possible adequate angiographic evaluation of long lesions, the angiographic cohort was expanded by 196 consecutive patients who were receiving 24- or 32-mm stents, resulting in a total of 732 patients in the follow-up angiographic cohort.
Categorical variables were compared by means of the likelihood-ratio chi-square test or Fisher's exact test. Continuous variables are presented as means ±SD or medians with interquartile ranges and were compared with the use of Student's t-test or the Wilcoxon two-sample test. The influence of base-line variables on nine-month categorical end points was evaluated with logistic regression with the use of Wald's chi-square test. This analysis included all base-line clinical and angiographic features, treatment assignment, and procedural variables, and the results are expressed as odds ratios with 95 percent confidence intervals. The statistical-analysis plan prespecified that the primary intention-to-treat population would consist of all patients in whom an attempt was made to implant a study stent. All P values are two-sided.
Results
Enrollment and Base-Line Characteristics
Between March 29 and July 8, 2002, 1326 patients at 73 U.S. centers were assigned to receive either a paclitaxel-eluting stent (667 patients) or a bare-metal stent (659 patients). Twelve patients (0.9 percent) were subsequently excluded because the appropriate stent size was not available for three patients, the guide wire or pre-dilation balloon could not be successfully passed in three, complications occurred before stenting in three, the lesion was reevaluated before stenting and determined to meet exclusion criteria in two, and withdrawal of consent by one. The population included in the analysis therefore consisted of 1314 patients: 662 were assigned to receive paclitaxel-eluting stents, and 652 to receive the bare-metal stents. The base-line characteristics of the two groups were well matched (Table 1Table 1
Base-Line Clinical and Angiographic Characteristics.).Procedural Outcomes
The number of stents implanted per patient, the mean length and diameter of the stents, and other deployment and implantation variables were similar in the two groups (Table 2Table 2
Stent Implantation and Procedural Results.). The initial angiographic results were also similar in the two cohorts.Clinical Outcomes
As shown in Table 3Table 3
Clinical Outcomes at Nine Months., implantation of the paclitaxel-eluting stent, as compared with the bare-metal stent, reduced the primary end point of the risk of target-vessel revascularization at nine months by 61 percent and lowered the risk of target-lesion revascularization by 73 percent, a consequence of significant reductions in the rates of both percutaneous coronary intervention and coronary-artery bypass grafting. Multivariate analysis showed that randomization to the group receiving a paclitaxel-eluting stent was an independent predictor of freedom from target-vessel revascularization (odds ratio, 0.34; 95 percent confidence interval, 0.22 to 0.54; P<0.001). The rates of death, myocardial infarction, and stent thrombosis were low and similar in the two groups. Thus, at the end of the nine-month follow-up period, the rates of target-vessel failure and major adverse cardiac events were significantly lower after the receipt of a paclitaxel-eluting stent than after the receipt of a bare-metal stent (Table 3).Angiographic Results
Follow-up angiography at nine months was completed in 559 of the 732 prespecified patients (76.4 percent), including 442 of the 536 patients (82.5 percent) from the original prespecified angiographic cohort and 117 of the 196 patients (59.7 percent) from the extended long-lesion cohort, from whom consent for angiographic follow-up had not initially been obtained. There were no significant base-line clinical or angiographic differences between patients in whom follow-up angiography was scheduled and those in whom it was not scheduled, except that the lesion was significantly longer in patients in the follow-up angiographic cohort (mean, 14.4±6.9 vs. 12.1±5.1 mm; P<0.001). Among patients in the angiographic follow-up cohort, diabetes mellitus was present in 27.7 percent of those who received a paclitaxel-eluting stent and 23.8 percent of those who received a bare-metal stent (P=0.24), and the mean lesion length was 14.4±6.7 and 14.4±7.1 mm, respectively (P=0.94).
Quantitative follow-up data were available for 559 patients. As compared with those who received a bare-metal stent, patients who received a paclitaxel-eluting stent had a significantly smaller amount of late loss and a lower loss index, resulting in greater luminal dimensions and a smaller degree of stenosis at follow-up, both within the stented segment and at its edges (Table 4Table 4
Angiographic Measures at Nine Months. and Figure 1Figure 1Cumulative Distribution Curves (Paired-Lesion Analysis) for Percent Stenosis of the Luminal Diameter in the Group That Received a Paclitaxel-Eluting Stent and the Group That Received a Bare-Metal Stent before and Immediately after the Intervention and at Nine Months.). The use of a paclitaxel-eluting stent reduced the risk of binary restenosis by 77 percent within the stent and by 70 percent in the analysis segment.Multivariate analysis showed that randomization to the group that received a paclitaxel-eluting stent was an independent predictor of freedom from restenosis (odds ratio, 0.16; 95 percent confidence interval, 0.08 to 0.30; P<0.001).
The relative reduction in the risk of restenosis with the paclitaxel-eluting stent, as compared with the bare-metal stent, was independent of diabetes mellitus status, epicardial-vessel location, and the length and diameter of the lesion or stent (Figure 2Figure 2
Subgroup Analysis for the Nine-Month Rate of Angiographic Restenosis in the Analysis Segment among Patients Assigned to Receive a Paclitaxel-Eluting Stent as Compared with Those Assigned to Receive a Bare-Metal Stent.). Among patients with restenosis, those treated with the paclitaxel-eluting stent were much less likely than those who received a bare-metal stent to have a diffuse or proliferative pattern of hyperplasia, and they had a significantly shorter restenosed segment (Table 4). Aneurysms were present at nine months in two patients (0.7 percent) in each group; only one of these aneurysms (in a patient who received a bare-metal stent) developed during the nine-month follow-up period.Among patients in the angiographic cohort who completed follow-up angiography, the rate of target-lesion revascularization was reduced from 14.6 percent with the bare-metal stent to 3.8 percent with the paclitaxel-eluting stent (P<0.001). Among patients who did not undergo angiographic follow-up, the rate of target-lesion revascularization was reduced from 9.2 percent with the bare-metal stent to 2.4 percent with the paclitaxel-eluting stent (P<0.001).
Discussion
In this prospective, randomized, double-blind study, the implantation of a slow-release, polymer-based, paclitaxel-eluting stent markedly reduced the risk of clinical and angiographic restenosis as compared with the implantation of a bare-metal stent, in patients with a wide range of previously untreated coronary lesions. Despite the relatively low rate of restenosis in the control group, the biologic potency of the paclitaxel-eluting stent was evidenced by a 70 percent relative reduction in the risk of angiographic restenosis, with a corresponding 73 percent reduction in the risk of target-lesion revascularization. In addition to reducing the need for repeated percutaneous coronary intervention, the paclitaxel-eluting stent also reduced the need for coronary-artery bypass grafting. Notably, target-lesion revascularization was required in only 3.8 percent of patients assigned to receive a paclitaxel-eluting stent who underwent protocol-specified angiographic follow-up, and the rate was also significantly reduced among patients who received a paclitaxel-eluting stent who did not undergo routine angiographic follow-up.
The paclitaxel-eluting stent effectively reduced the risk of restenosis in a broad range of lesions and patients undergoing percutaneous intervention. The three principal determinants of restenosis after coronary-stent implantation are diabetes mellitus status, the reference-vessel diameter, and the lesion length (or the length of the implanted stent).26-30 We found that the risk of restenosis was increased by approximately 50 percent among diabetic patients who received a bare-metal stent as compared with those without diabetes who received such a stent. In contrast, the risk of restenosis was reduced by more than 80 percent among patients with diabetes who received a paclitaxel-eluting stent, so that these patients and patients without diabetes had similar rates of angiographic recurrence after the receipt of such a stent. The marked efficacy of site-specific paclitaxel delivery in reducing the risk of restenosis among patients with diabetes may be explained by paclitaxel's ability to disrupt microtubules, leading to inhibition of signal-transduction pathways regulated by insulin that mediate growth, differentiation, and stress responses.31 The rates of restenosis after the implantation of a bare-metal stent in small coronary arteries (no more than 2.5 mm in diameter) and long lesions (longer than 20 mm) were also increased, by 38.5 percent and 41.5 percent, respectively. The benefits of the paclitaxel-eluting stent were particularly evident in these subtypes of lesions, which had the greatest absolute reductions in the risk of restenosis.
The ability of the paclitaxel-eluting stent to reduce the extent of neointimal hyperplasia was evident both within the stent and at the proximal and distal margins of the stent. Moreover, when restenosis did occur after the implantation of a paclitaxel-eluting stent, the pattern was much more likely to be focal than diffuse or proliferative, potentially translating into easier subsequent management.25
Use of the paclitaxel-eluting stent was safe, with no excess risks apparent. Stent thrombosis was infrequent in both groups, and no late stent thromboses occurred after clopidogrel was discontinued at six months. The rates of death from cardiac causes and myocardial infarction over the nine-month follow-up period were also low and were not significantly different between the two groups. Aneurysms did not develop during the nine-month follow-up period in any patient who received a paclitaxel-eluting stent.
The safety and efficacy of the slow-release, polymer-based, paclitaxel-eluting stent in our study population cannot be generalized to patients and types of lesions that were excluded from randomization, including lesions resulting from acute myocardial infarction, thrombus-containing lesions, bifurcations, stenoses of the left main coronary artery, heavily calcified stenoses, vessels visually estimated as less than 2.5 mm or greater than 3.75 mm in diameter, diseased saphenous-vein grafts, or lesions with in-stent restenosis. The extent to which an injured or unstented margin contributed to the remaining cases of focal restenosis with the paclitaxel-eluting stent cannot be determined with certainty. Moreover, overlapping stents were implanted in relatively few patients in this trial, and thus, further study is required to evaluate the treatment of lesions that are longer than 28 mm, which require at least two stents. Extended follow-up is required to establish the long-term safety of this and other drug-eluting stent devices. All of our patients received clopidogrel for six months in order to maximize the safety of this device (though preclinical studies demonstrated equivalent rates of healing with the use of nonoverlapping bare-metal stents and slow-release, paclitaxel-eluting stents). Though the use of a prolonged course of clopidogrel is consistent with current studies demonstrating an incremental benefit of extended thienopyridine therapy,32 it is unknown whether this duration of treatment is necessary to prevent subacute thrombosis after the implantation of a paclitaxel-eluting stent. Finally, appropriately powered, head-to-head, randomized trials comparing different drug-eluting stent systems are required to evaluate their relative safety and efficacy.
Supported by Boston Scientific, Natick, Mass.
Drs. Stone, Ellis, Hermiller, and Caputo report having served as consultants or advisors to Boston Scientific; Dr. Stone transiently held an equity interest in Boston Scientific, which was liquidated before the study results became available; Dr. Greenberg reports holding an equity interest in Boston Scientific; Drs. Stone, Hermiller, Caputo, and Popma report having received lecture fees from the sponsor; Dr. Russell reports serving as a full-time employee of the sponsor and holding equity.
Source Information
From the Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York (G.W.S.); the Cleveland Clinic Foundation, Cleveland (S.G.E.); Mid Carolina Cardiology, Charlotte, N.C. (D.A.C.); St. Vincent's Hospital, Indianapolis (J.H.); Elyria Memorial Hospital, Elyria, Ohio (C.O.); WakeMed, Raleigh, N.C. (J.T.M.); Washington Adventist Hospital, Tacoma Park, Md. (M.T.); St. Joseph's Hospital, Syracuse, N.Y. (R.C.); Sacred Heart Medical Center, Eugene, Oreg. (P.B.); Florida Hospital, Orlando (J.G.); Brigham and Women's Hospital, Boston (J.J.P.); and Boston Scientific, Natick, Mass. (M.E.R.).
Address reprint requests to Dr. Stone at the Cardiovascular Research Foundation, 55 E. 59th St., 6th Fl., New York, NY 10022, or at gstone@crf.org.
The investigators, research coordinators, and institutions participating in the TAXUS-IV Trial appear in the Appendix.
Appendix
Members of the TAXUS-IV Study were as follows: Executive Committee — G. Stone (principal investigator), Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York; S. Ellis (co-principal investigator), Cleveland Clinic Foundation, Cleveland; P. Teirstein, Scripps Clinic, La Jolla, Calif.; D. Cohen, Beth Israel Deaconess Medical Center, Boston; M. Russell, Boston Scientific, Natick, Mass.; Data Monitoring — PAREXEL International, Waltham, Mass.: R. Baldwin (coordinator), Boston Scientific; Data Management and Biostatistical Analysis — PAREXEL International: P. Lam (director); M. Cody (coordinator), Boston Scientific; Clinical Events Adjudication Committee — Harvard Cardiovascular Research Institute, Boston: D. Cutlip (chair), M. Chauhan, K. Ho, J. Aroesty, J. Kannam; Data and Safety Monitoring Committee — B. Gersh (chair), Mayo Clinic, Rochester, Minn.; M. Ohman, University of North Carolina, Chapel Hill, Chapel Hill; T. Ryan, Boston Medical Center, Boston; D. Faxon, University of Chicago, Chicago; D. DeMets, University of Wisconsin, Madison; Angiographic Core Laboratory — Brigham and Women's Hospital, Boston: J. Popma (director), J. Shah, A. Wong; Intravascular Ultrasound Imaging Core Laboratory — Washington Hospital Center, Washington, D.C.: N. Weissman (director); Study Sites, Principal Investigators, and Study Coordinators — Huntsville Hospital, Huntsville, Ala.: W. Strickland, D. McCrackin; Good Samaritan Regional Medical Center, Phoenix, Ariz.: N. Laufer, D. Cook; Scripps Memorial Hospital, La Jolla, Calif.: M. Buchbinder, S. Costello; Mercy General Hospital, Sacramento, Calif.: M. Chang, S. Bordash; University of California Davis Medical Center, Sacramento: R. Low, K. Harder; Good Samaritan Hospital, Los Angeles: R. Matthews, S. Mullin; Scripps Clinic, La Jolla, Calif.: P. Teirstein, E. Anderson; Stanford Medical Center, Stanford, Calif.: A. Yeung, P. Tsao; Columbia Medical Center of Aurora, Aurora, Colo.: B. Molk, K. Bickett; Aurora Denver Cardiology, Denver: B. Molk, K. Bickett; Connecticut Clinical Research, Bridgeport: E. Kosinski, M. Capasso; Washington Hospital Center, Washington, D.C.: L. Satler, R. Howery; Christiana Hospital, Newark, Del.: J. Hopkins, K. Sullivan; Sarasota Memorial Hospital, Sarasota, Fla.: S. Culp, J. Selby; MediQuest Research Group, Ocala, Fla.: R. Feldman, K. Tighe; Florida Hospital, Orlando: J. Greenberg, M. Allan; St. Vincent's Hospital, Jacksonville, Fla.: G. Pilcher, A. Dennis; Piedmont Hospital, Atlanta: C. Brown, A. Garvitte; Mercy Hospital Medical Center, Des Moines, Iowa: M. Tannenbaum, R. Porter; Mercy Medical Center, Des Moines, Iowa: M. Tannenbaum, M. Craig; Northwestern University Medical School, Chicago: C. Davidson, L. Goodreau; St. John's Hospital, Springfield, Ill.: G. Mishkel, P. Warren; Community Hospital Heart Institution, Indianapolis: W. Corey, M. Portrikus; St. Vincent's Hospital, Indianapolis: J. Hermiller, Jr., M. Fredericks; Central Baptist Hospital, Lexington, Ky.: M. Jones, J. Hamilton; Jewish Hospital Heart and Lung Institute, Louisville, Ky.: D. McMartin, P. Adkisson; Our Lady of the Lake Regional Medical Center, Baton Rouge, La.: A. Rees, B. Toler; Beth Israel Deaconess Medical Center, Boston: D. Cohen, P. Rooney; New England Medical Center, Boston: C. Kimmelstiel, S. Galvin; Brigham and Women's Hospital, Boston: C. Rogers, D. Barry; Sinai Hospital of Baltimore, Baltimore: P. Gurbel, K. Bliden; St. Joseph Medical Center, Towson, Md.: M. Midei, A. Dudek; Washington Adventist Hospital, Takoma Park, Md.: M. Turco, D. Shaddinger; Maine Medical Center, Portland: M. Kellett, C. Berg; St. Mary's Medical Center, Saginaw, Mich.: L. Cannon, C. Wituki; St. John's Hospital, Detroit: T. Davis, T. Ingle; St. Mary's Hospital, Duluth, Minn.: G. Albin, C. Neva; Abbott Northwestern Hospital, Minneapolis: M. Mooney, J. Cartland; Washington University School of Medicine, St. Louis: J. Lasala, J. Newgent; Mid-American Heart Institute, Kansas City, Mo.: B. Rutherford, C. Rutherford; Presbyterian Hospital Mid Carolina Cardiology, Charlotte, N.C.: D. Cox, B. Carroll; Wake Forest University Baptist Medical Center, Winston-Salem, N.C.: M. Kutcher, T. Young; Wake Medical Center, Raleigh, N.C.: J. Mann, T. Smallwood; Moses Cone Memorial Hospital, Greensboro, N.C.: T. Stuckey, D. Muncy; Carolinas Health Care System, Charlotte, N.C.: H. Wilson, G. Schwarz; Duke University Medical Center, Durham, N.C.: J. Zidar, S. Dickerson; Nebraska Heart Institute, Lincoln: S. Martin, T. Humlichek; Valley Hospital, Ridgewood, N.J.: C. Hirsch, K. Sayles; Our Lady of Lourdes Medical Center, Camden, N.J.: A. Moak, D. Palazzo; St. Joseph's Hospital and Health Center, Syracuse, N.Y.: R. Caputo, C. Lastinger; Albany Medical Center Hospital, Albany, N.Y.: A. DeLago, K. Edmunds; North Shore University Hospital, Manhassett, N.Y.: S. Katz, D. Redmond; Maimonides Medical Center, Brooklyn, N.Y.: J. Shani, L. Budzilowicz; St. Francis Hospital, Roslyn, N.Y.: R. Shlofmitz, E. Haag; Lenox Hill Hospital, New York: G. Stone, M. Arif; New York Presbyterian Hospital–Weill Medical College of Cornell University, New York: C. Wong, D. Reynolds; Cleveland Clinic Foundation, Cleveland: S. Ellis, L. Vivian; Christ Hospital, Cincinnati: D. Kereiakes, H. Benhase; Elyria Memorial Hospital, Elyria, Ohio: C. O'Shaughnessy, S. Tonich; Oklahoma Foundation for Cardiovascular Research, Oklahoma City: T. McGarry, S. Hanes, T. Ramsey; Sacred Heart Medical Center, Eugene, Oreg.: J. Chambers, D. Butler-Sharp; Lancaster General Hospital, Lancaster, Pa.: P. Casale, L. Kruse, M. Adams; Heart Care Group, Allentown, Pa.: J. Kleaveland, C. Trapp; Miriam Hospital, Providence, R.I.: P. Gordon, N. Wright; Rhode Island Hospital, Providence: D. Williams, J. Muratori; Apex Cardiology, Jackson, Tenn.: H. Lui, A. Hinton; St. Thomas Hospital, Nashville: R. Wheatley, J. McCarthy; Northeast Methodist Hospital, San Antonio, Tex.: C. Casey, S. Farris; Seton Medical Center, Austin, Tex.: S. DeMaio, L. Rogers; Capital Cardiovascular Specialists, Austin, Tex.: S. DeMaio, L. Rogers; St. Luke's Episcopal Hospital, Houston: D. Fish, M. Harlan; Covenant Health System–Medical Center, Lubbock, Tex.: P. Overlie, D. Zamora; Cardiac Catheterization Laboratory Research Center, Houston: A. Raizner, D. McCain; Hermann Hospital, Houston: R. Smalling, C. Carter; Medical Center Hospital of Vermont, Burlington: M. Watkins, L. Chadwick; Swedish Medical Center, Seattle: M. Reisman, W. Ronco.
- References
References
1
Serruys PW ,de Jaegere P ,Kiemeneij F , et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495
Full Text | Web of Science | Medline2
Fischman DL ,Leon MB ,Baim DS , et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501
Full Text | Web of Science | Medline3
Al Suwaidi J ,Berger PB ,Holmes DR Jr . Coronary artery stents. JAMA 2000;284:1828-1836
CrossRef | Web of Science | Medline4
Peterson ED ,Cowper PA ,DeLong ER ,Zidar JP ,Stack RS ,Mark DB . Acute and long-term cost implications of coronary stenting. J Am Coll Cardiol 1999;33:1610-1618
CrossRef | Web of Science | Medline5
Farb A ,Sangiorgi G ,Carter AJ , et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52
Web of Science | Medline6
Hoffmann R ,Mintz GS . Coronary in-stent restenosis -- predictors, treatment and prevention. Eur Heart J 2000;21:1739-1749
CrossRef | Web of Science | Medline7
Babapulle MN ,Eisenberg MJ . Coated stents for the prevention of restenosis. Circulation 2002;106:2859-2866
CrossRef | Web of Science | Medline8
Morice M-C ,Serruys PW ,Sousa JE , et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780
Full Text | Web of Science | Medline9
Moses JW ,Leon MB ,Popma JJ , et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323
Full Text | Web of Science | Medline10
Roberts RL ,Nath J ,Friedman MM ,Gallin JI . Effects of taxol on human neutrophils. J Immunol 1982;129:2134-2141
Web of Science | Medline11
Belotti D ,Vergani V ,Drudis T , et al. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 1996;2:1843-1849
Web of Science | Medline12
Jackson JK ,Tudan C ,Sahl B ,Pelech SL ,Burt HM . Calcium pyrophosphate dihydrate crystals activate MAP kinase in human neutrophils: inhibition of MAP kinase, oxidase activation and degranulation responses of neutrophils by taxol. Immunology 1997;90:502-510
CrossRef | Web of Science | Medline13
Hui A ,Min WX ,Tang J ,Cruz TF . Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes. Arthritis Rheum 1998;41:869-876
CrossRef | Web of Science | Medline14
Wang TH ,Wang HS ,Ichijo H , et al. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem 1998;273:4928-4936
CrossRef | Web of Science | Medline15
Giannakakou P ,Robey R ,Fojo T ,Blagosklonny MV . Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 2001;20:3806-3813
CrossRef | Web of Science | Medline16
Farb A ,Heller PF ,Shroff S , et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001;104:473-479
CrossRef | Web of Science | Medline17
Sollott SJ ,Cheng L ,Pauly RR , et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 1995;95:1869-1876
CrossRef | Web of Science | Medline18
Axel DI ,Kunert W ,Goggelmann C , et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-645
Web of Science | Medline19
Herdeg C ,Oberhoff M ,Baumbach A , et al. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol 2000;35:1969-1976
CrossRef | Web of Science | Medline20
Oberhoff M ,Kunert W ,Herdeg C , et al. Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter. Basic Res Cardiol 2001;96:275-282
CrossRef | Web of Science | Medline21
Signore PE ,Machan LS ,Jackson JK , et al. Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J Vasc Interv Radiol 2001;12:79-88
CrossRef | Web of Science | Medline22
Grube E ,Silber S ,Hauptmann KE , et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42
CrossRef | Web of Science | Medline23
Colombo A ,Drzewiecki J ,Banning A , et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stent for coronary artery lesions. Circulation 2003;108:788-794
CrossRef | Web of Science | Medline24
van der Zwet PM ,Reiber JH . A new approach for the quantification of complex lesion morphology: the gradient field transform: basic principles and validation results. J Am Coll Cardiol 1994;24:216-224
CrossRef | Web of Science | Medline25
Mehran R ,Dangas G ,Abizaid AS , et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-1878
Web of Science | Medline26
Ho KKL ,Senerchia C ,Rodriguez O ,Chauhan MS ,Kuntz RE . Predictors of angiographic restenosis after stenting: pooled analysis of 1197 patients with protocol-mandated angiographic follow-up from 5 randomized stent trials. Circulation 1998;98:Suppl I:I-362 abstract.27
Serruys PW ,Kay IP ,Disco C ,Deshpande NV ,de Feyter PJ . Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the Belgian Netherlands Stent Study (BENESTENT) I, BENESTENT II pilot, BENESTENT II and MUSIC trials. J Am Coll Cardiol 1999;34:1067-1074
CrossRef | Web of Science | Medline28
Kastrati A ,Schomig A ,Elezi S , et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436
CrossRef | Web of Science | Medline29
Mercado N ,Boersma E ,Wijns W , et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 2001;38:645-652
CrossRef | Web of Science | Medline30
Kasaoka S ,Tobis J ,Akiyama T , et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 1998;32:1630-1635
CrossRef | Web of Science | Medline31
Mitsuuchi Y ,Johnson SW ,Selvakumaran M ,Williams SJ ,Hamilton TC ,Testa JR . The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Cancer Res 2000;60:5390-5394
Web of Science | Medline32
Steinhubl SR ,Berger PB ,Mann JT III , et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-2420[Erratum, JAMA 2003;289:987.]
CrossRef | Web of Science | Medline
- Citing Articles (977)
Citing Articles
1
Anne Seidlitz, Werner Weitschies. (2012) In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing. Journal of Pharmacy and Pharmacologyno-no
CrossRef2
Bodo Cremers, John L. Toner, Lewis B. Schwartz, Randolf Oepen, Ulrich Speck, Nicola Kaufels, Yvonne P. Clever, Dirk Mahnkopf, Michael Böhm, Bruno Scheller. (2012) Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clinical Research in Cardiology
CrossRef3
Kirk N. Garratt, David P. Lee, Eileen M. Rose, Kellie J. Windle, Hsini Liao, Chuke E. Nwachuku, Kenneth J. Winters, Thomas S. Bowman, Keith D. Dawkins. (2012) Rationale and design of the TAXUS Libertē Post-Approval Study: Examination of patients receiving the TAXUS Liberté stent with concomitant prasugrel therapy in routine interventional cardiology practice. American Heart Journal 163:2, 142-148.e6
CrossRef4
Vivian G. Ng, Alexandra J. Lansky. (2012) The Generations of Drug-Eluting Stents and Outcomes in Women. Interventional Cardiology Clinics
CrossRef5
Toshiki Sawai, Masatoshi Miyahara, Hiroshi Nakajima, Shiro Nakamori, Masataka Sakai, Hiroya Tamada, Takashi Tanigawa, Norikazu Yamada, Mashio Nakamura, Masaaki Ito. (2012) The impact of preprocedural hemoglobin A1c on the efficacy of sirolimus-eluting and paclitaxel-eluting stents. Cardiovascular Intervention and Therapeutics
CrossRef6
Guo Hua Zheng, Jian Ping Liu, Jianfeng Chu, Lijuan Mei, Hai Ying Chen, Guo Hua Zheng. 2012. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease. .
CrossRef7
Giulio Guagliumi, Vasile Sirbu, Giuseppe Musumeci, Robert Gerber, Giuseppe Biondi-Zoccai, Hideyuki Ikejima, Elena Ladich, Nikoloz Lortkipanidze, Aleksandre Matiashvili, Orazio Valsecchi, Renu Virmani, Gregg W. Stone. (2012) Examination of the In Vivo Mechanisms of Late Drug-Eluting Stent Thrombosis. JACC: Cardiovascular Interventions 5:1, 12-20
CrossRef8
Masataka Nakano, Marc Vorpahl, Fumiyuki Otsuka, Masanori Taniwaki, Saami K. Yazdani, Aloke V. Finn, Elena R. Ladich, Frank D. Kolodgie, Renu Virmani. (2012) Ex Vivo Assessment of Vascular Response to Coronary Stents by Optical Frequency Domain Imaging. JACC: Cardiovascular Imaging 5:1, 71-82
CrossRef9
Robert J. Applegate, James B. Hermiller, Paul C. Gordon, Manejeh Yaqub, Poornima Sood, Xiaolu Su, Sherry Cao, Krishnankutty Sudhir, Gregg W. Stone. (2012) Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents. EuroIntervention 7:9, 1030-1042
CrossRef10
Corrado Tamburino, Davide Capodanno, Maria Elena Di Salvo, Alessandra Sanfilippo, Irene Cascone, Valentina Incardona, Giovanni Longo, Daniele Giacoppo, Piera Capranzano, Carmelo Sgroi, Gianpaolo Ussia, Alfio Monaco, Alessio La Manna. (2012) Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry. EuroIntervention 7:9, 1062-1068
CrossRef11
Syed Ahmed, Prabir Roy-Chaudhury. (2012) Radiation Therapy for Dialysis Access Stenosis: Unfulfilled Promise or False Expectations. Seminars in Dialysisno-no
CrossRef12
Yoshitaka Muraoka, Shinjo Sonoda, Kuninobu Kashiyama, Fumihiko Kamezaki, Yuki Tsuda, Masaru Araki, Masahiro Okazaki, Yutaka Otsuji. (2011) Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents. The International Journal of Cardiovascular Imaging
CrossRef13
Alessandro Cuneo, Peter Bramlage, Matthias Hochadel, Jochen Senges, Christoph Nienaber, Karl-Heinz Kuck, Ulrich Tebbe. (2011) Concurrent drug eluting/bare metal stent implantation during percutaneous coronary intervention in target vessel: outcomes and 1-year follow-up. Clinical Research in Cardiology
CrossRef14
Li Shen, Qibing Wang, Yizhe Wu, Xi Hu, Jian Xie, Junbo Ge. (2011) Short-term effects of fully bioabsorbable PLLA coronary stents in a porcine model. Polymer Bulletin
CrossRef15
Jithendra B Somaratne, Robert J Whitbourn. (2011) TAXUS ® Element™ stent system. Interventional Cardiology 3:6, 641-648
CrossRef16
Huan Wang, Wen-juan Zhong, Ming-wei Huang, Xiao-ying Wu, Hui Chen. (2011) Efficacy of dual antiplatelet therapy combined with Naoxintong Capsules (
) following coronary microembolization induced by homologous microthrombi in rats. Chinese Journal of Integrative Medicine 17:12, 917-924
CrossRef17
Angela S. Koh, L.M. Choi, L.L. Sim, Jack W. Tan, L.W. Khin, Terrance S.J. Chua, T.H. Koh, Stanley Chia. (2011) Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: A prospective registry. Acute Cardiac Care 13:4, 219-222
CrossRef18
Young-Guk Ko, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Myeong-Ki Hong, Dong Woon Jeon, Joo-Young Yang, Young Keun Ahn, Myung Ho Jeong, Cheol Woong Yu, Kyeong-Ho Yun, Do-Sun Lim, Yangsoo Jang. (2011) Efficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS]). The American Journal of Cardiology
CrossRef19
Dikla Gutman, Gershon Golomb. (2011) Liposomal alendronate for the treatment of restenosis. Journal of Controlled Release
CrossRef20
, B. Scheller, B. Levenson, M. Joner, R. Zahn, V. Klauss, C. Naber, V. Schächinger, A. Elsässer. (2011) Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter. Der Kardiologe
CrossRef21
Sharon M. Loverde, Michael L. Klein, Dennis E. Discher. (2011) Nanoparticle Shape Improves Delivery: Rational Coarse Grain Molecular Dynamics (rCG-MD) of Taxol in Worm-Like PEG-PCL Micelles. Advanced Materialsn/a-n/a
CrossRef22
Maarten A. Vink, Ferdinand C. Van Nooijen, Gerrit J. Laarman, Maarten J. Suttorp, Jan G. Tijssen, Ton Slagboom, Mark S. Patterson, Rene J. Van Der Schaaf, Ferdinand Kiemeneij, Giovanni Amoroso, Maurits T. Dirksen. (2011) Patency of Paclitaxel-Eluting Versus Bare Metal Stents Long Term After Implantation in Acute ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology 108:9, 1214-1219
CrossRef23
Young Jin Youn, Junghan Yoon, Jun-Won Lee, Sung-Gyun Ahn, Min-Soo Ahn, Jang-Young Kim, Byung-Soo Yoo, Seung-Hwan Lee, Kyung-Hoon Choe. (2011) Intravascular Ultrasound-Guided Primary Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction. Clinical Cardiology 34:11, 706-713
CrossRef24
Soon Yong Suh, Kyoung Hoon Lee, Jeonggeun Moon, Woong Chol Kang, Seung Hwan Han, Tae Hoon Ahn, Eak Kyun Shin. (2011) Comparison of efficacy between paclitaxel-eluting stents with different polymers in terms of major adverse cardiac events and stent thrombosis up to 12months of clinical follow-up. International Journal of Cardiology 152:3, 392-395
CrossRef25
Hideshi Ishii, Toru Kataoka, Yoshiki Kobayashi, Takara Tsumori, Hiroaki Takeshita, Ryo Matsumoto, Nobuyuki Shirai, Hiroki Nishioka, Takao Hasegawa, Shinji Nakata, Yoshihisa Shimada, Shoichi Ehara, Takashi Muro, Minoru Yoshiyama. (2011) Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation. Heart and Vessels 26:6, 572-581
CrossRef26
Kyung Woo Park, Woo-Hyun Lim, Ji-Hyun Kim, Si-Hyuck Kang, Jung-Won Seo, Young Bin Song, Joo-Yong Hahn, Hae-Young Lee, Hyun-Jae Kang, Young-Seok Cho, Tae-Jin Youn, Bon-Kwon Koo, Seung-Hyuk Choi, In-ho Chae, Hyeon-Cheol Gwon, Dong-Ju Choi, Hyo-Soo Kim. (2011) Comparison between zotarolimus-eluting stents and first generation drug-eluting stents in the treatment of patients with acute ST-segment elevation myocardial infarction. International Journal of Cardiology
CrossRef27
Sa'ar Minha, Tamir Bental, Abid Assali, Hana Vaknin-Assa, Eli I. Lev, Eldad Rechavia, Alexander Battler, Ran Kornowski. (2011) A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients. Catheterization and Cardiovascular Interventions 78:5, 710-717
CrossRef28
Yoshitaka Muraoka, Shinjo Sonoda, Yuki Tsuda, Seiya Tanaka, Masahiro Okazaki, Yutaka Otsuji. (2011) Effect of intravascular ultrasound-guided adjuvant high-pressure non-compliant balloon post-dilation after drug-eluting stent implantation. Heart and Vessels 26:6, 565-571
CrossRef29
James J. Kleinedler, John D. Foley, J. Steven Alexander, Sandra C. Roerig, Valeria Y. Hebert, Tammy R. Dugas. (2011) Synergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devices. Journal of Biomedical Materials Research Part B: Applied Biomaterials 99B:2, 266-275
CrossRef30
Michael A. Kutcher. (2011) Second-Generation Everolimus-Eluting Stents. JACC: Cardiovascular Interventions 4:11, 1216-1217
CrossRef31
Saami Yazdani, Marc Vorpahl, Masataka Nakano, Shih-Horng Su, Frank Kolodgie, Renu Virmani. (2011) In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent. EuroIntervention 7:7, 835-843
CrossRef32
Erde Can, Gokce Udenir, Ayse Irem Kanneci, Gamze Kose, Seyda Bucak. (2011) Investigation of PLLA/PCL Blends and Paclitaxel Release Profiles. AAPS PharmSciTech
CrossRef33
Adnan Kastrati, Robert A. Byrne, Stefanie Schulz. (2011) Will We Ever Know the Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation?. JACC: Cardiovascular Interventions 4:10, 1129-1132
CrossRef34
Peter Radke, Michael Joner, Alexander Joost, Robert Byrne, Sonja Hartwig, Gerd Bayer, Kristin Steigerwald, Eric Wittchow. (2011) Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. EuroIntervention 7:6, 730-737
CrossRef35
Mario Grassi, Gaetano Lamberti, Sara Cascone, Gabriele Grassi. (2011) Mathematical modeling of simultaneous drug release and in vivo absorption. International Journal of Pharmaceutics 418:1, 130-141
CrossRef36
Shoichiro Daimon, Hidenobu Terai. (2011) Influence of Antiplatelet Medications on Bleeding Events in Hemodialysis Patients. Therapeutic Apheresis and Dialysis 15:5, 454-459
CrossRef37
Carlos A. Collet, J. Ribamar Costa, Alexandre Abizaid, Daniel Chamié, Rodolfo Staico, Ricardo Costa, Dimytri Siquera, Javier Obregon, Fausto Feres, Amanda Sousa, Jose Eduardo Sousa. (2011) Assessing the Temporal Course of Neointimal Hyperplasia Formation After Different Generations of Drug-Eluting Stents. JACC: Cardiovascular Interventions 4:10, 1067-1074
CrossRef38
Emilio Lorenzo, Giannignazio Carbone, Luigi Sauro, Alfredo Casafina, Michele Capasso, Rosario Sauro. (2011) Bare-Metal Stents Versus Drug-Eluting Stents for Primary Angioplasty: Long-Term Outcome. Current Cardiology Reports 13:5, 459-464
CrossRef39
Jochem van Werkum, Thea Godschalk, Tom Oirbans, Jurriën ten Berg. (2011) Coronary stent thrombosis: incidence, predictors and triggering mechanisms. Interventional Cardiology 3:5, 581-588
CrossRef40
KISHORE J. HARJAI, SUDHAKAR SATTUR, PAMELA ORSHAW, JUDY BOURA. (2011) Long-Term Safety and Effectiveness of Drug-Eluting Stents Compared to Bare Metal Stents following Successful PCI in Non-ST-Elevation Myocardial Infarction: Findings from the Guthrie Health Off-Label StenT (GHOST) Registry. Journal of Interventional Cardiologyno-no
CrossRef41
Linda C. Battes, Susanne S. Pedersen, Rohit M. Oemrawsingh, Robert J. van Geuns, Ibtihal Al Amri, Evelyn Regar, Peter P.T. de Jaegere, Patrick Serruys, Ron T. van Domburg. (2011) Beta blocker therapy is associated with reduced depressive symptoms 12months post percutaneous coronary intervention. Journal of Affective Disorders
CrossRef42
E. G. Marcos, A. C. Fonseca, S. H. Hofma. (2011) Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation. Netherlands Heart Journal 19:10, 412-417
CrossRef43
MOHAMED ABDEL-WAHAB, RALPH TOELG, GUIDO KASSNER, LOTHAR KLATT, MOHAMMAD A. SHERIF, VOLKER GEIST, GERT RICHARDT. (2011) Long-Term Clinical Outcome of Thin-Strut Cobalt-Chromium Stents in the Drug-Eluting Stent Era: Results of the COBALT (Comparison of Bare-Metal Stents in All-Comers’ Lesion Treatment) Registry. Journal of Interventional Cardiologyno-no
CrossRef44
Achala de Mel, Ferid Murad, Alexander M. Seifalian. (2011) Nitric Oxide: A Guardian for Vascular Grafts?. Chemical Reviews 111:9, 5742-5767
CrossRef45
Woong Chol Kang, Yae Min Park, Kwen-Chul Shin, Chan Il Moon, Kyounghoon Lee, Seung Hwan Han, Mi Seung Shin, Jeonggeun Moon, Taehoon Ahn, Eak Kyun Shin. (2011) Comparison of edge vascular response after sirolimus- and paclitaxel-eluting stent implantation. International Journal of Cardiology
CrossRef46
Jung-Sun Kim, David Wallace-Bradley, Carlos L. Alviar, Gerard Conditt, Krzysztof Milewski, Maxwell E. Afari, Yanping Cheng, Catalina Gallego, Armando Tellez, Gregg W. Stone, Greg L. Kaluza, Juan F. Granada. (2011) Correlation of Angiographic Late Loss With Neointimal Proliferation in Stents Evaluated by OCT and Histology in Porcine Coronary Arteries. JACC: Cardiovascular Imaging 4:9, 1002-1010
CrossRef47
Ming-Hui Chen, Joseph G. Ibrahim, Peter Lam, Alan Yu, Yuanye Zhang. (2011) Bayesian Design of Noninferiority Trials for Medical Devices Using Historical Data. Biometrics 67:3, 1163-1170
CrossRef48
Tadateru Takayama, Takafumi Hiro, Atsushi Hirayama. (2011) Stent thrombosis and drug-eluting stents. Journal of Cardiology 58:2, 92-98
CrossRef49
Jia Liu, Jian Xiu, Junxian Cao, Qianping Gao, Dan Ma, Lu Fu. (2011) Berberine cooperates with adrenal androgen dehydroepiandrosterone sulfate to attenuate PDGF-induced proliferation of vascular smooth muscle cell A7r5 through Skp2 signaling pathway. Molecular and Cellular Biochemistry 355:1-2, 127-134
CrossRef50
Kailash Prasad. (2011) Do Statins have a Role in Reduction/Prevention of Post-PCI Restenosis?. Cardiovascular Therapeuticsno-no
CrossRef51
Dennis T. Ko, Helen Guo, Harindra C. Wijeysundera, Mohammad I. Zia, Vladimír Džavík, Michael W.A. Chu, Stephen E. Fremes, Eric A. Cohen, Jack V. Tu. (2011) Long-Term Safety and Effectiveness of Drug-Eluting Stents for the Treatment of Saphenous Vein Grafts Disease. JACC: Cardiovascular Interventions 4:9, 965-973
CrossRef52
Gaku Nakazawa. (2011) Stent thrombosis of drug eluting stent: Pathological perspective. Journal of Cardiology 58:2, 84-91
CrossRef53
Shigeru Saito, Ross Prpic, Jeffery J. Popma, John Alexander, Mitchell W. Krucoff. (2011) The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study. Cardiovascular Revascularization Medicine 12:5, 273-279
CrossRef54
Amir Lotfi, Jiang Cui, Siddharth Wartak, Jesse Columbo, Scott Mulvey, Mary Davis, Marc Schweiger, Gregory R. Giugliano. (2011) Influence of Low-Dose Aspirin (81 mg) on the Incidence of Definite Stent Thrombosis in Patients Receiving Bare-Metal and Drug-Eluting Stents. Clinical Cardiology 34:9, 567-571
CrossRef55
HIROKI ITO, JAMES B. HERMILLER, MANEJEH YAQUB, WILLIAM NEWMAN, POORNIMA SOOD, JOHN C. WANG, LOUIS CANNON, JAMES E. MADDUX, KRISHNANKUTTY SUDHIR, GREGG W. STONE. (2011) Performance of Everolimus-Eluting versus Paclitaxel-Eluting Coronary Stents in Small Vessels: Results from the SPIRIT III and SPIRIT IV Clinical Trials. Journal of Interventional Cardiologyno-no
CrossRef56
Ankur Raval, Jigisha Parikh, Chhaya Engineer. (2011) Mechanism and in Vitro Release Kinetic Study of Sirolimus from a Biodegradable Polymeric Matrix Coated Cardiovascular Stent. Industrial & Engineering Chemistry Research 50:16, 9539-9549
CrossRef57
Johannes Lammer, Marc Bosiers, Thomas Zeller, Martin Schillinger, Els Boone, Margo J. Zaugg, Patrick Verta, Lei Peng, Xingyu Gao, Lewis B. Schwartz. (2011) First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. Journal of Vascular Surgery 54:2, 394-401
CrossRef58
Christopher Kaufmann, Gopinath Mani, Denes Marton, David Johnson, C. Mauli Agrawal. (2011) Long-term stability of self-assembled monolayers on electropolished L605 cobalt chromium alloy for stent applications. Journal of Biomedical Materials Research Part B: Applied Biomaterials 98B:2, 280-289
CrossRef59
Mohammad Almalla, Jörg W. Schröder, Verena Pross, Emilia Stegemann, Nikolaus Marx, Rainer Hoffmann. (2011) Everolimus-Eluting Versus Paclitaxel-Eluting Stents for Treatment of Bare Metal Stent Restenosis. The American Journal of Cardiology 108:4, 518-522
CrossRef60
EMMANOUIL S. BRILAKIS, JOHN M. LASALA, DAVID A. COX, THOMAS S. BOWMAN, RUTH M. STARZYK, KEITH D. DAWKINS. (2011) Two-Year Outcomes after Utilization of the TAXUS Paclitaxel-Eluting Stent in Bifurcations and Multivessel Stenting in the ARRIVE Registries. Journal of Interventional Cardiology 24:4, 342-350
CrossRef61
Volker Klauss, Patrick W. Serruys, Thomas Pilgrim, Pawel Buszman, Axel Linke, Thomas Ischinger, Franz Eberli, Roberto Corti, William Wijns, Marie-Claude Morice, Carlo di Mario, Robert Jan van Geuns, Gerrit-Anne van Es, Bindu Kalesan, Peter Wenaweser, Peter Jüni, Stephan Windecker. (2011) 2-Year Clinical Follow-Up From the Randomized Comparison of Biolimus-Eluting Stents With Biodegradable Polymer and Sirolimus-Eluting Stents With Durable Polymer in Routine Clinical Practice. JACC: Cardiovascular Interventions 4:8, 887-895
CrossRef62
C-L. Poh, M. Y. Chan, C. Lau, S-G. Teo, A. F. Low, H-C. Tan, C-H. Lee. (2011) Prevalence and predictors of premature discontinuation of dual antiplatelet therapy after drug-eluting stent implantation: importance of social factors in Asian patients. Internal Medicine Journal 41:8, 623-629
CrossRef63
Corrado Tamburino, Daniele Giacoppo, Davide Capodanno. (2011) The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial. Interventional Cardiology 3:4, 451-460
CrossRef64
SUSAN BEZENEK, JAMES HERMILLER, ALEXANDRA LANSKY, MANEJEH YAQUB, KYOKO HATTORI, SHERRY CAO, POORNIMA SOOD, KRISHNAKUTTY SUDHIR. (2011) Low Stent Thrombosis Risk with the XIENCE V® Everolimus-Eluting Coronary Stent: Evidence from Randomized and Single-Arm Clinical Trials. Journal of Interventional Cardiology 24:4, 326-341
CrossRef65
Kengo Tanabe, Satoru Kishi, Jiro Aoki, Shuzou Tanimoto, Yoshinobu Onuma, Sen Yachi, Masanori Taniwaki, Yoshifumi Nakajima, Hiroyoshi Nakajima, Kazuhiro Hara, Mitsuaki Isobe. (2011) Impact of Coronary Calcium on Outcome Following Sirolimus-Eluting Stent Implantation. The American Journal of Cardiology 108:4, 514-517
CrossRef66
Margo Klomp, Marcel A. Beijk, Chetan Varma, Jacques J. Koolen, Emmanuel Teiger, Gert Richardt, Florian Bea, Nan van Geloven, Niels J. Verouden, Yu Kwan Chan, Pier Woudstra, Peter Damman, Jan G. Tijssen, Robbert J. de Winter. (2011) 1-Year Outcome of TRIAS HR (TRI-Stent Adjudication Study–High Risk of Restenosis). JACC: Cardiovascular Interventions 4:8, 896-904
CrossRef67
Sarah Power, Michael M. Slattery, Michael J. Lee. (2011) Nanotechnology and its Relationship to Interventional Radiology. Part II: Drug Delivery, Thermotherapy, and Vascular Intervention. CardioVascular and Interventional Radiology 34:4, 676-690
CrossRef68
Tarek A.N. Ahmed, Sandrin C. Bergheanu, Theo Stijnen, Josepha W.M. Plevier, Paul H.A. Quax, J. Wouter Jukema. (2011) Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review. EuroIntervention 7:4, 505-516
CrossRef69
Tae-Hyun Yang, Doo-Il Kim, Han-Young Jin, Young-Wan Cho, Sang Ryul Chung, Dong-Kie Kim, Yong-Bok Kim, Jae-Sik Jang, Ung Kim, Sang-Hoon Seol, Dae-Kyeong Kim, Dong-Soo Kim. (2011) “Angiographic late catch-up” phenomenon after sirolimus-eluting stent implantation. International Journal of Cardiology
CrossRef70
Tae-Hoon Kim, Jung-Sun Kim, Byoung-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong. (2011) Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results. The International Journal of Cardiovascular Imaging 27:6, 875-881
CrossRef71
Esdras A. Arrieta, Mohamed Aly, Richard Parrish, Sander Dubovy, Leonard Pinchuk, Yasushi Kato, Francisco Fantes, Jean-Marie Parel. (2011) Clinicopathologic Correlations of Poly-(styrene-b-isobutylene-b-styrene) Glaucoma Drainage Devices of Different Internal Diameters in Rabbits. Ophthalmic Surgery, Lasers, and Imaging 42:4, 338-345
CrossRef72
Antoinette Waha, Alban Dibra, Sebastian Kufner, Dietrich Baumgart, Manel Sabate, Aleardo Maresta, Albert Schömig, Adnan Kastrati. (2011) Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials. Clinical Research in Cardiology 100:7, 561-570
CrossRef73
Michael Lee, Tae Yang, John Lasala, David Cox, Thomas Bowman, Ruth Starzyk, Keith Dawkins. (2011) Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme. EuroIntervention 7:3, 314-322
CrossRef74
Daniel Chamié, Alexandre Abizaid, J. Ribamar Costa, Fausto Feres, J. Fábio Almiro da Silva, Luiz Alberto P. Mattos, Rodolfo Staico, Ricardo A. Costa, Andréa Abizaid, Luiz Fernando L. Tanajura, Amanda G. M. R. Sousa, J. Eduardo Sousa. (2011) Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late “catch-up” phenomenon after cypher® sirolimus-eluting stent implantation. The International Journal of Cardiovascular Imaging 27:6, 867-874
CrossRef75
Maria Radu, Erik Jørgensen, Henning Kelbæk, Steffen Helqvist, Lene Skovgaard, Kari Saunamäki. (2011) Optical coherence tomography at follow-up after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing. EuroIntervention 7:3, 353-361
CrossRef76
Feng Qian, Edward L. Hannan, Laurent G. Glance, Charles E. Phelps, Frederick S. Ling, Peter J. Veazie. (2011) Coronary stent use in New York State in the drug-eluting stent era. Journal of Evaluation in Clinical Practiceno-no
CrossRef77
Young-Guk Ko, Dong-Min Kim, Jin Man Cho, So Yeon Choi, Jung Han Yoon, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong. (2011) Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation. The International Journal of Cardiovascular Imaging
CrossRef78
Juan Luis Gutiérrez-Chico, Evelyn Regar, Robert-Jan van Geuns, Scot Garg, Carl Schultz, Nicolas van Mieghem, Henricus Duckers, Patrick W Serruys. (2011) Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease. EuroIntervention 7:2, 274-277
CrossRef79
William A. Gray, Alan C. Yeung, Donald E. Cutlip, Jeffrey J. Popma, Peter J. Fitzgerald, David O. Williams, Hubertus Heuer, Charles D. O'Shaughnessy, Paul A. Overlie, J. Tift Mann, Louis A. Cannon, James B. Hermiller, Timothy D. Henry, Robert Whitbourn, Thomas D. Stuckey, Mark G. Midei, Jessie Coe, Lewis B. Schwartz. (2011) A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: Final results of the ZoMaxx II trial. International Journal of Cardiology
CrossRef80
Waqar H. Ahmed, Oscar A. Mendiz, Martyn R. Thomas, . (2011) Usage patterns and 1-year outcomes with the TAXUS Liberté stent: Results of the TAXUS OLYMPIA registry. Catheterization and Cardiovascular Interventions 77:7, 979-992
CrossRef81
Dong-Hyun Choi, Kyung Woo Park, Han-Mo Yang, Hae-Young Lee, Jin-Shik Park, Hyun-Jai Kang, Yong-Jin Kim, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim. (2011) Renal dysfunction and high levels of hsCRP are additively associated with hard endpoints after percutaneous coronary intervention with drug eluting stents. International Journal of Cardiology 149:2, 174-181
CrossRef82
Evren Caglayan, Marius Vantler, Olli Leppänen, Felix Gerhardt, Lenard Mustafov, Henrik ten Freyhaus, Kai Kappert, Margarete Odenthal, Wolfram H. Zimmermann, Michelle D. Tallquist, Stephan Rosenkranz. (2011) Disruption of Platelet-Derived Growth Factor–Dependent Phosphatidylinositol 3-Kinase and Phospholipase Cγ 1 Activity Abolishes Vascular Smooth Muscle Cell Proliferation and Migration and Attenuates Neointima Formation In Vivo. Journal of the American College of Cardiology 57:25, 2527-2538
CrossRef83
Shan Li, Yutang Wang, Luyue Gai, Tingshu Yang, Hongbin Liu, Zhifeng Wang, Qicai Bai, Xiuli Xu, Yundai Chen. (2011) Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12months after implantation by optical coherence tomography. International Journal of Cardiology
CrossRef84
Tarun W. Dasari, Thomas A. Hennebry, Elias B. Hanna, Jorge F. Saucedo. (2011) Drug eluting versus bare metal stents in cardiac allograft vasculopathy. Catheterization and Cardiovascular Interventions 77:7, 962-969
CrossRef85
Masato Nakamura. (2011) Review of the everolimus-eluting coronary stent system. Interventional Cardiology 3:3, 299-307
CrossRef86
Thomas Pilgrim, Lorenz Räber, Andreas Limacher, Lukas Löffel, Peter Wenaweser, Stéphane Cook, Jean-Christophe Stauffer, Mario Togni, Rolf Vogel, Ali Garachemani, Aris Moschovitis, Ahmed A. Khattab, Christian Seiler, Bernhard Meier, Peter Jüni, Stephan Windecker. (2011) Comparison of Titanium-Nitride-Oxide–Coated Stents With Zotarolimus-Eluting Stents for Coronary Revascularization. JACC: Cardiovascular Interventions 4:6, 672-682
CrossRef87
PEI-HSIU HUANG, MICHAEL YEUNG, JOHN M. LASALA, DAVID A. COX, THOMAS S. BOWMAN, RUTH M. STARZYK, KEITH D. DAWKINS. (2011) Two-Year Clinical Outcomes with Paclitaxel-Eluting Coronary Stents in Patients with Chronic Total Occlusions: Analysis from the TAXUS ARRIVE Program. Journal of Interventional Cardiology 24:3, 232-240
CrossRef88
R. Tsuburaya, S. Yasuda, T. Shiroto, Y. Ito, J. Y. Gao, K. Aizawa, Y. Kikuchi, K. Ito, J. Takahashi, H. Ishibashi-Ueda, H. Shimokawa. (2011) Long-term treatment with nifedipine suppresses coronary hyperconstricting responses and inflammatory changes induced by paclitaxel-eluting stent in pigs in vivo: possible involvement of Rho-kinase pathway. European Heart Journal
CrossRef89
M. Kollum, C. Bode. (2011) Neue Entwicklungen bei medikamentenfreisetzenden Stents. Herz 36:3, 177-189
CrossRef90
Giulio G. Stefanini, Patrick W. Serruys, Sigmund Silber, Ahmed A. Khattab, Robert J. van Geuns, Gert Richardt, Pawel E. Buszman, Henning Kelbæk, Adrianus J. van Boven, Sjoerd H. Hofma, Axel Linke, Volker Klauss, William Wijns, Carlos Macaya, Philippe Garot, Carlo Di Mario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio L. Bartorelli, Pierre Gobbens, Stephan Windecker. (2011) The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents. Journal of the American College of Cardiology 57:22, 2221-2232
CrossRef91
Lorenz Räber, Peter Jüni, Eveline Nüesch, Bindu Kalesan, Peter Wenaweser, Aris Moschovitis, Ahmed A. Khattab, Maryam Bahlo, Mario Togni, Stéphane Cook, Rolf Vogel, Christian Seiler, Bernhard Meier, Stephan Windecker. (2011) Long-Term Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents for Coronary Revascularization. Journal of the American College of Cardiology 57:21, 2143-2151
CrossRef92
Tudor Poerner, Sylvia Otto, Johannes Gassdorf, Florian Janiak, Constance Danzer, Markus Ferrari, Hans Figulla. (2011) A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods. EuroIntervention 7:K, K93-K99
CrossRef93
Werner Zimmerli, Parham Sendi. (2011) Pathogenesis of implant-associated infection: the role of the host. Seminars in Immunopathology 33:3, 295-306
CrossRef94
Ian T. Meredith, Robert Whitbourn, Douglas Scott, Seif El-Jack, Robaayah Zambahari, Gregg W. Stone, Paul S. Teirstein, Ruth M. Starzyk, Dominic J. Allocco, Keith D. Dawkins. (2011) PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses. EuroIntervention 7:1, 84-90
CrossRef95
Shengxian Tu, Peiyuan Hao, Gerhard Koning, Xianglong Wei, Xudong Song, Aihua Chen, Johan H.C. Reiber. (2011) In vivo assessment of optimal viewing angles from X-ray coronary angiography. EuroIntervention 7:1, 112-120
CrossRef96
Margo Klomp, Marcel A.M. Beijk, Jan G.P. Tijssen, Robbert J. de Winter. (2011) One-year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent. Catheterization and Cardiovascular Interventions 77:6, 809-817
CrossRef97
Laura Mauri, Martin B. Leon, Alan C. Yeung, Manuela Negoita, Michelle J. Keyes, Joseph M. Massaro. (2011) Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial). American Heart Journal 161:5, 807-814
CrossRef98
Jian Ma, Weiwei Yang, Manpreet Singh, Tianqing Peng, Ningyuan Fang, Meng Wei. (2011) Meta-analysis of long-term outcomes of drug-eluting stent implantations for chronic total coronary occlusions. Heart & Lung: The Journal of Acute and Critical Care 40:3, e32-e40
CrossRef99
Flavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, Giacomo Boccuzzi, Patrizia Presbitero, Gabriele Pesarini, Valeria Ferrero, Anna S. Ghini, Ramadan Abukaresh, Cristina Aurigemma, Leonardo De Luca, Dennis Zavalloni, Daniela Soregaroli, Paolo Marino, Roberto Garbo, Luisa Zanolla, Corrado Vassanelli. (2011) Immunosuppressive Therapy with Oral Prednisone to Prevent Restenosis after PCI. A Multicenter Randomized Trial. The American Journal of Medicine 124:5, 434-443
CrossRef100
Cheong J Lee, Mark D Morasch. (2011) Endovascular management of vertebral artery disease. Expert Review of Cardiovascular Therapy 9:5, 575-578
CrossRef101
Shuichi Hamasaki, Chuwa Tei. (2011) Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. Journal of Cardiology 57:3, 231-238
CrossRef102
Sigmund Silber, Juan Luis Gutiérrez-Chico, Steffen Behrens, Bernhard Witzenbichler, Marcus Wiemer, Stefan Hoffmann, Ton Slagboom, Darius Harald, Harry Suryapranata, Christoph Nienaber, Bernard Chevalier, Patrick Serruys. (2011) Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial. EuroIntervention 7:1, 64-73
CrossRef103
Shinsuke Nanto, Masaki Awata, Hideki Shimomura, Takatoshi Hayashi, Shinjo Sonoda, Yoshio Ohashi, Yoshihiro Iwasaki, Hitoshi Nakashima. (2011) Clinical usefulness of the Driver® stent in a retrospective, collaborative, multicenter, open-label study in Japanese real-world patients with coronary artery disease and the drug-eluting stent era. Cardiovascular Intervention and Therapeutics 26:2, 131-137
CrossRef104
Gregg W. Stone, Stephen G. Ellis, Antonio Colombo, Eberhard Grube, Jeffrey J. Popma, Takahiro Uchida, Jill S. Bleuit, Keith D. Dawkins, Mary E. Russell. (2011) Long-Term Safety and Efficacy of Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions 4:5, 530-542
CrossRef105
Roberto Martín-Reyes, Raul Moreno, Angel Sánchez-Recalde, Felipe Navarro, Juan Franco, Antonio Piñero, José Luis López Sendón. (2011) Comparison of the safety between first- and second-generation drug eluting stents. International Journal of Cardiology
CrossRef106
Toshiyuki Nagai, Masaru Shibata, Satoru Suzuki, Takashi Matsubara. (2011) The potential of surgical strategy for incomplete stent apposition after implantation of a sirolimus eluting stent. Cardiovascular Intervention and Therapeutics 26:2, 157-161
CrossRef107
Leif Thuesen. 2011. Bifurcation Lesions. , 298-311.
CrossRef108
Ajay J. Kirtane, Adriano Caixeta, Philippe Généreux, Rikesh Patel, Jeffrey W. Moses. 2011. Sirolimus and Paclitaxel Eluting Stent Clinical Studies. , 502-518.
CrossRef109
Jiro Aoki, Adriano Caixeta, George D. Dangas, Roxana Mehran. 2011. In-Stent Restenosis in the DES Era. , 442-463.
CrossRef110
Adriano Caixeta, Alexandre Abizaid, George D. Dangas, Martin B. Leon. 2011. Novel Drug Eluting Stent Systems. , 539-555.
CrossRef111
Jiayin Zhang, Minghua Li, Zhigang Lu, Jingyu Hang, Jingwei Pan, Leiqing Sun. (2011) In vivo evaluation of stent patency by 64-slice multidetector CT coronary angiography: shall we do it or not?. The International Journal of Cardiovascular Imaging
CrossRef112
David Martin, Fergal J. Boyle. (2011) Computational structural modelling of coronary stent deployment: a review. Computer Methods in Biomechanics and Biomedical Engineering 14:4, 331-348
CrossRef113
Raul Moreno, Roberto Martin-Reyes, Santiago Jimenez-Valero, Angel Sanchez-Recalde, Guillermo Galeote, Luis Calvo, Ignacio Plaza, Jose-Luis Lopez-Sendon. (2011) Determining clinical benefits of drug-eluting coronary stents according to the population risk profile: A meta-regression from 31 randomized trials. International Journal of Cardiology 148:1, 23-29
CrossRef114
Ung Kim, Doo-Il Kim, Dong-Kie Kim, Sang-Hoon Seol, Jae-Sik Jang, Tae-Hyun Yang, Dae-Kyeong Kim, Dong-Soo Kim, Ho-Ki Min, Kang-Joo Choi. (2011) Long-term clinical and angiographic outcomes of patients with sirolimus-eluting stent fracture. International Journal of Cardiology
CrossRef115
Asmir Syed, Itsik Ben-Dor, Yanlin Li, Sara Collins, Rebecca Torguson, Kohei Wakabayashi, Manuel Gonzalez, Gabriel Maluenda, Cedric Delhaye, Loic Belle, Michael Gaglia, Zhenyi Xue, Kimberly Kaneshige, Nelson Bernardo, Kenneth Kent, William Suddath, Lowell Satler, Augusto Pichard, Joseph Lindsay, Ron Waksman. (2011) Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention. EuroIntervention 6:9, 1085-1090
CrossRef116
Sigmund Silber, Stephan Windecker, Pascal Vranckx, Patrick W Serruys. (2011) Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. The Lancet 377:9773, 1241-1247
CrossRef117
TAKESHI SERIKAWA, TOMOHIRO KAWASAKI, HISASHI KOGA, YOSHIYA ORITA, SHINSUKE IKEDA, YOSHITAKA GOTO, YOSHIAKI SHINTANI, MASATAKA KAJIWARA, HIDENORI TANAKA, TAKAYA FUKUYAMA, NOBUHIKO KOGA. (2011) Late Catch-Up Phenomenon Associated with Stent Fracture after Sirolimus-Eluting Stent Implantation: Incidence and Outcome. Journal of Interventional Cardiology 24:2, 165-171
CrossRef118
Alan C. Yeung, Martin B. Leon, Ash Jain, Thaddeus R. Tolleson, Douglas J. Spriggs, Brent T. Mc Laurin, Jeffrey J. Popma, Peter J. Fitzgerald, Donald E. Cutlip, Joseph M. Massaro, Laura Mauri. (2011) Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries. Journal of the American College of Cardiology 57:17, 1778-1783
CrossRef119
Steffen Desch, Denis Schloma, Sven Möbius-Winkler, Sandra Erbs, Stephan Gielen, Axel Linke, Jiangtao Yu, Bernward Lauer, Klaus Kleinertz, Wilfried Dänschel, Gerhard Schuler, Holger Thiele. (2011) Randomized Comparison of a Polymer-Free Sirolimus-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent in Patients With Diabetes Mellitus. JACC: Cardiovascular Interventions 4:4, 452-459
CrossRef120
Yoritaka Otsuka, Nobuaki Kokubu, Yoichiro Kasahara. (2011) Usefulness of a 0.010-inch guidewire compatible balloon for crossing stent-jailed sidebranches. International Journal of Cardiology 148:2, 228-231
CrossRef121
Mariano Valdés Chavarri, Armando Bethencourt, Eduardo Pinar, Alfredo Gomez, Javier Fernández Portales, Francisco Pomar, Isabel Calvo, Jose Ramón López Minguez, Raúl Valdesuso, José Moreu, Antonio Martínez, Wail Nammas. (2011) Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry. Heart and Vessels
CrossRef122
Gregory M. Lanza, Shelton D. Caruthers, Anne H. Schmieder, Patrick M. Winter, Tillmann Cyrus, Samuel A. Wickline. 2011. Perfluorocarbon Nanoparticles: A Multidimensional Platform for Targeted Image-Guided Drug Delivery. , 725-753.
CrossRef123
Ioannis Tentzeris, Rudolf Jarai, Serdar Farhan, Johann Wojta, Martin Schillinger, Alexander Geppert, Michael Nürnberg, Gerhard Unger, Kurt Huber. (2011) Long-term outcome after drug-eluting stent implantation in comparison with bare metal stents: a single centre experience. Clinical Research in Cardiology 100:3, 191-200
CrossRef124
K. Anette Birkmeier, Adnan Kastrati, Robert A. Byrne, Heidrun Holle, Stefanie Schulz, Klaus Tiroch, Sebastian Kufner, Steffen Massberg, Karl-Ludwig Laugwitz, Albert Schömig, Julinda Mehilli. (2011) Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients. Catheterization and Cardiovascular Interventions 77:4, 494-501
CrossRef125
Teruo Okabe, Akio Kawamura, Yuichiro Maekawa, Toshihisa Anzai, Shiro Iwanaga, Tsutomu Yoshikawa, Satoshi Ogawa. (2011) Can intravascular ultrasound guidance modify the efficacy of drug-eluting stent over bare-metal stent in an aorto-ostial lesion?. Cardiovascular Revascularization Medicine 12:2, 105-110
CrossRef126
Hyun-Sook Kim, Jae-Hwan Lee, Seung-Whan Lee, Young-Hak Kim, Jae-Hyeong Park, Si-Wan Choi, Jin-Ok Jeong, In-Whan Seong, Kyoung-Suk Rhee, Jae-Ki Ko, Sang-Ho Jo, Young Jin Choi. (2011) Long-term safety and efficacy of sirolimus- vs. paclitaxel-eluting stent implantation for acute ST-elevation myocardial infarction: 3-year follow-up of the PROSIT trial. International Journal of Cardiology 147:2, 253-257
CrossRef127
Satheesh Nair, Farzin Fath-Ordoubadi, Bernard Clarke, Magdi El-Omar, James Foley, Doug G. Fraser, Vaikom S. Mahadevan, Ludwig Neyses, Raj S. Khattar, Mamas A. Mamas. (2011) Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention. EuroIntervention 6:8, 985-991
CrossRef128
Dhavalkumar Patel, Brian Walitt, Joseph Lindsay, Robert L. Wilensky. (2011) Role of Pioglitazone in the Prevention of Restenosis and Need for Revascularization After Bare-Metal Stent Implantation. JACC: Cardiovascular Interventions 4:3, 353-360
CrossRef129
Geraud Souteyrand, Sebastien Levesque, Lemlih Ouchchane, Laurent Sarry, Romain Eschalier, Jean-René Lusson, Pascal Motreff. (2011) Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography. Archives of Cardiovascular Diseases 104:3, 147-154
CrossRef130
Cheong J. Lee, Mark D. Morasch. (2011) Treatment of Vertebral Disease: Appropriate Use of Open and Endovascular Techniques. Seminars in Vascular Surgery 24:1, 24-30
CrossRef131
David M. Martin, Fergal J. Boyle. (2011) Drug-eluting stents for coronary artery disease: A review. Medical Engineering & Physics 33:2, 148-163
CrossRef132
Sandhir B. Prasad, Thomas David, Yuvaraj Malaiapan, James D. Cameron, Ian T. Meredith. (2011) Selective drug-eluting stent implantation for high-risk patients with acute ST-elevation myocardial infarction: Rationale and safety. Catheterization and Cardiovascular Interventions 77:2, 193-200
CrossRef133
Satoko Tahara, Daniel Chamié, Motaz Baibars, Chadi Alraies, Marco Costa. (2011) Optical coherence tomography endpoints in stent clinical investigations: strut coverage. The International Journal of Cardiovascular Imaging 27:2, 271-287
CrossRef134
Takamitsu Nakamura, Brigitta C. Brott, Irena Brants, Deepal Panchal, Jinsheng Li, Jack P. Chen, Spencer B. King, Nicolas Chronos, Dongming Hou. (2011) Vasomotor Function After Paclitaxel-Coated Balloon Post-Dilation in Porcine Coronary Stent Model. JACC: Cardiovascular Interventions 4:2, 247-255
CrossRef135
David M. Charytan, Manu R. Varma, Treacy S. Silbaugh, Ann F. Lovett, Sharon-Lise T. Normand, Laura Mauri. (2011) Long-term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients With Severely Reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. American Journal of Kidney Diseases 57:2, 202-211
CrossRef136
PASI P. KARJALAINEN, ANTTI YLITALO, JUHANI KE AIRAKSINEN, WAIL NAMMAS. (2011) Five-Year Clinical Outcome of Titanium-Nitride-Oxide-Coated Bioactive Stent Implantation in a Real-World Population: A Comparison with Paclitaxel-eluting Stents: The PORI Registry. Journal of Interventional Cardiology 24:1, 1-8
CrossRef137
Shengxian Tu, Niels R. Holm, Gerhard Koning, Zheng Huang, Johan H. C. Reiber. (2011) Fusion of 3D QCA and IVUS/OCT. The International Journal of Cardiovascular Imaging 27:2, 197-207
CrossRef138
Sang Min Park, Jong-Youn Kim, Bum-Kee Hong, Byoung Kwon Lee, Pil-Ki Min, Sejoong Rim, Hee-Sun Mun, Sung Woo Kwon, Sung-Joo Lee, Jong Kwan Park, Hyuck Moon Kwon. (2011) Predictors of stent fracture in patients treated with closed-cell design stents. Coronary Artery Disease 22:1, 40-44
CrossRef139
Yu Kataoka, Nobuhito Yagi, Nobuaki Kokubu, Yoichiro Kasahara, Mitsuru Abe, Yoritaka Otsuka. (2011) Efficacy of Paclitaxel-Eluting Stent in Patients With Impaired Glucose Tolerance. Circulation Journal 75:4, 868-873
CrossRef140
Marcus Wiemer, Andreas König, Johannes Rieber, Hae-Young Sohn, Marcus Leibig, Karl Theisen, Volker Klauss, Christoph Langer, Oliver Lindner, Dieter Horstkotte, Thomas Schiele. (2011) Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial. EuroIntervention 6:6, 687-694
CrossRef141
Young-June Yang, Mihyun Kim, Choongki Kim, Junbeom Park, Jaewon Oh, Hoyoun Won, Byeong-Keuk Kim, Myeong-Ki Hong. (2011) Late Stent Thrombosis After Drug-Eluting Stent Implantation: A Rare Case of Accelerated Neo-Atherosclerosis and Early Manifestation of Neointimal Rupture. Korean Circulation Journal 41:7, 409
CrossRef142
Yajun Wang, Leticia Hosta-Rigau, Hannah Lomas, Frank Caruso. (2011) Nanostructured polymer assemblies formed at interfaces: applications from immobilization and encapsulation to stimuli-responsive release. Physical Chemistry Chemical Physics 13:11, 4782
CrossRef143
S. Garg, M. Magro, P.W. Serruys. 2011. Drug-Eluting Stents. , 427-448.
CrossRef144
John A. Ormiston, Mark A. Turco, Jack J. Hall, Louis A. Cannon, Steven J. Yakubov, Michael J. Lucca, Gregg W. Stone, Charles D. O'Shaughnessy, Joseph A. Kozina, Ian C. Gilchrist, Barry D. Bertolet, Stephen G. Worthley, Paul L. Underwood, Keith D. Dawkins. (2011) Long-Term Benefit of the TAXUS Liberté Stent in Small Vessels and Long Lesions. Circulation Journal 75:5, 1120-1129
CrossRef145
Kazushige Kadota, Toshiya Muramatsu, Masashi Iwabuchi, Shigeru Saito, Yasuhiko Hayashi, Yuji Ikari, Shinsuke Nanto, Kenshi Fujii, Naoto Inoue, Atsuo Namiki, Takeshi Kimura, Kazuaki Mitsudo. (2011) Randomized comparison of the nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef146
Gaku Nakazawa, Aloke V. Finn, Marc Vorpahl, Elena R. Ladich, Frank D. Kolodgie, Renu Virmani. (2011) Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents. Journal of the American College of Cardiology 57:4, 390-398
CrossRef147
Niklas Millauer, Peter Jüni, Alexandra Hofmann, Simon Wandel, Anupham Bhambhani, Michael Billinger, Niklaus Urwyler, Peter Wenaweser, Gerrit Hellige, Lorenz Räber, Stéphane Cook, Rolf Vogel, Mario Togni, Christian Seiler, Bernhard Meier, Stephan Windecker. (2011) Sirolimus versus paclitaxel coronary stents in clinical practice. Catheterization and Cardiovascular Interventions 77:1, 5-12
CrossRef148
Ki Hong Lee, Youngkeun Ahn, Nam Sik Yoon, Hyun Ju Yoon, Young Joon Hong, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, Myung Ho Jeong, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang. (2011) Are Drug-Eluting Stents Safer and More Effective Than Bare-Metal Stents in Patients With Acute Myocardial Infarction?. International Heart Journal 52:2, 78-83
CrossRef149
Ung Kim, Sang-Hoon Seol, Doo-Il Kim, Dong-Kie Kim, Jae-Sik Jang, Tae-Hyun Yang, Dae-Kyeong Kim, Dong-Soo Kim, Ho-Ki Min, Kang-Ju Choi. (2011) Clinical Outcomes and the Risk Factors of Coronary Artery Aneurysms That Developed After Drug-Eluting Stent Implantation. Circulation Journal 75:4, 861-867
CrossRef150
Doo Sun Sim, Myung Ho Jeong, Youngkeun Ahn, Young Jo Kim, Shung Chull Chae, Taek Jong Hong, In Whan Seong, Jei Keon Chae, Chong Jin Kim, Myeong Chan Cho, Ki Bae Seung, Seung Jung Park, . (2011) Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction. Journal of Korean Medical Science 26:4, 521
CrossRef151
Takashi Kuwano, Shin-ichiro Miura, Kazuyuki Shirai, Amane Ike, Ken Mori, Tomohiko Shimizu, Bo Zhang, Atsushi Iwata, Hiroaki Nishikawa, Akira Kawamura, Keijiro Saku. (2011) Serum Levels of Bilirubin as an Independent Predictor of Coronary In-Stent Restenosis: A New Look at an Old Molecule. Journal of Atherosclerosis and Thrombosis 18:7, 574-583
CrossRef152
Xavier Freixa, Ali S. Almasood, Sohail Q. Khan, Rodrigo Wainstein, Azriel Osherov, Karen Mackie, Peter H. Seidelin, Vladimír Džavík. (2011) Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: Results of long-term follow-up. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef153
Antonio Curcio, Daniele Torella, Ciro Indolfi. (2011) Mechanisms of Smooth Muscle Cell Proliferation and Endothelial Regeneration After Vascular Injury and Stenting. Circulation Journal 75:6, 1287-1296
CrossRef154
Sripal Bangalore, Helen A. Vlachos, Faith Selzer, Robert L. Wilensky, Kevin E. Kip, David O. Williams, David P. Faxon. (2011) Percutaneous coronary intervention of moderate to severe calcified coronary lesions: Insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheterization and Cardiovascular Interventions 77:1, 22-28
CrossRef155
Takenori Okada, Hideya Yamamoto, Tomokazu Okimoto, Masaya Otsuka, Ken Ishibashi, Yoshihiro Dohi, Takashi Fujii, Futoshi Tadehara, Satoshi Kurisu, Yasuhiko Hayashi, Yasuki Kihara, Coronary Atherosclerosis Reduction. (2011) Beneficial Effects of Valsartan on Target Lesion Revascularization After Percutaneous Coronary Interventions With Bare-Metal Stents. Circulation Journal 75:7, 1641-1648
CrossRef156
Thomas A. Will, Anthony J. Polcari, Julia G. Garcia, Michael K. Ouwenga, Bryan B. Voelzke, Howard P. Greisler, Thomas M.T. Turk. (2011) Paclitaxel Inhibits Ureteral Smooth Muscle Cell Proliferation and Collagen Production in the Absence of Cell Toxicity. The Journal of Urology 185:1, 335-340
CrossRef157
X ZHAO. 2011. Bioactive materials in drug delivery systems. , 247-265.
CrossRef158
Eric M. Saurer, Dai Yamanouchi, Bo Liu, David M. Lynn. (2011) Delivery of plasmid DNA to vascular tissue in vivo using catheter balloons coated with polyelectrolyte multilayers. Biomaterials 32:2, 610-618
CrossRef159
Chi-Ling Hang, Bor-Tsung Hsieh, Chiung-Jen Wu, Hon-Kan Yip, Cheng-Hsu Yang, Shyh-Ming Chen, Yuan-Kai Hsieh, Morgan Fu, Sarah Chua, Gary Bih-Fang Guo, Stephen Wan Leung. (2011) Six-Year Clinical Follow-up After Treatment of Diffuse In-Stent Restenosis With Cutting Balloon Angioplasty Followed by Intracoronary Brachytherapy With Liquid Rhenium-188-Filled Balloon via Transradial Approach. Circulation Journal 75:1, 113-120
CrossRef160
Tetsuya Amano, Tatsuaki Matsubara, Tadayuki Uetani, Masataka Kato, Bunichi Kato, Tomohiro Yoshida, Ken Harada, Soichiro Kumagai, Ayako Kunimura, Yusaku Shinbo, Hideki Ishii, Toyoaki Murohara. (2011) Lipid-Rich Plaques Predict Non-Target-Lesion Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention. Circulation Journal 75:1, 157-166
CrossRef161
Gennaro Sardella, Giulia Conti, Teodoro Bisceglia, Emanuele Canali, Massimo Mancone, Carlotta De Carlo, Leonardo Spedicato, Giorgio Morocutti, Francesco Fedele, Guglielmo Bernardi. (2011) Long-term outcome after drug-eluting stent implantation in unselected population: ROME and UDINE Experience (The RUDI Registry). Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef162
Eun Hui Bae, Sang Yup Lim, Young Hwan Choi, Sang Heon Suh, Kyung Hoon Cho, Joon Seok Choi, Chang Seong Kim, Jeong Woo Park, Seong Kwon Ma, Myung Ho Jeong, Soo Wan Kim, Korea Acute Myocardial Infarction R. (2011) Drug-Eluting vs. Bare-Metal Stents for Treatment of Acute Myocardial Infarction With Renal Insufficiency. Circulation Journal
CrossRef163
John Fani Srour, Gerald W. Smetana. (2011) Triple therapy in hospitalized patients: Facts and controversies. Journal of Hospital Medicinen/a-n/a
CrossRef164
Kenneth Tandjung, Mounir W.Z. Basalus, Esther Muurman, Hans W. Louwerenburg, K. Gert van Houwelingen, Martin G. Stoel, Frits H.A.F. de Man, Hanneke Jansen, Jennifer Huisman, Gerard C.M. Linssen, Herman T. Droste, Mark B. Nienhuis, Clemens von Birgelen. (2011) Incidence of periprocedural myocardial infarction following stent implantation: Comparison between first and second generation drug-eluting stents. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef165
Alfredo E. Rodriguez, Alfredo M. Rodriguez-Granillo, David Antoniucci, Juan Mieres, Carlos Fernandez-Pereira, Gaston A. Rodriguez-Granillo, Omar Santaera MD, Bibiana Rubilar MD, Igor F. Palacios, Patrick W. Serruys, . (2011) Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: Three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef166
Makito Ozawa, Atsunori Okamura, Motoo Date, Yoshiharu Higuchi, Hiroyuki Nagai, Masahiko Shibuya, Kimura Ryusuke, Koichi Inoue, Yasushi Koyama, Katsuomi Iwakura, Kenshi Fujii. (2011) Third in-stent restenosis in sirolimus eluting stents. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef167
Kentaro Ejiri, Masaharu Ishihara, Kazuoki Dai, Takashi Miki, Ichiro Inoue, Takuji Kawagoe, Yuji Shimatani, Fumiharu Miura, Yasuharu Nakama, Takayuki Otani, Hiroki Ikenaga, Nozomu Oda, Masayuki Nakamura. (2011) Three-Year Follow-up of Sirolimus-Eluting Stents vs. Bare Metal Stents for Acute Myocardial Infarction. Circulation Journal
CrossRef168
Lisa Fleming. (2011) Frequency and impact of bleeding in elective coronary stent clinical trials - utility of three commonly used definitions. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef169
Michael Maeng, Niels Ramsing Holm, Anne Kaltoft, Lisette Okkels Jensen, Hans-Henrik Tilsted, Leif Thuesen, Jens Flensted Lassen. (2010) Zotarolimus-eluting versus sirolimus-eluting coronary stent implantation. Interventional Cardiology 2:6, 807-812
CrossRef170
Ghada W. Mikhail, Robert T. Gerber, David A. Cox, Stephen G. Ellis, John M. Lasala, John A. Ormiston, Gregg W. Stone, Mark A. Turco, Anita A. Joshi, Donald S. Baim, Antonio Colombo. (2010) Influence of Sex on Long-Term Outcomes After Percutaneous Coronary Intervention With the Paclitaxel-Eluting Coronary Stent. JACC: Cardiovascular Interventions 3:12, 1250-1259
CrossRef171
Ahmed Abdel-Latif, Debabrata Mukherjee, Paymon Mesgarzadeh, Khaled M. Ziada. (2010) Drug-eluting stents in patients with end-stage renal disease: Meta-analysis and systematic review of the literature. Catheterization and Cardiovascular Interventions 76:7, 942-948
CrossRef172
Carlos Macaya. (2010) Nuevos avances en cardiología intervencionista. Clínica e Investigación en Arteriosclerosis 22, 42-47
CrossRef173
Laura Mauri, Dean J. Kereiakes, Sharon-Lise T. Normand, Stephen D. Wiviott, David J. Cohen, David R. Holmes, Sripal Bangalore, Donald E. Cutlip, Michael Pencina, Joseph M. Massaro. (2010) Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. American Heart Journal 160:6, 1035-1041.e1
CrossRef174
Subroto Acharjee, Christopher P. Cannon. (2010) Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug-eluting Stents. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 9:4, 203-206
CrossRef175
Adriano Caixeta, Alexandra J. Lansky, Patrick W. Serruys, James B. Hermiller, Peter Ruygrok, Yoshinobu Onuma, Paul Gordon, Manejeh Yaqub, Karine Miquel-Hebert, Susan Veldhof, Poornima Sood, Xiaolu Su, Lalitha Jonnavithula, Krishnankutty Sudhir, Gregg W. Stone. (2010) Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions 3:12, 1220-1228
CrossRef176
Laura Mauri, Joseph M. Massaro, Songtao Jiang, Ian Meredith, William Wijns, Jean Fajadet, David E. Kandzari, Martin B. Leon, Donald E. Cutlip, Kweli P. Thompson. (2010) Long-Term Clinical Outcomes With Zotarolimus-Eluting Versus Bare-Metal Coronary Stents. JACC: Cardiovascular Interventions 3:12, 1240-1249
CrossRef177
Saami Yazdani, Masataka Nakano, Fumiyuki Otsuka, Frank Kolodgie, Renu Virmani. (2010) Atheroma and coronary bifurcations: before and after stenting. EuroIntervention 6:J, J24-J30
CrossRef178
Nicole Soucy, Julia Feygin, Radhika Tunstall, Melissa Casey, Douglas Pennington, Barbara Huibregtse, James Barry. (2010) Strut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating. EuroIntervention 6:5, 630-637
CrossRef179
Erick D. McNair, Calvin R. Wells, A. Mabood Qureshi, Rashpal Basran, Colin Pearce, Jason Orvold, Jacobus Devilliers, Kailash Prasad. (2010) Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictor of Restenosis Following Percutaneous Coronary Intervention. Clinical Cardiology 33:11, 678-685
CrossRef180
Jin M. Cheng, Yoshinobu Onuma, Nicolo Piazza, Rutger-Jan M. Nuis, Ron T. Van Domburg, Patrick W. Serruys. (2010) Comparison of Five-Year Outcome of Octogenarians Undergoing Percutaneous Coronary Intervention With Drug-Eluting Versus Bare-Metal Stents (from the RESEARCH and T-SEARCH Registries). The American Journal of Cardiology 106:10, 1376-1381
CrossRef181
Jean Fajadet, William Wijns, Gert-Jan Laarman, Karl-Heinz Kuck, John Ormiston, Stephan Baldus, Karl Hauptmann, Maarten Suttorp, Janusz Drzewiecki, Michael Pieper, Heinz-Peter Schultheiss, Laura Mauri. (2010) Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study. EuroIntervention 6:5, 562-567
CrossRef182
Olivio F. Donati, Matthias C. Burg, Lotus Desbiolles, Christoph Karlo, Paul Stolzmann, Alexander Bunck, Stephan Baumueller, Borut Marincek, Harald Seifarth, Hatem Alkadhi, Sebastian Leschka, David Maintz. (2010) High-Pitch 128-Slice Dual-Source CT for the Assessment of Coronary Stents in a Phantom Model. Academic Radiology 17:11, 1366-1374
CrossRef183
George D. Dangas, Bimmer E. Claessen, Adriano Caixeta, Elias A. Sanidas, Gary S. Mintz, Roxana Mehran. (2010) In-Stent Restenosis in the Drug-Eluting Stent Era. Journal of the American College of Cardiology 56:23, 1897-1907
CrossRef184
, , W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M. F. Piepoli, C. Pirlet, J. L. Pomar, N. Reifart, F. L. Ribichini, M. J. Schalij, P. Sergeant, P. W. Serruys, S. Silber, M. Sousa Uva, D. Taggart, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. E. Vardas, P. Widimsky, , P. Kolh, O. Alfieri, J. Dunning, S. Elia, P. Kappetein, U. Lockowandt, G. Sarris, P. Vouhe, , P. Kearney, L. von Segesser, S. Agewall, A. Aladashvili, D. Alexopoulos, M. J. Antunes, E. Atalar, A. Brutel de la Riviere, A. Doganov, J. Eha, J. Fajadet, R. Ferreira, J. Garot, J. Halcox, Y. Hasin, S. Janssens, K. Kervinen, G. Laufer, V. Legrand, S. A. M. Nashef, F.-J. Neumann, K. Niemela, P. Nihoyannopoulos, M. Noc, J. J. Piek, J. Pirk, Y. Rozenman, M. Sabate, R. Starc, M. Thielmann, D. J. Wheatley, S. Windecker, M. Zembala. (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 31:20, 2501-2555
CrossRef185
Maria Alexandra Rodriguez, David L Fischman, Michael P Savage. (2010) Advances in vein graft intervention. Interventional Cardiology 2:5, 735-754
CrossRef186
Zuzana Motovska, Jiri Knot, Petr Widimsky. (2010) REVIEW: Stent Thrombosis-Risk Assessment and Prevention. Cardiovascular Therapeutics 28:5, e92-e100
CrossRef187
John J. Lopez, Michelle J. Keyes, Sandeep Nathan, Robert Piana, Michael Pencina, Gaurav Dhar, Steven Marso, Sunil Rao, Salim Shammo, Walt Marquardt, David J. Cohen, Neal S. Kleiman. (2010) Rapid adoption of drug-eluting stents: Clinical practices and outcomes from the early drug-eluting stent era. American Heart Journal 160:4, 767-774.e1
CrossRef188
Duk-Woo Park, Young-Hak Kim, Sung-Cheol Yun, Soo-Jin Kang, Seung-Whan Lee, Cheol-Whan Lee, Seong-Wook Park, In-Whan Seong, Jae-Hwan Lee, Seung-Jea Tahk, Myung-Ho Jeong, Yangsoo Jang, Sang-Sig Cheong, Joo-Young Yang, Do-Sun Lim, Ki-Bae Seung, Jei-Keon Chae, Seung-Ho Hur, Sang-Gon Lee, Junghan Yoon, Nae-Hee Lee, Young-Jin Choi, Hyun-Sook Kim, Kee-Sik Kim, Hyo-Soo Kim, Taeg-Jong Hong, Hun-Sik Park, Seung-Jung Park. (2010) Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization. Journal of the American College of Cardiology 56:15, 1187-1195
CrossRef189
Bimmer E Claessen, Adriano Caixeta, José PS Henriques, Jan J Piek. (2010) Current status of the Xience V ® everolimus-eluting coronary stent system. Expert Review of Cardiovascular Therapy 8:10, 1363-1374
CrossRef190
Alisa L. Becker, Angus P. R. Johnston, Frank Caruso. (2010) Layer-By-Layer-Assembled Capsules and Films for Therapeutic Delivery. Small 6:17, n/a-n/a
CrossRef191
Pasi P. Karjalainen, Antti-Pekka Annala, Antti Ylitalo, Tero Vahlberg, K.E. Juhani Airaksinen. (2010) Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. International Journal of Cardiology 144:1, 42-46
CrossRef192
Hiroki Ito, James B Hermiller. (2010) Percutaneous coronary intervention for small-vessel coronary disease: highlight on the everolimus-eluting stent. Expert Review of Cardiovascular Therapy 8:9, 1239-1245
CrossRef193
Pasi P Karjalainen, Antti Ylitalo, Juhani KE Airaksinen, Wail Nammas. (2010) Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new horizon for coronary intervention. Expert Review of Medical Devices 7:5, 599-604
CrossRef194
Srinivas Iyengar, LeRoy E Rabbani. (2010) Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction: Drug-Eluting Stents or Bare Metal Stents?. American Journal of Therapeutics 17:5, 516-522
CrossRef195
Robert Applegate, James Hermiller, Mark Sanz, Julie Doostzadeh, Wesley Pierson, Xiaolu Su, Alexandra Lansky, Krishnankutty Sudhir, Gregg Stone. (2010) Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention 6:4, 437-446
CrossRef196
Nathan D Lambert, Robert J Applegate. (2010) The comparative safety of bare-metal and drug-eluting intracoronary stents. Expert Review of Medical Devices 7:5, 611-624
CrossRef197
Tamir Bental, Abid Assali, Hana Vaknin-Assa, Eli I. Lev, David Brosh, Shmuel Fuchs, Alexander Battler, Ran Kornowski. (2010) A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheterization and Cardiovascular Interventions 76:3, 374-380
CrossRef198
Ronald J. Krone, Sunil V. Rao, David Dai, H. Vernon Anderson, Eric D. Peterson, Michael A. Brown, Ralph G. Brindis, Lloyd W. Klein, Richard E. Shaw, William S. Weintraub. (2010) Acceptance, Panic, and Partial Recovery. JACC: Cardiovascular Interventions 3:9, 902-910
CrossRef199
Victor Novack, Michael C. Nguyen, Meredith Rooney, Riya Chacko, Lena Novack, Michael Pencina, Patricia Apruzzese, Laura Mauri, Sidney A. Cohen, Jeffrey Moses, Martin B. Leon, Donald E. Cutlip. (2010) Effect of Coronary Target Lesion Revascularization on Late Cardiac Events After Insertion of Sirolimus-Eluting or Bare Metal Stents. The American Journal of Cardiology 106:6, 774-779
CrossRef200
Elvin Kedhi, Gregg W Stone. (2010) Everolimus-eluting stents: insights from the SPIRIT IV and COMPARE trials. Expert Review of Cardiovascular Therapy 8:9, 1207-1210
CrossRef201
Anne Kaltoft, Henning Kelbæk, Leif Thuesen, Jens Flensted Lassen, Peter Clemmensen, Lene Kløvgaard, Thomas Engstrøm, Hans E. Bøtker, Kari Saunamäki, Lars R. Krusell, Erik Jørgensen, Hans-Henrik Tilsted, Evald H. Christiansen, Jan Ravkilde, Lars Køber, Klaus F. Kofoed, Christian J. Terkelsen, Steffen Helqvist. (2010) Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology 56:8, 641-645
CrossRef202
Inder M. Singh, Steven J. Filby, Fredy El Sakr, Eiran Z. Gorodeski, A. Michael Lincoff, Stephen G. Ellis, Mehdi H. Shishehbor. (2010) Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis. Catheterization and Cardiovascular Interventions 76:2, 257-262
CrossRef203
Michael S. Lee, Patrick P. Hu, Joseph Aragon, Atman Shah, Ravi Bhatia, Nathaniel Jones, William Penny, William French, Jonathan Tobis, Ehtisham Mahmud. (2010) Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: A multicenter Southern Californian Registry. Catheterization and Cardiovascular Interventions 76:2, 272-278
CrossRef204
Yoshihisa Nakagawa, Takeshi Kimura, Takeshi Morimoto, Masanori Nomura, Keijiro Saku, Seiichi Haruta, Toshiya Muramatsu, Masakiyo Nobuyoshi, Kazushige Kadota, Hiroshi Fujita, Ryozo Tatami, Nobuo Shiode, Hideo Nishikawa, Yoshisato Shibata, Shunichi Miyazaki, Yoshiharu Murata, Takashi Honda, Tomohiro Kawasaki, Osamu Doi, Yoshikazu Hiasa, Yasuhiko Hayashi, Masunori Matsuzaki, Kazuaki Mitsudo. (2010) Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry). The American Journal of Cardiology 106:3, 329-336
CrossRef205
Clare E. Appleby, Karen Mackie, Vladimír Džavík, Joan Ivanov. (2010) Late outcomes following percutaneous coronary interventions: Results from a large, observational registry. Canadian Journal of Cardiology 26:7, e218-e224
CrossRef206
Yukio Ozaki, Pedro Lemos, Tetsu Yamaguchi, Takahiko Suzuki, Masato Nakamura, Tevfik Ismail, Michihiko Kitayama, Hideo Nishikawa, Osamu Kato, Patrick Serruys. (2010) A quantitative coronary angiography-matched comparison between a prospective randomised multicentre cutting balloon angioplasty and bare metal stent trial (REDUCE III) and the Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESEARCH) study. EuroIntervention 6:3, 400-406
CrossRef207
Giuseppe Luca, Rosario Sauro, Attilio Varricchio, Michele Capasso, Tonino Lanzillo, Fiore Manganelli, Ciro Mariello, Francesco Siano, Giannignazio Carbone, Maria Rosaria Pagliuca, Giuseppe Rosato, Emilio Lorenzo. (2010) Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors and BMS or DES. Journal of Thrombosis and Thrombolysis 30:2, 133-141
CrossRef208
Shengxian Tu, Zheng Huang, Gerhard Koning, Kai Cui, Johan H.C. Reiber. (2010) A novel three-dimensional quantitative coronary angiography system: In-vivo comparison with intravascular ultrasound for assessing arterial segment length. Catheterization and Cardiovascular Interventions 76:2, 291-298
CrossRef209
Scot Garg, Patrick W. Serruys. (2010) Coronary Stents. Journal of the American College of Cardiology 56:10, S1-S42
CrossRef210
Alfredo E Rodriguez, Agustina Rodriguez-Granillo. (2010) Stent selection in patients with acute coronary syndromes and unstable coronary lesions. Interventional Cardiology 2:4, 545-557
CrossRef211
Scot Garg, Patrick W. Serruys. (2010) Coronary Stents. Journal of the American College of Cardiology 56:10, S43-S78
CrossRef212
Raúl Valdesuso, Pasi Karjalainen, Joan García, José Díaz, Javier Fernández Portales, Mónica Masotti, Francisco Picó, Antonio Serra, José Moreu Burgos, Luis Insa, Fina Mauri, Javier Rodriguez Collado, Wail Nammas. (2010) The EXTREME registry: Titanium-nitride-oxide coated stents in small coronary arteries. Catheterization and Cardiovascular Interventions 76:2, 281-287
CrossRef213
Hui-li Gan, Jian-qun Zhang, Fangjong Huang, Cheng-xiong Gu, Qing-yu Kong, Xiong-rong Cao, Ping Bo, Chun-Shang Lu. (2010) Prognosis of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafts for Ostial Right Coronary Lesions in Propensity-Matched Individuals. Cardiovascular Therapeuticsno-no
CrossRef214
Giuseppe Biondi-Zoccai, Claudio Moretti, Antonio Abbate, Imad Sheiban. (2010) Percutaneous coronary intervention for small vessel coronary artery disease. Cardiovascular Revascularization Medicine 11:3, 189-198
CrossRef215
Dean J. Kereiakes, Louis A. Cannon, Robert L. Feldman, Jeffrey J. Popma, Raymond Magorien, Robert Whitbourn, Ira M. Dauber, Abram C. Rabinowitz, Michael W. Ball, Barry Bertolet, Ameer Kabour, Michael C. Foster, John C. Wang, Paul Underwood, Keith D. Dawkins. (2010) Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent. Journal of the American College of Cardiology 56:4, 264-271
CrossRef216
Sung-Gwon Kang, Se Chul Lee, Seong Hoon Choi, Sangsoo Park, Seok Jeong, Don Haeng Lee, Mina Kim. (2010) Paclitaxel-polyurethane film for anti-cancer drug delivery: Film characterization and preliminary in vivo study. Macromolecular Research 18:7, 680-685
CrossRef217
David E Kandzari. (2010) Development and performance of the zotarolimus-eluting Endeavor ® coronary stent. Expert Review of Medical Devices 7:4, 449-459
CrossRef218
Jael Z. Atary, Bas L. van der Hoeven, Su San Liem, J. Wouter Jukema, Johanna G. van der Bom, Douwe E. Atsma, Marianne Bootsma, Katja Zeppenfeld, Ernst E. van der Wall, Martin J. Schalij. (2010) Three-Year Outcome of Sirolimus-Eluting Versus Bare-Metal Stents for the Treatment of ST-Segment Elevation Myocardial Infarction (from the MISSION! Intervention Study). The American Journal of Cardiology 106:1, 4-12
CrossRef219
Cihan Simsek, Yoshinobu Onuma, Michael Magro, Sanneke de Boer, Linda Battes, Ron T. van Domburg, Eric Boersma, Patrick W. Serruys. (2010) Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Catheterization and Cardiovascular Interventions 76:1, 41-49
CrossRef220
Tingfei Xi, Runlin Gao, Bo Xu, Liang Chen, Tong Luo, Jing Liu, Yan Wei, Shengping Zhong. (2010) In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents. Biomaterials 31:19, 5151-5158
CrossRef221
Tomomi Koizumi, Peter J. Fitzgerald, Yasuhiro Honda, Stephen G. Ellis, Kenneth Kent, Steven L. Martin, Charles L. Brown, A.R. Zaki Masud, John B. Patterson, Joel Greenberg, Mark Friedman, Takahiro Uchida, Gregg W. Stone. (2010) Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR Trial. Cardiovascular Revascularization Medicine 11:3, 140-148
CrossRef222
Ronald J. Krone. (2010) Selection of Patients for Drug-Eluting Stents Based on Insurance Coverage. JACC: Cardiovascular Interventions 3:7, 780-782
CrossRef223
K. Enomoto, T. Hasebe, R. Asakawa, A. Kamijo, Y. Yoshimoto, T. Suzuki, K. Takahashi, A. Hotta. (2010) Controlling the drug release rate from biocompatible polymers with micro-patterned diamond-like carbon (DLC) coating. Diamond and Related Materials 19:7-9, 806-813
CrossRef224
Nazario Carrabba, Joanne D. Schuijf, Fleur R. Graaf, Guido Parodi, Erica Maffei, Renato Valenti, Alessandro Palumbo, Annick C. Weustink, Nico R. Mollet, Gabriele Accetta, Filippo Cademartiri, David Antoniucci, Jeroen J. Bax. (2010) Diagnostic accuracy of 64-slice computed tomography coronary angiography for the detection of in-stent restenosis: A meta-analysis. Journal of Nuclear Cardiology 17:3, 470-478
CrossRef225
Niels Grabow, David P. Martin, Klaus-Peter Schmitz, Katrin Sternberg. (2010) Absorbable polymer stent technologies for vascular regeneration. Journal of Chemical Technology & Biotechnology 85:6, 744-751
CrossRef226
Johann Auer, Alexander Leitner, Robert Berent, Gudrun Lamm, Elisabeth Lassnig, Gerald Krennmair. (2010) Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation. Atherosclerosis 210:2, 503-509
CrossRef227
BEATRIZ VAQUERIZO, ANTONIO SERRA, FAUSTINO MIRANDA, JOSÉ LUIS TRIANO, GILBERTO SIERRA, GUILLERMO DELGADO, ANGEL PUENTES, SERGI MOJAL, JORDI BRUGERA. (2010) Aggressive Plaque Modification with Rotational Atherectomy and/or Cutting Balloon before Drug-Eluting Stent Implantation for the Treatment of Calcified Coronary Lesions. Journal of Interventional Cardiology 23:3, 240-248
CrossRef228
Hee-Hwa Ho, Vincent Pong, Chung-Wah Siu, Man-Hong Jim, Raymond Miu, Kai-Hang Yiu, Ryan Ko, Hung-Fat Tse, On-Hing Kwok, Wing-Hing Chow. (2010) Long-term Clinical Outcomes of Drug-Eluting Stents Vs Bare-Metal Stents in Chinese Patients. Clinical Cardiology 33:6, E22-E29
CrossRef229
NICK MEZILIS, PETROS DARDAS, VLASIS NINIOS, DIMITRIOS TSIKADERIS. (2010) Rotablation in the Drug Eluting Era: Immediate and Long-Term Results from a Single Center Experience. Journal of Interventional Cardiology 23:3, 249-253
CrossRef230
Ung Kim, Dong-Kie Kim, Sang-Hoon Seol, Tae-Hyun Yang, Dae-Kyung Kim, Doo-Il Kim, Dong-Soo Kim, Sang-Hee Lee, Geu-Ru Hong, Jong-Seon Park, Dong-Gu Shin, Young-Jo Kim, Yoon-Kyung Cho, Hyung-Seop Kim, Chang-Wook Nam, Seung-Ho Hur, Kwon-Bae Kim. (2010) Clinical and Angiographic Outcomes of Drug-Eluting Stents in Patients With Large Vessel and Single Coronary Artery Lesion. Clinical Cardiology 33:6, 340-344
CrossRef231
Eyal Afergan, Meital Ben David, Hila Epstein, Nickolay Koroukhov, Dalia Gilhar, Keren Rohekar, Haim D. Danenberg, Gershon Golomb. (2010) Liposomal Simvastatin Attenuates Neointimal Hyperplasia in Rats. The AAPS Journal 12:2, 181-187
CrossRef232
Zachary M. Gertz, Robert L. Wilensky. (2010) Local Drug Delivery for Treatment of Coronary and Peripheral Artery Disease. Cardiovascular Therapeuticsno-no
CrossRef233
Janette Greenhalgh, Juliet Hockenhull, Naveen Rao, Yenal Dundar, Rumona C Dickson, Adrian Bagust, Janette Greenhalgh. 2010. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. .
CrossRef234
Xacobe Flores-Ríos, Juan P. Abugattás-de Torres, Rosa Campo-Pérez, Pablo Piñón-Esteban, Guillermo Aldama-López, Jorge Salgado-Fernández, Ramón Calviño-Santos, José M. Vázquez- Rodríguez, Nicolás Vázquez-González, Alfonso Castro-Beiras. (2010) Influencia de la trombosis del stent en la relación riesgo-beneficio de los stents farmacoactivos y los stents convencionales. Revista Española de Cardiología 63:5, 528-535
CrossRef235
Mike Seddon, Nick Curzen. (2010) CORONARY REVASCULARISATION IN CHRONIC KIDNEY DISEASE PART 1: STABLE CORONARY ARTERY DISEASE. Journal of Renal Care 36, 106-117
CrossRef236
Byeong-Keuk Kim, Dong Whan Kim, Seungjin Oh, Se-Jung Yoon, Sungha Park, Dong Woon Jeon, Joo Young Yang. (2010) Impact of the attainment of current recommended low-density lipoprotein cholesterol goal of less than 70 mg/dl on clinical outcomes in very high-risk patients treated with drug-eluting stents. Coronary Artery Disease 21:3, 182-188
CrossRef237
Cheol Whan Lee, Su-Jin Kang, Duk-Woo Park, Seung-Hwan Lee, Young-Hak Kim, Jae-Joong Kim, Seong-Wook Park, Gary S. Mintz, Seung-Jung Park. (2010) Intravascular Ultrasound Findings in Patients With Very Late Stent Thrombosis After Either Drug-Eluting or Bare-Metal Stent Implantation. Journal of the American College of Cardiology 55:18, 1936-1942
CrossRef238
Daniel H. Steinberg, Gary S. Mintz, Lazar Mandinov, Alan Yu, Steven G. Ellis, Eberhard Grube, Keith D. Dawkins, John Ormiston, Mark A. Turco, Gregg W. Stone, Neil J. Weissman. (2010) Long-Term Impact of Routinely Detected Early and Late Incomplete Stent Apposition. JACC: Cardiovascular Interventions 3:5, 486-494
CrossRef239
Mandy J. Binning, L. Nelson Hopkins. (2010) Vascular disease: Endovascular treatment of vertebral artery stenosis. Nature Reviews Cardiology 7:5, 245-246
CrossRef240
Aris Moschovitis, Rüdiger Simon, Antje Seidenstücker, Volker Klauss, Monika Baylacher, Thomas Lüscher, Tiziano Moccetti, Stephan Windecker, Bernhard Meier, Otto Hess. (2010) Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial. EuroIntervention 6:1, 63-68
CrossRef241
Somjot S Brar, Gregg W Stone. (2010) Decision-making: stenting in acute myocardial infarction. Future Cardiology 6:3, 301-314
CrossRef242
João S. Soares, Paolo Zunino. (2010) A mixture model for water uptake, degradation, erosion and drug release from polydisperse polymeric networks. Biomaterials 31:11, 3032-3042
CrossRef243
Jon Suh, Duk-Woo Park, Jong-Young Lee, In Hyun Jung, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Sang-Sig Cheong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2010) The Relationship and Threshold of Stent Length With Regard to Risk of Stent Thrombosis After Drug-Eluting Stent Implantation. JACC: Cardiovascular Interventions 3:4, 383-389
CrossRef244
MARCUS WIEMER, RALF DEGENHARDT, CHRISTIAN VALLBRACHT, DIETER HORSTKOTTE, HENRIK SCHNEIDER, CHRISTOPH NIENABER, WOLFGANG BOCKSCH, MICHAEL BOXBERGER, MARTIN UNVERDORBEN, . (2010) The Paclitaxel-Eluting Coroflex™ Stent Study II (PECOPS II) Acute and 6-Month Clinical and Angiographic Follow-Up, 1-Year Clinical Follow-Up. Journal of Interventional Cardiology 23:2, 160-166
CrossRef245
Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Sang Hoon Lee, Myung-Ho Jeong, Hyo-Soo Kim, In-Whan Seong, Ju-Young Yang, Seung Woon Rha, Yangsoo Jang, Jung Han Yoon, Seung-Jea Tahk, Ki Bae Seung, Seung-Jung Park, Hyeon-Cheol Gwon. (2010) Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary Bifurcations. Journal of the American College of Cardiology 55:16, 1743-1750
CrossRef246
Flavio Ribichini, Gerardo Ansalone, Antonio Bartorelli, Federico Beqaraj, Andrea Berni, Salvatore Colangelo, Maurizio DʼAmico, Francesco Della Rovere, Antonio Fiscella, Gabriele Gabrielli, Ciro Indolfi, Luigi La Vecchia, Paolo Loschiavo, Giampietro Marinoni, Antonio Marzocchi, Diego Milazzo, Michele Romano, Pietro Sangiorgio, Imad Sheiban, Corrado Tamburino, Bernardino Tuccillo, Rosvaldo Villani, Barbara Cappi, Maria Josè Lopera Quijada, Corrado Vassanelli. (2010) A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. Journal of Cardiovascular Medicine 11:4, 299-309
CrossRef247
Michael S. Lee, Tae Yang, David E. Kandzari, Jonathan M. Tobis, Hsini Liao, Ehtisham Mahmud. (2010) Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft Intervention. The American Journal of Cardiology 105:8, 1076-1082
CrossRef248
Gaku Nakazawa, Saami K. Yazdani, Aloke V. Finn, Marc Vorpahl, Frank D. Kolodgie, Renu Virmani. (2010) Pathological Findings at Bifurcation Lesions. Journal of the American College of Cardiology 55:16, 1679-1687
CrossRef249
MANDEEP S. SIDHU, JEREMIAH R. BROWN, RAYSON C. YANG, JAMES T. DeVRIES, JOHN E. JAYNE, BRUCE D. HETTLEMAN, BRUCE J. FRIEDMAN, NATHANIEL W. NILES, AARON V. KAPLAN, JOHN F. ROBB, DAVID J. MALENKA, CRAIG A. THOMPSON, . (2010) Real World, Long-Term Outcomes Comparison Between Paclitaxel-Eluting and Sirolimus-Eluting Stent Platforms. Journal of Interventional Cardiology 23:2, 167-175
CrossRef250
Seong-Rim Kim, Seung-Hoon You, Won-Ki Yoon, Young-Woo Kim, Sang-Don Kim, Ik-Seong Park, Min-Woo Baik. (2010) Computed tomography angiography, perfusion computed tomography, and a drug-eluting stent for the treatment of in-stent restenosis of the middle cerebral artery. Journal of Neurosurgery 112:4, 729-733
CrossRef251
Michael S. Lee, Giuseppe Tarantini, Jola Xhaxho, Tae Yang, Ashkan Ehdaie, Ravi Bhatia, Enrico Favaretto, Jonathan Tobis. (2010) Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy. JACC: Cardiovascular Interventions 3:4, 378-382
CrossRef252
Eberhard Grube, Joachim Schofer, Karl E. Hauptmann, Georg Nickenig, Nicholas Curzen, Dominic J. Allocco, Keith D. Dawkins. (2010) A Novel Paclitaxel-Eluting Stent With an Ultrathin Abluminal Biodegradable Polymer. JACC: Cardiovascular Interventions 3:4, 431-438
CrossRef253
Takahiro Uchida, Jeffrey Popma, Gregg W. Stone, Stephen G. Ellis, Mark A. Turco, John A. Ormiston, Toshiya Muramatsu, Masato Nakamura, Shinsuke Nanto, Hiroyoshi Yokoi, Donald S. Baim. (2010) The Clinical Impact of Routine Angiographic Follow-Up in Randomized Trials of Drug-Eluting Stents. JACC: Cardiovascular Interventions 3:4, 403-411
CrossRef254
J. Doostzadeh, S. Bezenek, W.-F. Cheong, P. Sood, L. Schwartz, K. Sudhir. 2010. Clinical Trials in Interventional Cardiology: Focus on XIENCE V Drug-Eluting Stent. .
CrossRef255
Konstantinos Toutouzas, Andreas Synetos, Antonis Karanasos, Maria Drakopoulou, Eleutherios Tsiamis, Stamatios Lerakis, Christodoulos Stefanadis. (2010) Percutaneous Coronary Intervention in Chronic Stable Angina. The American Journal of the Medical Sciences1
CrossRef256
M Early, D J Kelly. (2010) The role of vessel geometry and material properties on the mechanics of stenting in the coronary and peripheral arteries. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 224:3, 465-476
CrossRef257
James E. Moore, Joao S. Soares, Kumbakonam R. Rajagopal. (2010) Biodegradable Stents: Biomechanical Modeling Challenges and Opportunities. Cardiovascular Engineering and Technology 1:1, 52-65
CrossRef258
Klaus Rasmussen, Michael Maeng, Anne Kaltoft, Per Thayssen, Henning Kelbæk, Hans Henrik Tilsted, Ulrik Abildgaard, Evald Høj Christiansen, Thomas Engstrøm, Lars Romer Krusell, Jan Ravkilde, Peter Riis Hansen, Knud Nørregaard Hansen, Steen Zabell Abildstrøm, Jens Aarøe, Jan Skov Jensen, Steen Dalby Kristensen, Hans Erik Bøtker, Morten Madsen, Søren Paaske Johnsen, Lisette Okkels Jensen, Henrik Toft Sørensen, Leif Thuesen, Jens Flensted Lassen. (2010) Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. The Lancet 375:9720, 1090-1099
CrossRef259
Douglass A. Morrison. (2010) Limitations of stints: A good, albeit imperfect, therapy; For a less than perfect world. Catheterization and Cardiovascular Interventions 75:3, 343-344
CrossRef260
Martin B. Leon, Laura Mauri, Jeffrey J. Popma, Donald E. Cutlip, Eugenia Nikolsky, Charles O'Shaughnessy, Paul A. Overlie, Brent T. McLaurin, Stuart L. Solomon, John S. Douglas, Michael W. Ball, Ronald P. Caputo, Ash Jain, Thaddeus R. Tolleson, Bernard M. Reen, Ajay J. Kirtane, Peter J. Fitzgerald, Kweli Thompson, David E. Kandzari. (2010) A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions. Journal of the American College of Cardiology 55:6, 543-554
CrossRef261
Ashok Seth, Patrick Serruys, Alexandra Lansky, James Hermiller, Yoshinobu Onuma, Karine Miquel-Hebert, Shui Yu, Susan Veldhof, Poornima Sood, Krishnankutty Sudhir, Gregg Stone. (2010) A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis. EuroIntervention 5:7, 788-794
CrossRef262
Timothy Canan, Michael S. Lee. (2010) Drug-eluting stent fracture: Incidence, contributing factors, and clinical implications. Catheterization and Cardiovascular Interventions 75:2, 237-245
CrossRef263
Jon-David R. Schwalm, Mayraj Ahmad, James L. Velianou, Dan Pericak, Madhu K. Natarajan. (2010) Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: A Canadian experience. Canadian Journal of Cardiology 26:2, e40-e44
CrossRef264
Fred Strickler, Robert Richard, Sharon McFadden, Jeff Lindquist, Marlene C. Schwarz, Rudolf Faust, Gregory J. Wilson, Mark Boden. (2010) In vivo and in vitro characterization of poly(styrene-b-isobutylene-b-styrene) copolymer stent coatings for biostability, vascular compatibility and mechanical integrity. Journal of Biomedical Materials Research Part A 92A:2, 773-782
CrossRef265
Takashi Kubo, Akiko Maehara, Gary S. Mintz, Hector M. Garcia-Garcia, Patrick W. Serruys, Takahiko Suzuki, Volker Klauss, Satoru Sumitsuji, Amir Lerman, Steven P. Marso, M. Pauliina Margolis, James R. Margolis, Michael C. Foster, Bernard De Bruyne, Martin B. Leon, Gregg W. Stone. (2010) Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. American Heart Journal 159:2, 271-277
CrossRef266
Rahul Sakhuja, Laura Mauri. (2010) Controversies in the Use of Drug-Eluting Stents for Acute Myocardial Infarction: A Critical Appraisal of the Data. Annual Review of Medicine 61:1, 215-231
CrossRef267
Ralf Zahn, Christian W. Hamm, Uwe Zeymer, Gert Richardt, Malte Kelm, Benny Levenson, Tassilo Bonzel, Ulrich Tebbe, Georg Sabin, Christoph A. Nienaber, Thomas Pfannebecker, Jochen Senges. (2010) Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry. Clinical Research in Cardiology 99:2, 99-106
CrossRef268
Daniel Chamié, J. Ribamar Costa, Alexandre Abizaid, Fausto Feres, Rodolfo Staico, Fernando Devito, Ricardo A. Costa, Andréa Abizaid, Luiz Fernando Tanajura, Amanda G.M.R. Sousa, Peter J. Fitzgerald, Robert J. Whitbourn, J. Eduardo Sousa. (2010) Serial Angiography and Intravascular Ultrasound: Results of the SISC Registry (Stents In Small Coronaries). JACC: Cardiovascular Interventions 3:2, 191-202
CrossRef269
Özcan Birim, Ad Bogers, A. Pieter Kappetein. (2010) Cost effectiveness of coronary revascularisation. EuroIntervention 5:7, 763-767
CrossRef270
Jung-Sun Kim, Myeong-Ki Hong, Chunyu Fan, Tae-Hoon Kim, Jae-Min Shim, Sang-Min Park, Young-Guk Ko, Donghoon Choi, Yangsoo Jang. (2010) Intracoronary thrombus formation after drug-eluting stents implantation: Optical coherence tomographic study. American Heart Journal 159:2, 278-283
CrossRef271
MAN-HONG JIM, HEE-HWA HO, RYAN LAP-YAN KO, CHUNG-WAH SIU, KAI-HANG YIU, CHU-PAK LAU, WING-HING CHOW. (2010) Paclitaxel-Eluting Stents for Chronically Occluded Saphenous Vein Grafts (EOS) Study. Journal of Interventional Cardiology 23:1, 40-45
CrossRef272
RALF ZAHN, CHRISTIAN W. HAMM, STEFFEN SCHNEIDER, GERT RICHARDT, MALTE KELM, BENNY LEVENSON, TASSILO BONZEL, ULRICH TEBBE, GEORG SABIN, CHRISTOPH A. NIENABER, . (2010) Coronary Stenting with the Sirolimus-Eluting Stent in Clinical Practice: Final Results from the Prospective Multicenter German Cypher Stent Registry. Journal of Interventional Cardiology 23:1, 18-25
CrossRef273
Paul C. Gordon, Robert J. Applegate, James B. Hermiller, Steven B. Weinsier, Julie Doostzadeh, Sherry Cao, Krishnankutty Sudhir, Alexandra J. Lansky, Gregg W. Stone. (2010) Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: The SPIRIT III 4.0 mm registry. Catheterization and Cardiovascular Interventions 75:2, 179-186
CrossRef274
Kyung Woo Park, Si-Hyuck Kang, Woo-Young Chung, Hae-Young Lee, Jin-Shik Park, Hyun-Jae Kang, Young-Seok Cho, Tae-Jin Youn, Bon-Kwon Koo, In-Ho Chae, Dong-Ju Choi, Seokyung Hahn, Byung-Joo Park, Hyo-Soo Kim. (2010) `Real World' Comparison of Drug-Eluting Stents vs Bare Metal Stents in the Treatment of Unselected Patients With Acute ST-Segment Elevation Myocardial Infarction. Circulation Journal 74:6, 1111-1120
CrossRef275
S. James Chen, John C. Messenger, John D. Carroll, Kenneth L. Jerina, Michael R. Mitchell, Terry O. Woods, Brian T. Berg, S. W. Dean. (2010) A Methodology for Quantifying Deformations in Stented Coronary Arteries Based on Three-Dimensional Angiography. Journal of ASTM International 7:1, 101873
CrossRef276
Yoshihisa Nakagawa. (2010) What Is the Effectiveness of Drug-Eluting Stents in the Treatment of ST-Elevation Myocardial Infarction?. Circulation Journal 74:10, 2225-2231
CrossRef277
Amane Kozuki, Junya Shite, Toshiro Shinke, Naoki Miyoshi, Takahiro Sawada, Farrel Hellig, Mark Abelson, Basil Brown, Sajidah Khan, Martin Mpe, Mpiko Ntsekhe, Damian Conway, Ken-ichi Hirata. (2010) STELLIUM 1: First-In-Man Follow-up Evaluation of Bioabsorbable Polymer-Coated Paclitaxel-Eluting Stent. Circulation Journal 74:10, 2089-2096
CrossRef278
Joo-Yong Hahn, Young Bin Song, Jin-Ho Choi, Sung-Hyuk Choi, Sung Yun Lee, Hun Sik Park, Seung Ho Hur, Sahng Lee, Kyoo-Rok Han, Seung-Woon Rha, Byung Ryul Cho, Jong-Sun Park, Junghan Yoon, Do Sun Lim, Sang Hoon Lee, Hyeon-Cheol Gwon, The DATE Registry Investigators. (2010) Three-Month Dual Antiplatelet Therapy After Implantation of Zotarolimus-Eluting Stents. Circulation Journal 74:11, 2314-2321
CrossRef279
MAN-HONG JIM, HEE-HWA HO, RYAN LAP-YAN KO, CHUNG-WAH SIU, KAI-HANG YIU, CHU-PAK LAU, WING-HING CHOW. (2010) Paclitaxel-Eluting Stents for Chronically Occluded Saphenous Vein Grafts (EOS) Study. Journal of Interventional Cardiology
CrossRef280
Stefanie Schulz, Julinda Mehilli, Albert Schömig, Adnan Kastrati. (2010) ISAR. Circulation Journal 74:9, 1771-1778
CrossRef281
Yoshihiro Morino, Seiji Tamiya, Naoki Masuda, Yota Kawamura, Masakazu Nagaoka, Takashi Matsukage, Nobuhiko Ogata, Gaku Nakazawa, Teruhisa Tanabe, Yuji Ikari. (2010) Intravascular Ultrasound Criteria for Determination of Optimal Longitudinal Positioning of Sirolimus-Eluting Stents. Circulation Journal 74:8, 1609-1616
CrossRef282
Hiromasa Horiguchi, Hideo Yasunaga, Hideki Hashimoto, Shinya Matsuda. (2010) Impact of Drug-Eluting Stents on Treatment Option Mix for Coronary Artery Disease in Japan. Circulation Journal 74:8, 1635-1643
CrossRef283
Katsumi Inoue. (2010) Drug-Eluting Stents Are Not Indicated for Patients With Acute Coronary Syndrome. Circulation Journal 74:10, 2232-2238
CrossRef284
Jiro Aoki. (2010) Application of Drug Eluting Stents to Clinical Practice in Japan. Circulation Journal 74:8, 1532-1533
CrossRef285
M. Gagliardi, D. Silvestri, C. Cristallini, M. Guadagni, G. Crifaci, P. Giusti. (2010) Combined drug release from biodegradable bilayer coating for endovascular stents. Journal of Biomedical Materials Research Part B: Applied Biomaterials 9999B, NA-NA
CrossRef286
Seung-Pyo Lee, Song-Yi Kim, Kyung-Woo Park, Dong-Ho Shin, Hyun-Jae Kang, Bon-Kwon Koo, Jung-Won Suh, Young-Seok Cho, Tae-Jin Yeon, In-Ho Chae, Dong-Ju Choi, Hyo-Soo Kim. (2010) Long-Term Clinical Outcome of Chronic Total Occlusive Lesions Treated With Drug-Eluting Stents:. Circulation Journal 74:4, 693-700
CrossRef287
Julie Doostzadeh, Lee N. Clark, Susan Bezenek, Wesley Pierson, Poornima R. Sood, Krishnankutty Sudhir. (2010) Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Coronary Artery Disease 21:1, 46-56
CrossRef288
Corrado Tamburino, Davide Capodanno, Alessio La Manna, Marilena di Salvo, Alessandra Sanfilippo, Francesco Prati. (2010) Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design. Journal of Cardiovascular Medicine 11:1, 53-58
CrossRef289
Elvin Kedhi, Kaiyum Sheik Joesoef, Eugene McFadden, Jochem Wassing, Carlos van Mieghem, Dick Goedhart, Pieter Cornelis Smits. (2010) Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. The Lancet 375:9710, 201-209
CrossRef290
Sandhir B. Prasad, Walid Ahmar, Yuvaraj Malaiapan, Ian T. Meredith. (2010) Drug-eluting Stents for the Treatment of Acute Myocardial Infarction: The View to the HORIZONS. Heart, Lung and Circulation 19:1, 11-18
CrossRef291
Takahiro Shirasawa, Masaaki Miyata, Hideyuki Eto, Narisato Hamada, Yuichi Akasaki, Takahiro Miyauchi, Yuko Furusho, Koji Orihara, Shuichi Hamasaki, Bruce J. Aronow, Jonathan D. Smith, Chuwa Tei. (2010) Deficiency of Clusterin Inhibits Neointimal Hyperplasia After Vascular Injury. Journal of Atherosclerosis and Thrombosis 16:6, 772-781
CrossRef292
Samip Vasaiwala, Daniel E. Forman, Laura Mauri. (2010) Drug-Eluting Stents in the Elderly. Current Treatment Options in Cardiovascular Medicine 12:1, 76-83
CrossRef293
Paul Wexberg, Franz Weidinger. (2010) Revaskularisation der koronaren Herzerkrankung bei Diabetes mellitus. Wiener Medizinische Wochenschrift 160:1-2, 40-43
CrossRef294
Narisato Hamada, Masaaki Miyata, Hideyuki Eto, Takahiro Shirasawa, Yuichi Akasaki, Aya Nagaki, Chuwa Tei. (2010) Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model. Atherosclerosis 208:1, 97-103
CrossRef295
Sun-Jung Song, Yu Jeong Park, Jun Park, Myung Duck Cho, Jong-Ho Kim, Myung Ho Jeong, Yong Sook Kim, Dong Lyun Cho. (2010) Preparation of a drug-eluting stent using a TiO2 film deposited by plasma enhanced chemical vapour deposition as a drug-combining matrix. Journal of Materials Chemistry 20:23, 4792
CrossRef296
Marcus Wiemer, Patrick W. Serruys, Karine Miquel-Hebert, Franz-Josef Neumann, Jan J. Piek, Eberhard Grube, Jürgen Haase, Leif Thuesen, Christian Hamm. (2010) Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef297
Takahisa Fujikawa, Akira Tanaka, Toshihiro Abe, Yasunori Yoshimoto, Katsuhiro Kondo, Hiroyoshi Yokoi, Kei Shiraishi, Tomoharu Yoshida, Katsuhiro Seo, Masakiyo Nobuyoshi. (2010) Surgery Against Cancer of Gastrointestinal Tract and Perioperative Management in Patients Receiving Drug-Eluting Coronary Stent Implantation. The Japanese Journal of Gastroenterological Surgery 43:9, 882-892
CrossRef298
Bogoljub Mihajlovic, Svetozar Nicin, Nada Cemerlic-Adjic, Katica Pavlovic, Slobodan Dodic, Lazar Velicki, Miklos Fabri. (2010) Trends of risk factors in coronary surgery. Srpski arhiv za celokupno lekarstvo 138:9-10, 570-576
CrossRef299
Frederick G. Kushner, Mary Hand, Sidney C. Smith, Spencer B. King, Jeffrey L. Anderson, Elliott M. Antman, Steven R. Bailey, Eric R. Bates, James C. Blankenship, Donald E. Casey, Lee A. Green, Judith S. Hochman, Alice K. Jacobs, Harlan M. Krumholz, Douglass A. Morrison, Joseph P. Ornato, David L. Pearle, Eric D. Peterson, Michael A. Sloan, Patrick L. Whitlow, David O. Williams. (2009) 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). Journal of the American College of Cardiology 54:23, 2205-2241
CrossRef300
Martin B. Leon, David E. Kandzari, Eric L. Eisenstein, Kevin J. Anstrom, Laura Mauri, Donald E. Cutlip, Eugenia Nikolsky, Charles O'Shaughnessy, Paul A. Overlie, Ajay J. Kirtane, Brent T. McLaurin, Stuart L. Solomon, John S. Douglas, Jeffrey J. Popma. (2009) Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions. JACC: Cardiovascular Interventions 2:12, 1208-1218
CrossRef301
Frederick G. Kushner, Mary Hand, Sidney C. Smith, Spencer B. King, Jeffrey L. Anderson, Elliott M. Antman, Steven R. Bailey, Eric R. Bates, James C. Blankenship, Donald E. Casey, Lee A. Green, Alice K. Jacobs, Judith S. Hochman, Harlan M. Krumholz, Douglass A. Morrison, Joseph P. Ornato, David L. Pearle, Eric D. Peterson, Michael A. Sloan, Patrick L. Whitlow, David O. Williams. (2009) 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). Catheterization and Cardiovascular Interventions 74:7, E25-E68
CrossRef302
Issam D. Moussa, Antonio Colombo. (2009) Antiplatelet therapy discontinuation following drug-eluting stent placement: Dangers, reasons, and management recommendations. Catheterization and Cardiovascular Interventions 74:7, 1047-1054
CrossRef303
James E. Tcheng, David A. Zidar. (2009) Gone But Not Forgotten. JACC: Cardiovascular Interventions 2:12, 1266-1268
CrossRef304
Eric L. Eisenstein, William Wijns, Jean Fajadet, Laura Mauri, Rex Edwards, Patricia A. Cowper, David F. Kong, Kevin J. Anstrom. (2009) Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent. JACC: Cardiovascular Interventions 2:12, 1178-1187
CrossRef305
Elena Ladich, Marc Vorpahl, Masataka Nakano, Renu Virmani. (2009) Latest on the pathology of drug-eluting stents. Interventional Cardiology 1:2, 165-174
CrossRef306
Stephen G. Ellis, Gregg W. Stone, David A. Cox, James Hermiller, Charles O'Shaughnessy, Tift Mann, Mark Turco, Ronald Caputo, Patrick J. Bergin, Thomas S. Bowman, Donald S. Baim. (2009) Long-Term Safety and Efficacy With Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions 2:12, 1248-1259
CrossRef307
Hiroshi Doi, Akiko Maehara, Gary S. Mintz, Alan Yu, Hong Wang, Lazar Mandinov, Jeffrey J. Popma, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins, Neil J. Weissman, Mark A. Turco, John A. Ormiston, Gregg W. Stone. (2009) Impact of Post-Intervention Minimal Stent Area on 9-Month Follow-Up Patency of Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions 2:12, 1269-1275
CrossRef308
Edoardo Camenzind, William Wijns, Laura Mauri, Eric Boersma, Keyur Parikh, Volkhard Kurowski, Runlin Gao, Christoph Bode, John P. Greenwood, Anthony Gershlick, William O'Neill, Patrick W. Serruys, Brenda Jorissen, P. Gabriel Steg. (2009) Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation. American Heart Journal 158:6, 902-909.e5
CrossRef309
James B. Hermiller, Todd Fergus, Wesley Pierson, Xiaolu Su, Poornima Sood, Krishnankutty Sudhir, Gregg W. Stone. (2009) Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial. American Heart Journal 158:6, 1005-1010
CrossRef310
Marc Vorpahl, Aloke Finn, Masataka Nakano, Renu Virmani. (2009) The bioabsorption process: tissue and cellular mechanisms and outcomes. EuroIntervention 5:F, F28-F35
CrossRef311
Sripal Bangalore, Laura Mauri. (2009) Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?. EuroIntervention 5:F, F43-F48
CrossRef312
Carlo Di Mario, Francesco Borgia. (2009) Assimilating the current clinical data of fully bioabsorbable stents. EuroIntervention 5:F, F103-F108
CrossRef313
S. Schulz, T. Schuster, J. Mehilli, R. A. Byrne, J. Ellert, S. Massberg, J. Goedel, O. Bruskina, K. Ulm, A. Schomig, A. Kastrati. (2009) Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. European Heart Journal 30:22, 2714-2721
CrossRef314
Sebastian Kufner, Jörg Hausleiter, Gjin Ndrepepa, Stefanie Schulz, Olga Bruskina, Robert A. Byrne, Massimiliano Fusaro, Adnan Kastrati, Albert Schömig, Julinda Mehilli. (2009) Long-Term Risk of Adverse Outcomes and New Malignancies in Patients Treated With Oral Sirolimus for Prevention of Restenosis. JACC: Cardiovascular Interventions 2:11, 1142-1148
CrossRef315
Massimo Boffini, Fabrizio Ceresa, Fabrizio Sansone, Marco Ribezzo, Chiara Comoglio, Mauro Rinaldi. (2009) Emergent coronary artery bypass grafting for cardiogenic shock caused by very late drug-eluting stent thrombosis. General Thoracic and Cardiovascular Surgery 57:11, 609-611
CrossRef316
Zhenhua Zhou, Shugui Shi, Mingbao Song, Heqing Huang, Kangning Chen, Jianhong Mi, Lusi Li, Guisheng Chen, Chunli Hou, Guangyu Huang, Chuhong Zhu. (2009) Development of transgenic endothelial progenitor cell-seeded stents. Journal of Biomedical Materials Research Part A 91A:2, 623-628
CrossRef317
Harvey S. Hecht, Sotir Polena, Vladimir Jelnin, Marcelo Jimenez, Tandeep Bhatti, Manish Parikh, Georgia Panagopoulos, Gary Roubin. (2009) Stent Gap by 64-Detector Computed Tomographic Angiography. Journal of the American College of Cardiology 54:21, 1949-1959
CrossRef318
Seung-Ho Hur, Yun-Kyeong Cho, Chang-Wook Nam, Hyungseop Kim, Seong-Wook Han, Yoon-Nyun Kim, Hee-Joon Park, Jong-Seon Park, Dong-Gu Shin, Young-Jo Kim, Bong-Sup Shim, Tae-Hyun Yang, Dae-Kyeong Kim, Doo-Il Kim, Dong-Soo Kim, Kwon-Bae Kim. (2009) Comparison of Long-term Outcomes Following Sirolimus-eluting Stent vs Paclitaxel-eluting Stent Implantation in Patients with Long Calcified Coronary Lesions. Clinical Cardiology 32:11, 633-638
CrossRef319
Gaku Nakazawa, Aloke V. Finn, Marc Vorpahl, Elena Ladich, Robert Kutys, Isidora Balazs, Frank D. Kolodgie, Renu Virmani. (2009) Incidence and Predictors of Drug-Eluting Stent Fracture in Human Coronary Artery. Journal of the American College of Cardiology 54:21, 1924-1931
CrossRef320
Martin Unverdorben, Ralf Degenhardt, Marcus Wiemer, Dieter Horstkotte, Henrik Schneider, Christoph Nienaber, Wolfgang Bocksch, Michael Gross, Michael Boxberger, Christian Vallbracht, . (2009) The paclitaxel-eluting coroflex™ please stent study (PECOPS I): The 3-year clinical follow-up. Catheterization and Cardiovascular Interventions 74:5, 674-682
CrossRef321
Petra Hoppmann, Anna Erl, Serin Türk, Klaus Tiroch, Julinda Mehilli, Albert Schömig, Adnan Kastrati, Werner Koch. (2009) No Association of Chromosome 9p21.3 Variation With Clinical and Angiographic Outcomes After Placement of Drug-Eluting Stents. JACC: Cardiovascular Interventions 2:11, 1149-1155
CrossRef322
R. A. Byrne, A. Kastrati, S. Kufner, S. Massberg, K. A. Birkmeier, K.-L. Laugwitz, S. Schulz, J. Pache, M. Fusaro, M. Seyfarth, A. Schomig, J. Mehilli, . (2009) Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. European Heart Journal 30:20, 2441-2449
CrossRef323
Jochen Wöhrle, Thorsten Nusser, Stephanie Hoffmann, Matthias Kochs. (2009) Angiographic results of the cobalt chromium Vision and Mini-Vision stents. Canadian Journal of Cardiology 25:10, 581-584
CrossRef324
Z. Vajda, E. Miloslavski, T. Guthe, S. Fischer, G. Albes, A. Heuschmid, H. Henkes. (2009) Treatment of Stenoses of Vertebral Artery Origin Using Short Drug-Eluting Coronary Stents: Improved Follow-Up Results. American Journal of Neuroradiology 30:9, 1653-1656
CrossRef325
Eugenia Nikolsky, Alexandra J. Lansky, Krishnankutty Sudhir, Julie Doostzadeh, Donald E. Cutlip, Robert Piana, Xiaolu Su, Roseann White, Charles A. Simonton, Gregg W. Stone. (2009) SPIRIT IV trial design: A large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease. American Heart Journal 158:4, 520-526.e2
CrossRef326
Tonga Nfor, Imran Ansaarie, Anjan Gupta, Tanvir Bajwa, Suhail Allaqaband. (2009) Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy. Catheterization and Cardiovascular Interventions 74:4, 543-549
CrossRef327
John A. Ormiston, Mark W.I. Webster, Robert S. Schwartz, Patrick Gladding, James T. Stewart, I. Patrick Kay, Peter N. Ruygrok, Robert Hatrick. (2009) Feasibility, Safety, and Efficacy of a Novel Polymeric Pimecrolimus-Eluting Stent. JACC: Cardiovascular Interventions 2:10, 1017-1024
CrossRef328
David Austin, Keith G. Oldroyd, David R. Holmes, Charanjit S. Rihal, P. Diane Galbraith, William A. Ghali, Victor Legrand, Yves Taeymans, Alex McConnachie, Jill P. Pell. (2009) Drug-eluting stents: A study of international practice. American Heart Journal 158:4, 576-584
CrossRef329
Emilio Di Lorenzo, Rosario Sauro, Attilio Varricchio, Michele Capasso, Tonino Lanzillo, Fiore Manganelli, Ciro Mariello, Francesco Siano, Maria Rosaria Pagliuca, Giovanni Stanco, Giuseppe Rosato, Giuseppe De Luca. (2009) Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: Four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. American Heart Journal 158:4, e43-e50
CrossRef330
Robert A. Byrne, Nikolaus Sarafoff, Adnan Kastrati, Albert Schömig. (2009) Drug-Eluting Stents in Percutaneous Coronary Intervention. Drug Safety 32:9, 749-770
CrossRef331
Christopher Lichtenwalter, James A. de Lemos, Michele Roesle, Owen Obel, Elizabeth M. Holper, Donald Haagen, Bilal Saeed, Jose Miguel Iturbe, Kendrick Shunk, Joseph K. Bissett, Rajesh Sachdeva, Vassilios V. Voudris, Panagiotis Karyofillis, Biswajit Kar, James Rossen, Panayotis Fasseas, Peter Berger, Subhash Banerjee, Emmanouil S. Brilakis. (2009) Clinical Presentation and Angiographic Characteristics of Saphenous Vein Graft Failure After Stenting. JACC: Cardiovascular Interventions 2:9, 855-860
CrossRef332
Michael A. Kutcher. (2009) Drug-eluting stents versus bypass surgery for multivessel coronary disease. Current Cardiovascular Risk Reports 3:5, 331-338
CrossRef333
Rainer Hoffmann, Helene Klinker, Umar Adamu, Malte Kelm, Rüdiger Blindt. (2009) The risk of definitive stent thrombosis is increased after “off-label” stent implantation irrespective of drug-eluting stent or bare-metal stent use. Clinical Research in Cardiology 98:9, 549-554
CrossRef334
E. Meliga, H.M. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A.O. Maree, N. Gonzalo, S. Cook, S. Marra, C. Moretti, S. De Servi, I.F. Palacios, S. Windecker, R. van Domburg, A. Colombo, I. Sheiban, P.W. Serruys. (2009) Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). International Journal of Cardiology 137:1, 16-21
CrossRef335
Philippe Steg, Gregory Ducrocq. (2009) Stent selection in patients on oral anticoagulants: can we prevent restenosis and avoid bleeding?. EuroIntervention 5:4, 405-407
CrossRef336
Qiao Shu Bin, Liu Sheng Wen, Xu Bo, Chen Jue, Liu Hai Bo, Yang Yue Jin, Chen Ji Lin, Gao Run Lin. (2009) Clinical Outcomes for Single Stent and Multiple Stents in Contemporary Practice. Clinical Cardiology 32:9, E33-E39
CrossRef337
Adi Rachelson, Meital Zilberman. (2009) Highly Porous Nano- and Microstructured Films Loaded with Bioactive Agents for Biomedical Applications: Structure-Release Profile Effects. Advanced Engineering Materials 11:8, B122-B128
CrossRef338
Fausto Feres, Pedro Andrade, Ricardo Costa, J. de Ribamar Costa, Alexandre Abizaid, Rodolfo Staico, Luiz Tanajura, Dimytri Siqueira, Julio Maia, Leandro Lasave, Amanda Sousa, J. Sousa. (2009) Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice. EuroIntervention 5:3, 355-362
CrossRef339
Anelize S. Fogo, Eliane Antonioli, João B. Calixto, Alexandre H. Campos. (2009) Tormentic acid reduces vascular smooth muscle cell proliferation and survival. European Journal of Pharmacology 615:1-3, 50-54
CrossRef340
Umesh Tamhane, Pascal Meier, Stanley Chetcuti, Kang-Yin Chen, Seung-Woon Rha, Michael Grossman, Hitinder Gurm. (2009) Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. EuroIntervention 5:3, 384-393
CrossRef341
Jin Oh Na, Jin Won Kim, Cheol Ung Choi, Un Jung Choi, Seung Yong Shin, Hong Euy Lim, Eung Ju Kim, Seung-Woon Rha, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh. (2009) Bare-metal stents versus drug-eluting stents in large (≥3.5mm) single coronary artery: Angiographic and clinical outcomes at 6 months. Journal of Cardiology 54:1, 108-114
CrossRef342
Robert Richard, Marlene Schwarz, Ken Chan, Nikolai Teigen, Mark Boden. (2009) Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations. Journal of Biomedical Materials Research Part A 90A:2, 522-532
CrossRef343
Mariann Gyöngyösi, Günter Christ, Irene Lang, Gerhard Kreiner, Heinz Sochor, Peter Probst, Thomas Neunteufl, Rosa Badr-Eslam, Susanne Winkler, Noemi Nyolczas, Aniko Posa, Franz Leisch, Ronald Karnik, Peter Siostrzonek, Stefan Harb, Matthias Heigert, Gerald Zenker, Werner Benzer, Gerhard Bonner, Alexandra Kaider, Dietmar Glogar. (2009) 2-Year Results of the AUTAX (Austrian Multivessel TAXUS-Stent) Registry. JACC: Cardiovascular Interventions 2:8, 718-727
CrossRef344
Shinichi Furuichi, Giuseppe Sangiorgi, Cosmo Godino, Flavio Airoldi, Matteo Montorfano, Alaide Chieffo, Iassen Michev, Mauro Carlino, Antonio Colombo. (2009) Rotational atherectomy followed by drug-eluting stent implantation in calcified coronary lesions. EuroIntervention 5:3, 370-374
CrossRef345
SUDHIR RATHORE, MITSUYASU TERASHIMA, M. HABARA, YOSHIHISA KINOSHITA, KENYA NASU, OSAMU KATOH, TAKAHIKO SUZUKI. (2009) Incomplete Stent Apposition after Coronary Stent Implantation: Myth or Reality?. Journal of Interventional Cardiology 22:4, 341-349
CrossRef346
Cheol Ung Choi, Seung-Woon Rha, Kang-Yin Chen, Zhe Jin, Yoshiyasu Minami, Seung Yong Shin, Jin Oh Na, Soon Yong Suh, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh. (2009) Mid-term angiographic benefit of sirolimus-eluting stents compared with paclitaxel-eluting stents in patients with acute myocardial infarction. Journal of Cardiology 54:1, 80-85
CrossRef347
Giuseppe Luca, Marco Valgimigli, Christian Spaulding, Maurizio Menichelli, Hans Peter Brunner-La Rocca, Bas L. Hoeven, Emilio Lorenzo, Luis-S. Diaz Llera, Vincenzo Pasceri, Undine Pittl, Gianfranco Percoco, Roberto Violini, Gregg W. Stone. (2009) Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Journal of Thrombosis and Thrombolysis 28:2, 200-210
CrossRef348
Li-Jian Gao, Ji-Lin Chen, Jun Chen, Yue-Jin Yang, Run-Lin Gao, Jian-Jun Li, Xue-Wen Qin, Shu-Bin Qiao, Bo Xu, Min Yao, Hai-Bo Liu, Yong-Jian Wu, Jin-Qing Yuan, Jue Chen, Shi-Jie You, Jun Dai. (2009) Long-Term Clinical Efficacy of Cutting Balloon Angioplasty Followed by Bare Metal Stent Implantation for Treating Ostial Left Anterior Descending Artery Lesions. Clinical Cardiology 32:8, E31-E35
CrossRef349
R. Cohen, R. Foucher, A. Sfaxi, M. Hakim, T. Domniez, S. Elhadad. (2009) Résultats immédiats et à long terme après angioplastie coronaire avec stents actifs de lésions de bifurcation par la technique du « crush stenting ». Annales de Cardiologie et d'Angéiologie 58:4, 208-214
CrossRef350
Khaled M. Ziada, Ahmed Abdel-Latif. (2009) Drug-Eluting Stents in Patients With ESRD on Dialysis: A Small Step Forward. American Journal of Kidney Diseases 54:2, 197-200
CrossRef351
Victor Novack, Donald Cutlip, Neal Kleiman, Michael Pencina, Laura Mauri, Chen-Hsing Yen, Peter Berger, Steven Goldberg, Mirle Kellett, Ronald Waksman, Mun Hong, Albert E. Raizner, David J. Cohen. (2009) In-Hospital and 1-Year Outcomes Among Unselected Percutaneous Coronary Intervention Patients Treated With Either Sirolimus- or Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions 2:8, 767-775
CrossRef352
Joseph Jagur-Grodzinski. (2009) Polymers for targeted and/or sustained drug delivery. Polymers for Advanced Technologies 20:7, 595-606
CrossRef353
Andrew D. Frutkin, Jason B. Lindsey, Sameer K. Mehta, John A. House, John A. Spertus, David J. Cohen, John S. Rumsfeld, Steven P. Marso. (2009) Drug-Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients With Class I Indications for Coronary Artery Bypass Surgery Undergoing Index Revascularization. JACC: Cardiovascular Interventions 2:7, 614-621
CrossRef354
Yong-Seok Kim, Bon-Kwon Koo, Jae-Bin Seo, Kyung Woo Park, Jung-Won Suh, Hae-Young Lee, Jin-Shik Park, Hyun-Jae Kang, Young-Seok Cho, Woo-Young Chung, In-Ho Chae, Dong-Ju Choi, Hyo-Soo Kim, Byung-Hee Oh, Young-Bae Park. (2009) The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation. Catheterization and Cardiovascular Interventions 74:1, 58-63
CrossRef355
Somjot S. Brar, Gregg W. Stone. (2009) Advances in percutaneous coronary intervention. Current Cardiology Reports 11:4, 245-251
CrossRef356
Adel Aminian, Tito Kabir, Eric Eeckhout. (2009) Treatment of drug-eluting stent restenosis: An emerging challenge. Catheterization and Cardiovascular Interventions 74:1, 108-116
CrossRef357
Karine Vallières, Éric Petitclerc, Gaétan Laroche. (2009) On the ability of imatinib mesylate to inhibit smooth muscle cell proliferation without delaying endothelialization: An in vitro study. Vascular Pharmacology 51:1, 50-56
CrossRef358
Judit E. Puskas, Lyn G. Muñoz-Robledo, Robert A. Hoerr, John Foley, Steven P. Schmidt, Michelle Evancho-Chapman, Jinping Dong, Chris Frethem, Greg Haugstad. (2009) Drug-eluting stent coatings. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 1:4, 451-462
CrossRef359
Xiushui Ren, Marina Trilesskaya, Damon M. Kwan, Kim Nguyen, Richard E. Shaw, Peter Y. Hui. (2009) Comparison of Outcomes Using Bare Metal Versus Drug-Eluting Stents in Coronary Artery Disease Patients With and Without Human Immunodeficiency Virus Infection. The American Journal of Cardiology 104:2, 216-222
CrossRef360
Yoshinobu Onuma, Neville Kukreja, Nicolo Piazza, Jannet Eindhoven, Chrysafios Girasis, Lisanne Schenkeveld, Ron van Domburg, Patrick W. Serruys. (2009) The Everolimus-Eluting Stent in Real-World Patients. Journal of the American College of Cardiology 54:3, 269-276
CrossRef361
Riya Chacko, Meredith Mulhearn, Victor Novack, Lena Novack, Laura Mauri, Sidney A. Cohen, Jeffrey Moses, Martin B. Leon, Donald E. Cutlip. (2009) Impact of Target Lesion and Nontarget Lesion Cardiac Events on 5-Year Clinical Outcomes After Sirolimus-Eluting or Bare-Metal Stenting. JACC: Cardiovascular Interventions 2:6, 498-503
CrossRef362
MOHAMMAD REZA MOVAHED, RADHAKRISHNAN RAMARAJ, M. MAZEN JAMAL, MEHRTASH HASHEMZADEH. (2009) Nationwide Trends in the Utilization of Multivessel Percutaneous Coronary Intervention (MVPCI) in the United States across Different Gender and Ethnicities. Journal of Interventional Cardiology 22:3, 247-251
CrossRef363
Saif Anwaruddin, Arman T. Askari, Hammad Saudye, Lilian Batizy, Penny L. Houghtaling, Mohammad Alamoudi, Michael Militello, Kamran Muhammad, Samir Kapadia, Stephen G. Ellis. (2009) Characterization of Post-Operative Risk Associated With Prior Drug-Eluting Stent Use. JACC: Cardiovascular Interventions 2:6, 542-549
CrossRef364
Henri Roukoz, Anthony A. Bavry, Michael L. Sarkees, Girish R. Mood, Dharam J. Kumbhani, Mark G. Rabbat, Deepak L. Bhatt. (2009) Comprehensive Meta-Analysis on Drug-Eluting Stents versus Bare-Metal Stents during Extended Follow-up. The American Journal of Medicine 122:6, 581.e1-581.e10
CrossRef365
MANABU OGITA, TOMOHIRO NAKAMURA, NAOKI FUJIWARA, KENICHI SAKAKURA, HIROSHI FUNAYAMA, YOSHITAKA SUGAWARA, NORIFUMI KUBO, JUNYA AKO, SHINICHI MOMOMURA. (2009) Long-Term Clinical Follow-up after Sirolimus-Eluting Stent versus Bare Metal Stent Implantation in Patients with Acute Coronary Syndrome. Journal of Interventional Cardiology 22:3, 216-221
CrossRef366
Roland Stocker. (2009) Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analogues. Current Opinion in Lipidology 20:3, 227-235
CrossRef367
Gennaro Sardella, Riccardo Colantonio, Leonardo De Luca, Giulia Conti, Angelo Di Roma, Massimo Mancone, Emanuele Canali, Giulia Benedetti, Francesco Fedele. (2009) Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes. Journal of Cardiovascular Medicine 10:6, 469-473
CrossRef368
Neville Kukreja, Yoshinobu Onuma, Hector M. Garcia-Garcia, Joost Daemen, Ron van Domburg, Patrick W. Serruys. (2009) The Risk of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Bare-Metal and Drug-Eluting Stents. JACC: Cardiovascular Interventions 2:6, 534-541
CrossRef369
Alfredo Rodriguez, Andrew Maree, Sonia Tarragona, Carlos Fernandez-Pereira, Omar Santaera, Alfredo Rodriguez Granillo, Gaston Rodriguez-Granillo, Miguel Russo-Felssen, Neville Kukreja, David Antoniucci, Igor Palacios, Patrick Serruys. (2009) Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study. EuroIntervention 5:2, 255-264
CrossRef370
Emilio Di Lorenzo, Giuseppe De Luca, Rosario Sauro, Attilio Varricchio, Michele Capasso, Tonino Lanzillo, Fiore Manganelli, Ciro Mariello, Francesco Siano, Maria Rosaria Pagliuca, Giovanni Stanco, Giuseppe Rosato. (2009) The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial. JACC: Cardiovascular Interventions 2:6, 515-523
CrossRef371
Bryan P. Yan, David J. Clark, Brian Buxton, Andrew E. Ajani, Julian A. Smith, Stephen J. Duffy, Gil C. Shardey, Peter D. Skillington, Omar Farouque, Michael Yii, Cheng-Hon Yap, Nick Andrianopoulos, Angela Brennan, Diem Dinh, Christopher M. Reid. (2009) Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Heart, Lung and Circulation 18:3, 184-190
CrossRef372
Jochen Wöhrle, Thorsten Nusser, Simone Langenwalder, Vinzenz Heombach, Matthias Kochs. (2009) Carbon-coated Stents in Patients with Acute Coronary Syndromes. Clinical Cardiology 32:6, E1-E6
CrossRef373
Francesco Tomassini, Ferdinando Varbella, Andrea Gagnor, Vincenzo Infantino, Stefania Luceri, Maria Rosa Conte. (2009) Severe multivessel coronary spasm after sirolimus-eluting stent implantation. Journal of Cardiovascular Medicine 10:6, 485-488
CrossRef374
Dennis T. Ko, Maria Chiu, Helen Guo, Peter C. Austin, Ron Goeree, Eric Cohen, Marino Labinaz, Jack V. Tu. (2009) Safety and Effectiveness of Drug-Eluting and Bare-Metal Stents for Patients With Off- and On-Label Indications. Journal of the American College of Cardiology 53:19, 1773-1782
CrossRef375
Francesco Saia, Giancarlo Piovaccari, Antonio Manari, Paolo Guastaroba, Luigi Vignali, Elisabetta Varani, Andrea Santarelli, Alberto Benassi, Armando Liso, Gianluca Campo, Stefano Tondi, Fabio Tarantino, Rossana De Palma, Antonio Marzocchi. (2009) Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry. EuroIntervention 5:1, 57-66
CrossRef376
Somjot S. Brar, Martin B. Leon, Gregg W. Stone, Roxana Mehran, Jeffrey W. Moses, Simerjeet K. Brar, George Dangas. (2009) Use of Drug-Eluting Stents in Acute Myocardial Infarction. Journal of the American College of Cardiology 53:18, 1677-1689
CrossRef377
Corrado Tamburino, Davide Capodanno. (2009) Evolution of stents: past, present and future. Expert Review of Cardiovascular Therapy 7:5, 443-446
CrossRef378
Neville Kukreja, Yoshinobu Onuma, Patrick W Serruys. (2009) Xience V™ everolimus-eluting coronary stent. Expert Review of Medical Devices 6:3, 219-229
CrossRef379
B. Struk, M. Gailani, C. Michael Gross. (2009) Die Behandlung der koronaren Mehrgefäßerkrankung: Bypassoperation oder perkutane Katheterintervention?. Clinical Research in Cardiology Supplements 4:S2, 154-159
CrossRef380
John Lasala, David Cox, Stephen Lewis, Peter Tadros, Robert Haas, Marc Schweiger, Anil Chhabra, William Untereker, Ruth Starzyk, Stephen Mascioli, Keith Dawkins, Donald Baim. (2009) Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme. EuroIntervention 5:1, 67-77
CrossRef381
Takeshi Serikawa, Tomohiro Kawasaki, Hisashi Koga. (2009) Impressive sirolimus-eluting stent fracture immediately after stent implantation: A case report. International Journal of Cardiology 134:3, e113-e116
CrossRef382
Tomoaki Higo, Yasunori Ueda, Jota Oyabu, Katsuki Okada, Mayu Nishio, Akio Hirata, Kazunori Kashiwase, Nobuyuki Ogasawara, Shinichi Hirotani, Kazuhisa Kodama. (2009) Atherosclerotic and Thrombogenic Neointima Formed Over Sirolimus Drug-Eluting Stent. JACC: Cardiovascular Imaging 2:5, 616-624
CrossRef383
Michelle J. Butler, David Eccleston, David J. Clark, Andrew E. Ajani, Nick Andrianopoulos, Angela Brennan, Gishel New, Alexander Black, Gregory Szto, Chris M. Reid, Bryan P. Yan, James A. Shaw, Anthony M. Dart, Stephen J. Duffy. (2009) The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. American Heart Journal 157:5, 899-907
CrossRef384
Xuebo Liu, Hiroshi Doi, Akiko Maehara, Gary S. Mintz, Jose de Ribamar Costa, Koichi Sano, Giora Weisz, George D. Dangas, Alexandra J. Lansky, Edward M. Kreps, Michael Collins, Martin Fahy, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, Roxana Mehran. (2009) A Volumetric Intravascular Ultrasound Comparison of Early Drug-Eluting Stent Thrombosis Versus Restenosis. JACC: Cardiovascular Interventions 2:5, 428-434
CrossRef385
Pamela S. Douglas, J. Matthew Brennan, Kevin J. Anstrom, Art Sedrakyan, Eric L. Eisenstein, Ghazala Haque, David Dai, David F. Kong, Bradley Hammill, Lesley Curtis, David Matchar, Ralph Brindis, Eric D. Peterson. (2009) Clinical Effectiveness of Coronary Stents in Elderly Persons. Journal of the American College of Cardiology 53:18, 1629-1641
CrossRef386
Horma Ouldzein, Jérome Roncalli, Walid Zouaoui, Vanina Bongard, Nicolas Boudou, Nicolas Dumonteil, Thibaut Lhermusier, Meyer Elbaz, Jacques Puel, Didier Carrié. (2009) Drug-eluting or bare-metal stents in subjects over 75 years of age: what is the best therapeutic strategy? Data from 460 consecutive patients with 1-year outcome. Cardiovascular Revascularization Medicine 10:2, 94-102
CrossRef387
ANDREI POP, CINDY L. GRINES. (2009) Choice of DES: A US Clinician's Perspective. Journal of Interventional Cardiology 22, S72-S85
CrossRef388
Tullio Palmerini, Antonio Marzocchi, Corrado Tamburino, Imad Sheiban, Massimo Margheri, Giuseppe Vecchi, Giuseppe Sangiorgi, Andrea Santarelli, Antonio L. Bartorelli, Carlo Briguori, Luigi Vignali, Francesco Di Pede, Angelo Ramondo, Luigi Inglese, Marco De Carlo, Leonardo Bolognese, Alberto Benassi, Cataldo Palmieri, Vincenzo Filippone, Diego Sangiorgi, Fabio Barlocco, Giulia Lauria, Stefano De Servi. (2009) Temporal Pattern of Ischemic Events in Relation to Dual Antiplatelet Therapy in Patients With Unprotected Left Main Coronary Artery Stenosis Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology 53:14, 1176-1181
CrossRef389
RAYMOND MIU, PATRICK W. SERRUYS, GREGG W. STONE. (2009) Performance of Everolimus-Eluting Stents: Pooled Analysis from the SPIRIT Trials. Journal of Interventional Cardiology 22, S41-S47
CrossRef390
Corrado Tamburino, Rossella Barbagallo, Davide Capodanno, Sergio di Matteo, Giorgio L Colombo, Martino Recchia, Saverio Ciriminna. (2009) Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry. Journal of Cardiovascular Medicine 10:4, 322-329
CrossRef391
Leandro Ignacio Lasave, J. Ribamar Costa, Ricardo Costa, Andrea Abizaid, Fausto Feres, Rodolfo Staico, Galo Maldonado, Luiz A. Mattos, Pedro Beraldo, Amanda G. M. R. Sousa, J. Eduardo Sousa, Alexandre Abizaid. (2009) Correlation between quantitative angiographic and intravascular ultrasound parameters in patients treated with sirolimus analogous-eluting stents. The International Journal of Cardiovascular Imaging 25:4, 345-351
CrossRef392
Nuno M. Pires, J. Wouter Jukema. (2009) Early Systemic Inflammatory Response to Drug-Eluting Stents Implantation: The Heart of the Difference?. Cardiovascular Drugs and Therapy 23:2, 103-105
CrossRef393
Thomas W. Johnson, I. Patrick Kay, John A. Ormiston. (2009) A novel paclitaxel-eluting dedicated bifurcation stent: A case report from the first human use Taxus Petal trial. Catheterization and Cardiovascular Interventions 73:5, 637-640
CrossRef394
Aloke V. Finn, Gaku Nakazawa, Frank D. Kolodgie, Renu Virmani. (2009) Temporal Course of Neointimal Formation After Drug-Eluting Stent Placement. JACC: Cardiovascular Interventions 2:4, 300-302
CrossRef395
Gilles Lemesle, Laurent Bonello, Axel de Labriolle, Daniel H. Steinberg, Probal Roy, Tina L. Pinto Slottow, Rebecca Torguson, Kimberly Kaneshige, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, Ron Waksman. (2009) Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheterization and Cardiovascular Interventions 73:5, 612-617
CrossRef396
GERRIT HELLIGE, STEPHAN WINDECKER. (2009) Head-to-Head and Extrapolated Comparisons of Different Drug-Eluting Stents: Differences in Late Loss, Restenosis, and Clinical Outcomes. Journal of Interventional Cardiology 22, S48-S63
CrossRef397
ABDALLAH G. REBEIZ, ELIE ZOGHBI, RAMI HARB, SONIA YOUHANNA, HADI N. SKOURI, ADEL DIMASSI, GILBERT ABOU-NADER, ANTOINE NASRALLAH, JABER SAWAYA, WALID GHARZUDDINE, SAMIR ALAM. (2009) Comparison of the Systemic Levels of Inflammatory Markers after Percutaneous Coronary Intervention with Bare Metal versus Sirolimus-Eluting Stents. Journal of Interventional Cardiology 22:2, 169-174
CrossRef398
Albert E. Alahmar, Antony D. Grayson, Mohammed Andron, Mohaned Egred, Elved D. Roberts, Bilal Patel, Roger K.G. Moore, Khaled Albouaini, Mark Jackson, Raphael A. Perry. (2009) Reduction in mortality and target-lesion revascularisation at 2 years: A comparison between drug-eluting stents and conventional bare-metal stents in the “real world”. International Journal of Cardiology 132:3, 398-404
CrossRef399
Cecilia Svedman, Susanne Ekqvist, Halvor Möller, Jonas Björk, Carl-Magnus Pripp, Birgitta Gruvberger, Eva Holmström, Carl-Gunnar Gustavsson, Magnus Bruze. (2009) A correlation found between contact allergy to stent material and restenosis of the coronary arteries. Contact Dermatitis 60:3, 158-164
CrossRef400
Alberto Berenguer, Pascual Bordes, Vicente Mainar, Jose Valencia, Silvia Gómez, Teresa Lozano. (2009) Predictors of death after coronary stenting with sirolimus-eluting stent in high-risk patients. International Journal of Cardiology 132:3, 342-347
CrossRef401
Lakshmana K. Pendyala, Jinsheng Li, Toshiro Shinke, Sarah Geva, Xinhua Yin, Jack P. Chen, Spencer B. King, Keith A. Robinson, Nicolas A.F. Chronos, Dongming Hou. (2009) Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress. JACC: Cardiovascular Interventions 2:3, 253-262
CrossRef402
Ehtisham Mahmud, John A. Ormiston, Mark A. Turco, Jeffrey J. Popma, Neil J. Weissman, Charles D. O'Shaughnessy, Tift Mann, Jack J. Hall, Thomas F. McGarry, Louis A. Cannon, Mark W.I. Webster, Lazar Mandinov, Donald S. Baim. (2009) TAXUS Liberté Attenuates the Risk of Restenosis in Patients With Medically Treated Diabetes Mellitus. JACC: Cardiovascular Interventions 2:3, 240-252
CrossRef403
Eberhard Grube, Keith Dawkins, Giulio Guagliumi, Adrian Banning, Krzysztof Zmudka, Antonio Colombo, Leif Thuesen, Karl Hauptman, Jean Marco, William Wijns, Anita Joshi, Stephen Mascioli. (2009) TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions. EuroIntervention 4:5, 572-577
CrossRef404
Corrado Tamburino, Alessio La Manna, Maria Elena Di Salvo, Giorgio Sacchetta, Davide Capodanno, Roxana Mehran, George Dangas, Thierry Corcos, Francesco Prati. (2009) First-in-Man 1-Year Clinical Outcomes of the Catania Coronary Stent System With Nanothin Polyzene-F in De Novo Native Coronary Artery Lesions. JACC: Cardiovascular Interventions 2:3, 197-204
CrossRef405
David A. Brown, Edward W. Lee, Christopher T. Loh, Stephen T. Kee. (2009) A New Wave in Treatment of Vascular Occlusive Disease: Biodegradable Stents—Clinical Experience and Scientific Principles. Journal of Vascular and Interventional Radiology 20:3, 315-324
CrossRef406
Susana Ayyanathan, David Hersh, Neil L. Coplan, Kirk Garratt. (2009) The Problem of Stent Thrombosis Associated With Drug-Eluting Stents and the Optimal Duration of Dual Antiplatelet Therapy. Preventive Cardiology 12:2, 59-64
CrossRef407
Hiroshi Doi, Akiko Maehara, Gary S. Mintz, Kenichi Tsujita, Takashi Kubo, Celia Castellanos, Jian Liu, Junqing Yang, Carlos Oviedo, Jiro Aoki, Theresa Franklin-Bond, Neil Dasgupta, Alexandra J. Lansky, George D. Dangas, Gregg W. Stone, Jeffrey W. Moses, Roxana Mehran, Martin B. Leon. (2009) Classification and Potential Mechanisms of Intravascular Ultrasound Patterns of Stent Fracture. The American Journal of Cardiology 103:6, 818-823
CrossRef408
Yoritaka Otsuka. (2009) A novel 0.010-inch guidewire for crossing jailed sidebranches. Catheterization and Cardiovascular Interventions 73:3, 346-349
CrossRef409
Michael Maeng, Lisette Okkels Jensen, Anders Michael Galloe, Per Thayssen, Evald Hoej Christiansen, Knud Nørregaard Hansen, Steffen Helqvist, Hans Erik Botker, Jens Flensted Lassen, Leif Thuesen. (2009) Comparison of the Sirolimus-Eluting Versus Paclitaxel-Eluting Coronary Stent in Patients With Diabetes Mellitus: The Diabetes and Drug-Eluting Stent (DiabeDES) Randomized Angiography Trial. The American Journal of Cardiology 103:3, 345-349
CrossRef410
Flavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, Giacomo Boccuzzi, Patrizia Presbitero, Gabriele Pesarini, Valeria Ferrero, Anna S Ghini, Francesca Pastori, Leonardo De Luca, Denis Zavalloni, Daniela Soregaroli, Roberto Garbo, Elena Franchi, Paolo Marino, Massimo Minelli, Corrado Vassanelli. (2009) A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) – study design and rationale. Journal of Cardiovascular Medicine 10:2, 192-199
CrossRef411
Anne Kaltoft, Lisette Okkels Jensen, Michael Maeng, Hans Henrik Tilsted, Per Thayssen, Morten Bøttcher, Jens Flensted Lassen, Lars Romer Krusell, Klaus Rasmussen, Knud Nørregaard Hansen, Lars Pedersen, Søren Paaske Johnsen, Henrik Toft Sørensen, Leif Thuesen. (2009) 2-Year Clinical Outcomes After Implantation of Sirolimus-Eluting, Paclitaxel-Eluting, and Bare-Metal Coronary Stents. Journal of the American College of Cardiology 53:8, 658-664
CrossRef412
Dean J. Kereiakes. (2009) Medical and catheter-based therapies for managing stable coronary disease: Lessons from the COURAGE trial. Current Treatment Options in Cardiovascular Medicine 11:1, 45-53
CrossRef413
Armin Arbab-Zadeh. (2009) Medical Therapy Versus Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease. Journal of the American College of Cardiology 53:6, 528-529
CrossRef414
Tomohiro Kawasaki, Hisashi Koga, Takeshi Serikawa, Yoshiya Orita, Shinsuke Ikeda, Takahiro Mito, Yoshitaka Gotou, Yoshiaki Shintani, Atsushi Tanaka, Hidenori Tanaka, Takaya Fukuyama, Nobuhiko Koga. (2009) Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion. Catheterization and Cardiovascular Interventions 73:2, 205-211
CrossRef415
Laurent Bonello, Axel De Labriolle, Gilles Lemesle, Probal Roy, Daniel H. Steinberg, Tina L. Pinto Slottow, Zhenyi Xue, Rebecca Torguson, Kimberly Kaneshige, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, Ron Waksman. (2009) Comparison of Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in Nonostial Proximal Left Anterior Descending Coronary Arteries. The American Journal of Cardiology 103:4, 496-500
CrossRef416
Jian Liu, Akiko Maehara, Gary S. Mintz, Neil J. Weissman, Alan Yu, Hong Wang, Lazar Mandinov, Jeffrey J. Popma, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins, Gregg W. Stone. (2009) An Integrated TAXUS IV, V, and VI Intravascular Ultrasound Analysis of the Predictors of Edge Restenosis After Bare Metal or Paclitaxel-Eluting Stents. The American Journal of Cardiology 103:4, 501-506
CrossRef417
Corrado Tamburino, Maria Elena Di Salvo, Davide Capodanno, Piera Capranzano, Rosario Parisi, Francesca Mirabella, Francesco Scardaci, Gianpaolo Ussia, Alfredo Ruggero Galassi, Damiana Fiscella, Roxana Mehran, George Dangas. (2009) Real world safety and efficacy of the Janus tacrolimus-eluting stent: Long-term clinical outcome and angiographic findings from the tacrolimus-eluting stent (TEST) registry. Catheterization and Cardiovascular Interventions 73:2, 243-248
CrossRef418
Daniel H. Steinberg, Michael A. Gaglia, Tina L. Pinto Slottow, Probal Roy, Laurent Bonello, Axel De Labriolle, Gilles Lemesle, Rebecca Torguson, Kimberly Kineshige, Zhenyi Xue, William O. Suddath, Kenneth M. Kent, Lowell F. Satler, Augusto D. Pichard, Joseph Lindsay, Ron Waksman. (2009) Outcome Differences With the Use of Drug-Eluting Stents for the Treatment of In-Stent Restenosis of Bare-Metal Stents Versus Drug-Eluting Stents. The American Journal of Cardiology 103:4, 491-495
CrossRef419
Taro Saito, Seiji Hokimoto, Syuichi Oshima, Katsuo Noda, Yasuko Kojyo, Kayoko Matsunaga. (2009) Metal allergic reaction in chronic refractory in-stent restenosis. Cardiovascular Revascularization Medicine 10:1, 17-22
CrossRef420
David Maintz, Matthias C. Burg, Harald Seifarth, Alexander C. Bunck, Murat Özgün, Roman Fischbach, Kai Uwe Jürgens, Walter Heindel. (2009) Update on multidetector coronary CT angiography of coronary stents: in vitro evaluation of 29 different stent types with dual-source CT. European Radiology 19:1, 42-49
CrossRef421
Takashi Nakayama, Yoshio Kobayashi, Hiroyuki Takano, Nakabumi Kuroda, Kenzo Hiroshima, Issei Komuro. (2009) Silent Very Late Thrombotic Occlusion of Sirolimus-Eluting Stent Confirmed by Directional Coronary Atherectomy. Circulation Journal 73:9, 1762-1764
CrossRef422
Tae-Hyun Yang, Doo-Il Kim, Seong-Gill Park, Jeong-Sook Seo, Hwan-Jin Cho, Sang-Hoon Seol, Seong-Man Kim, Dae-Kyeong Kim, Dong-Soo Kim. (2009) Clinical characteristics of stent fracture after sirolimus-eluting stent implantation. International Journal of Cardiology 131:2, 212-216
CrossRef423
Jack L. Martin, Stephen G. Ellis, Antonio Colombo, Eberhard Grube, Tom Maloney, Mark I. Friedman, Donald S. Baim, Keith Dawkins, Ron Caputo, Gregg W. Stone. (2009) Frequency of Coronary Artery Bypass Grafting Following Implantation of a Paclitaxel-Eluting or a Bare-Metal Stent Into a Single Coronary Artery. The American Journal of Cardiology 103:1, 11-16
CrossRef424
Neville Kukreja, Yoshinobu Onuma, Hector M. Garcia-Garcia, Joost Daemen, Ron van Domburg, Patrick W. Serruys. (2009) Three-Year Survival Following Multivessel Percutaneous Coronary Intervention With Bare-Metal or Drug-Eluting Stents in Unselected Patients. The American Journal of Cardiology 103:2, 203-211
CrossRef425
R.T. Gerber, A. Latib, A. Ielasi, J. Cosgrave, A. Qasim, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, J. Tobis, A. Colombo. (2009) Defining a new standard for IVUS optimized drug eluting stent implantation: The PRAVIO study. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef426
Joost Daemen, Maarten Simoons, William Wijns, Adrian Bagust, Gert Bos, James Bowen, Eugene Braunwald, Edoardo Camenzind, Bernard Chevalier, Carlo Di Mario, Jean Fajadet, Anselm Gitt, Giulio Guagliumi, Hans Hillege, Stefan James, Peter Jüni, Adnan Kastrati, Sabine Kloth, Steen Kristensen, Mitchell Krucoff, Victor Legrand, Matthias Pfisterer, Martin Rothman, Patrick Serruys, Sigmund Silber, Philippe Steg, Ibrahim Tariah, Lars Wallentin, Stephan Windecker. (2009) Meeting report ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007. EuroIntervention 4:4, 427-436
CrossRef427
Sinisa Stojkovic, Miodrag Ostojic, Milan Nedeljkovic, Goran Stankovic, Branko Beleslin, Vladan Vukcevic, Dejan Orlic, Aleksandra Arandjelovic, Jelena Kostic, Miodrag Dikic, Miloje Tomasevic. (2009) Systemic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef428
Takahiro Sawada, Junya Shite, Noriyuki Negi, Toshiro Shinke, Yusuke Tanino, Daisuke Ogasawara, Hiroyuki Kawamori, Hiroki Kato, Naoki Miyoshi, Naoki Yoshino, Amane Kozuki, Masanobu Koto, Ken-ichi Hirata. (2009) Factors That Influence Measurements and Accurate Evaluation of Stent Apposition by Optical Coherence Tomography. Circulation Journal 73:10, 1841-1847
CrossRef429
Zhongrong R. Miao, Lei Feng, Shengmao Li, Fengshui Zhu, Xunming Ji, Liqun Jiao, Feng Ling. (2009) TREATMENT OF SYMPTOMATIC MIDDLE CEREBRAL ARTERY STENOSIS WITH BALLOON-MOUNTED STENTS. Neurosurgery 64:1, 79-85
CrossRef430
Hong-Yu Peng, Ming Chen, Bo Zheng, Xin-Gang Wang, Yong Huo. (2009) Long-Term Effects of Novel Biodegradable, Polymer-Coated, Sirolimus-Eluting Stents on Neointimal Formation in a Porcine Coronary Model. International Heart Journal 50:6, 811-822
CrossRef431
Daisuke Murakami, Masamichi Takano, Masanori Yamamoto, Shigenobu Inami, Takayoshi Ohba, Yoshihiko Seino, Kyoichi Mizuno. (2009) Advanced Neointimal Growth is Not Associated With a Low Risk of In-Stent Thrombus. Circulation Journal 73:9, 1627-1634
CrossRef432
Gaku Nakazawa, Aloke V Finn, Frank D Kolodgie, Renu Virmani. (2009) A review of current devices and a look at new technology: drug-eluting stents. Expert Review of Medical Devices 6:1, 33-42
CrossRef433
Man Hong Jim, Hee Hwa Ho, Ryan Lap-yan Ko, Kai Hang Yiu, Chung Wah Siu, Chu Pak Lau, Wing Hing Chow. (2009) Paclitaxel-Eluting Stent Long-Term Outcomes in Percutaneous Saphenous Vein Graft Interventions (PELOPS) Study. The American Journal of Cardiology 103:2, 199-202
CrossRef434
Johannes Dahm, Tine Willems, Hans Wolpers, Hans Nordbeck, Jürgen Becker, Jörg Ruppert. (2009) Clinical investigation into the observation that silicon carbide coating on cobalt chromium stents leads to early differentiating functional endothelial layer, increased safety and DES-like recurrent stenosis rates: results of the PRO-Heal Registry (PRO-Kinetic enhancing rapid in-stent endothelialisation). EuroIntervention 4:4, 502-508
CrossRef435
Giuseppe De Luca, Harry Suryapranata, Arnoud WJ vanʼt Hof, Jan Paul Ottervanger, Jan CA Hoorntje, Jan-Henk Dambrink, AT Marcel Gosselink, Menko-Jan de Boer. (2009) Routine stenting vs. balloon angioplasty in ST-segment elevation myocardial infarction due to proximal left anterior descending coronary artery occlusion. Journal of Cardiovascular Medicine 10:1, 22-26
CrossRef436
Yun-Kyeong Cho, Seung-Ho Hur, Hyun-Tae Kim, In-Cheol Kim, Hyoung-Seob Park, Hyuck-Jun Yoon, Chang-Wook Nam, Hyungseop Kim, Seong-Wook Han, Yoon-Nyun Kim, Kwon-Bae Kim. (2009) Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study. The Korean Journal of Internal Medicine 24:4, 323
CrossRef437
Jozef Jakabc
in, Radim S
CrossRef438
Hideki Kitahara, Yoshio Kobayashi, Hideo Takebayashi, Yoshitake Nakamura, Nakabumi Kuroda, Akira Miyazaki, Seiichi Haruta, Issei Komuro. (2009) Angiographic Patterns of Restenosis After Sirolimus-Eluting Stent Implantation. Circulation Journal 73:3, 508-511
CrossRef439
Vassilis Voudris, Panagiotis Kariofillis, Sophia Thomopoulou, Sotiris Patsilinakos, Athanasios Manginas, Constantinos Spargias, Gregory Pavlides, Dennis Cokkinos. (2009) Predictors for very late stent thrombosis after drug-eluting stent implantation in diabetic patients. EuroIntervention 4:4, 485-491
CrossRef440
Wolfgang Bocksch, Francisco Pomar, Mieczyslaw Dziarmaga, Damras Tresukosol, Omar Ismail, Bronislav Janek, Joerg Carlsson, Jean-Philippe Simon, . (2009) Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: Results of the real world Coroflex Blue Registry. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef441
Harald Vik-Mo. (2009) Better results with the new generation bare metal stents. Scandinavian Cardiovascular Journal 43:2, 84-86
CrossRef442
Nilesh J. Goswami, Matthew Gaffigan, Gadiel Berrio, Anna L. Plessa, Amanda M. Pfeiffer, Stephen J. Markwell, Gregory J. Mishkel. (2009) Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease:. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef443
Sun-Jung Song, Kyoung Seok Kim, Yu Jeong Park, Myung Ho Jeong, Yeong-Mu Ko, Dong Lyun Cho. (2009) Preparation of a dual-drug-eluting stent by grafting of ALA with abciximab on a bare metal stent. Journal of Materials Chemistry 19:43, 8135
CrossRef444
Luis A. Brito, Saradha Chandrasekhar, Steven R. Little, Mansoor M. Amiji. (2009) In vitro and In vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stents. Journal of Biomedical Materials Research Part A 9999A, NA-NA
CrossRef445
Andrea Pavei, Jacopo Oreglia, Guillaume Martin, Petr Tousek, Faisal Sharif, Bruno Farah, Antoine Sauguet, Jean Fajadet. (2009) Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome. EuroIntervention 4:4, 457-463
CrossRef446
P. Commeau. (2008) Endovascular procedures for below the knee arteries in diabetics. Annales de Cardiologie et d'Angéiologie 57:6, 352-358
CrossRef447
Michael S. Lee, Jon Kobashigawa, Jonathan Tobis. (2008) Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft Vasculopathy. JACC: Cardiovascular Interventions 1:6, 710-715
CrossRef448
Michael S. Lee, Daniel Jurewitz, Raymond Zimmer, Antonio Pessegueiro, Ravi Bhatia, Jesse Currier, Larry Yeatman, Jonathan M. Tobis. (2008) Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents. Catheterization and Cardiovascular Interventions 72:7, 909-914
CrossRef449
Gopinath Mani, Dave M. Johnson, Denes Marton, Marc D. Feldman, Devang Patel, Arturo A. Ayon, C. Mauli Agrawal. (2008) Drug delivery from gold and titanium surfaces using self-assembled monolayers. Biomaterials 29:34, 4561-4573
CrossRef450
John Kao, Ricardo Vicuna, John A. House, John S. Rumsfeld, Henry H. Ting, John A. Spertus. (2008) Disparity in drug-eluting stent utilization by insurance type. American Heart Journal 156:6, 1133-1140
CrossRef451
Terrence L. Trentman, David M. Rosenfeld, David R. Danielson, Susan G. Hagstrom. (2008) Drug-Eluting Stents: Patient Understanding of the Risks of Premature Cessation of Antiplatelet Drugs. Journal of Cardiothoracic and Vascular Anesthesia 22:6, 806-810
CrossRef452
Christian Herdeg, Katrin Goehring-Frischholz, Christine Zuern, Tobias Geisler, Ulrike Hartmann, Tobias Hoevelborn, Karl K. Haase, Meinrad Gawaz. (2008) Local catheter-based delivery of antithrombotic or antiproliferative drugs: A new concept for prevention of restenosis. Thrombosis Research 123:2, 236-243
CrossRef453
CHI-HANG LEE, JUNJIE ZHANG, ANAND KAILASAM, BEE-CHOO TAI, FEI YE, ADRIAN F. LOW, XUMIN HOU, EDOURDO TIN HAY, SWEE-GUAN TEO, YEAN-TENG LIM, SHAOLIANG CHEN, HUAY-CHEEM TAN. (2008) An Intravascular Ultrasound Study of Cypher, Taxus, and Endeavor Stents on Relation between Neointimal Proliferation and Residual Plaque Burden. Journal of Interventional Cardiology 21:6, 519-527
CrossRef454
Filippo Cademartiri, Erica Maffei, Alessandro Palumbo, Nazario Carrabba, Diego Ardissino, Nico R. Mollet, Gabriel P. Krestin, Pim J. Feyter. (2008) Multi-slice CT coronary angiography for the detection of in-stent restenosis. Current Cardiovascular Imaging Reports 1:2, 119-124
CrossRef455
Mark A. Turco, John A. Ormiston, Jeffrey J. Popma, Jack J. Hall, Tift Mann, Louis A. Cannon, Mark W.I. Webster, Gregory J. Mishkel, Charles D. O'Shaughnessy, Thomas F. McGarry, Lazar Mandinov, Keith D. Dawkins, Donald S. Baim. (2008) Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent. JACC: Cardiovascular Interventions 1:6, 699-709
CrossRef456
Bryan P. Yan, Andrew E. Ajani, Gishel New, Stephen J. Duffy, Omar Farouque, James Shaw, Martin Sebastian, Robert Lew, Angela Brennan, Nick Andrianopoulos, Chris Reid, David J. Clark. (2008) Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry. International Journal of Cardiology 130:3, 374-379
CrossRef457
Qasim Bashir, Aamir Badruddin, Victor Aletich. (2008) Endovascular Techniques for Stroke Prevention. Neurologic Clinics 26:4, 1099-1127
CrossRef458
Nadia Garro, Davide Capodanno, Valeria Cammalleri, Corrado Tamburino. (2008) Very late thrombosis in acute myocardial infarction: drug-eluting versus uncoated stents. EuroIntervention 4:3, 324-330
CrossRef459
Nobuaki Suzuki, Dominick J. Angiolillo, Carmela Monteiro, Sania Shuja, Hideki Futamatsu, Ren Kawaguchi, Lyndon C. Box, Luis Guzman, Martin M. Zenni, Paul S. Gilmore, Theodore A. Bass, Marco A. Costa. (2008) Variable histological and ultrasonic characteristics of restenosis after drug-eluting stents. International Journal of Cardiology 130:3, 444-448
CrossRef460
Gaku Nakazawa, Aloke V Finn, Elena Ladich, Flavio Ribichini, Leslie Coleman, Frank D Kolodgie, Renu Virmani. (2008) Drug-eluting stent safety: findings from preclinical studies. Expert Review of Cardiovascular Therapy 6:10, 1379-1391
CrossRef461
Charles Chan, Robaayah Zambahari, Upendra Kaul, CP Lau, Hall Whitworth, Sidney Cohen, Maurice Buchbinder, . (2008) A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: The DECODE study. Catheterization and Cardiovascular Interventions 72:5, 591-600
CrossRef462
Trung Tran, Michael Brown, John Lasala. (2008) An evidence-based approach to the use of rotational and directional coronary atherectomy in the era of drug-eluting stents: When does it make sense?. Catheterization and Cardiovascular Interventions 72:5, 650-662
CrossRef463
William Hillegass. (2008) Native vessel PCI in the diabetic: DES whenever feasible. Catheterization and Cardiovascular Interventions 72:5, 608-609
CrossRef464
John M. Lasala, David A. Cox, David Dobies, Joseph B. Muhlestein, John N. Katopodis, George Revtyak, Donald S. Baim, . (2008) Usage patterns and 2-year outcomes with the TAXUS express stent: Results of the US ARRIVE 1 registry. Catheterization and Cardiovascular Interventions 72:4, 433-445
CrossRef465
Vedat Aytekin, Refik Erdim, Selcuk Gormez, Cemsid Demiroglu. (2008) Very late thrombosis of paclitaxel-eluting stent. Cardiovascular Revascularization Medicine 9:4, 275-277
CrossRef466
Cosmo Godino, Shinichi Furuichi, Azeem Latib, Nuccia Morici, Alaide Chieffo, Enrico Romagnoli, Corrado Tamburino, Rossella Barbagallo, Michela Cera, David Antoniucci, Omer Goktekin, Carlo Di Mario, Bernard Reimers, Eberhard Grube, Flavio Airoldi, Giuseppe M. Sangiorgi, Antonio Colombo. (2008) Clinical and Angiographic Follow-Up of Small Vessel Lesions Treated With Paclitaxel-Eluting Stents (from the TRUE Registry). The American Journal of Cardiology 102:8, 1002-1008
CrossRef467
Matthew J. Price, Paul S. Teirstein. (2008) The off- versus on-label use of medical devices in interventional cardiovascular medicine: Clarifying the ambiguity between regulatory labeling and clinical decision-making, Part 1: PCI. Catheterization and Cardiovascular Interventions 72:4, 500-504
CrossRef468
Jozef Jakabčin, Marian Bystroň, Radim Špaček, Josef Veselka, Martin Kvašňak, Petr Kala, Jaroslav Malý, Pavel Červinka. (2008) The lack of endothelization after drug-eluting stent implantation as a cause of fatal late stent thrombosis. Journal of Thrombosis and Thrombolysis 26:2, 154-158
CrossRef469
James A. Shaw, Nick Andrianopoulos, Stephen Duffy, Anthony S. Walton, David Clark, Robert Lew, Martin Sebastian, Gishel New, Angela Brennan, Chris Reid, Andrew E. Ajani. (2008) Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents. Cardiovascular Revascularization Medicine 9:4, 218-223
CrossRef470
Mayraj Ahmad, Jon-David R. Schwalm, James L. Velianou, Dan Pericak, Madhu K. Natarajan. (2008) Comparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice. Canadian Journal of Cardiology 24:10, 771-775
CrossRef471
KONSTANTINOS TOUTOUZAS, CHRYSOULA PATSA, ELEFTHERIOS TSIAMIS, COSTAS TSIOUFIS, ANASTASIOS SPANOS, ELLI STEFANADI, COSTAS TENTOLOURIS, CHRISTODOULOS STEFANADIS. (2008) Everolimus- and Zotarolimus-Eluting Stents for Bare Metal Stent In-Stent Restenosis Treatment: A Prospective Study. Journal of Interventional Cardiology 21:5, 388-394
CrossRef472
Keiichi Tsuchida, Joost Daemen, Shuzou Tanimoto, Héctor M. García-García, Neville Kukreja, Sophia Vaina, Andrew T.L. Ong, Georgios Sianos, Peter P.T. de Jaegere, Ron T. van Domburg, Patrick W. Serruys. (2008) Two-year outcome of the use of paclitaxel-eluting stents in aorto-ostial lesions. International Journal of Cardiology 129:3, 348-353
CrossRef473
Jiro Aoki, Gary S. Mintz, Neil J. Weissman, Lazar Mandinov, Eberhard Grube, Keith D. Dawkins, Stephen G. Ellis, Joel Greenberg, Alan Yu, J. Tift Mann, Louis Cannon, Patrick A. Cambier, Gregg W. Stone. (2008) Impact of Mild or Moderate Renal Insufficiency on the Intravascular Ultrasonic Analysis of Chronic Vascular Response to Paclitaxel-Eluting and Bare-Metal Stents (from the TAXUS IV, V, and VI Trials). The American Journal of Cardiology 102:8, 1009-1016
CrossRef474
Gilles Lemesle, Arnaud Sudre, Thomas Modine, Cédric Delhaye, Guillaume Rosey, Terry Gourlay, Christophe Bauters, Jean-Marc Lablanche. (2008) High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis. Catheterization and Cardiovascular Interventions 72:4, 470-478
CrossRef475
Gregg W. Stone, Stephen G. Ellis, Antonio Colombo, Eberhard Grube, Keith D. Dawkins, Mark Friedman, Donald S. Baim. (2008) Effect of Prolonged Thienopyridine Use After Drug-Eluting Stent Implantation (from the TAXUS Landmark Trials Data). The American Journal of Cardiology 102:8, 1017-1022
CrossRef476
J. M. Ruiz-Nodar, F. Marin, J. Sanchez-Paya, J. A. Hurtado, J. Valencia-Martin, S. Manzano-Fernandez, V. Roldan, V. Perez-Andreu, F. Sogorb, M. Valdes, G. Y.H. Lip. (2008) Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. European Heart Journal 30:8, 932-939
CrossRef477
S. R. Steinhubl, P. B. Berger. (2008) Aspirin following PCI: too much of a good thing?. European Heart Journal 30:8, 882-884
CrossRef478
Mauri, Laura, Silbaugh, Treacy S., Garg, Pallav, Wolf, Robert E., Zelevinsky, Katya, Lovett, Ann, Varma, Manu R., Zhou, Zheng, Normand, Sharon-Lise T., . (2008) Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction. New England Journal of Medicine 359:13, 1330-1342
Full Text479
Michael A. Brown, Trung H. D. Tran, Ronald J. Krone. (2008) Drug-eluting stents: Are they still the answer?. Current Cardiovascular Risk Reports 2:5, 334-341
CrossRef480
John P Girod, Suresh R Mulukutla, Oscar C Marroquin. (2008) Off-label use of stents: bare-metal versus drug-eluting stents. Expert Review of Cardiovascular Therapy 6:8, 1095-1106
CrossRef481
Rolf Dörr. (2008) Akutes Koronarsyndrom – eine Herausforderung für die Kooperation zwischen ambulanter und stationärer Versorgung. Herz Kardiovaskuläre Erkrankungen 33:6, 395-401
CrossRef482
Stephan Windecker, Patrick W Serruys, Simon Wandel, Pawel Buszman, Stanislaw Trznadel, Axel Linke, Karsten Lenk, Thomas Ischinger, Volker Klauss, Franz Eberli, Roberto Corti, William Wijns, Marie-Claude Morice, Carlo di Mario, Simon Davies, Robert-Jan van Geuns, Pedro Eerdmans, Gerrit-Anne van Es, Bernhard Meier, Peter Jüni. (2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. The Lancet 372:9644, 1163-1173
CrossRef483
Teruo Okabe, Joseph Lindsay, Ashesh N. Buch, Daniel H. Steinberg, Probal Roy, Tina L. Pinto Slottow, Kimberly Smith, Rebecca Torguson, Zhenyi Xue, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Neil J. Weissman, Ron Waksman. (2008) Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts. The American Journal of Cardiology 102:5, 530-534
CrossRef484
Rosetta Melfi, Annunziata Nusca, Giuseppe Patti, Germano Sciascio. (2008) The risks and benefits of drug-eluting stents in the setting of STEMI. Current Cardiology Reports 10:5, 402-406
CrossRef485
Giuseppe GL Biondi-Zoccai, Claudio Moretti, Marzia Lotrionte, Imad Sheiban. (2008) Safety of drug-coated stents. Expert Opinion on Drug Safety 7:5, 597-606
CrossRef486
E. Maor, A. Ivorra, J. Leor, B. Rubinsky. (2008) Irreversible Electroporation Attenuates Neointimal Formation After Angioplasty. IEEE Transactions on Biomedical Engineering 55:9, 2268-2274
CrossRef487
Luigi Pedon, Marco Zennaro, Diego Calzolari, Mario Zanchetta. (2008) Strut fracture: a further concern with drug-eluting stents. Journal of Cardiovascular Medicine 9:9, 949-952
CrossRef488
Ron Waksman. (2008) Drug-eluting stents: is new necessarily better?. The Lancet 372:9644, 1126-1128
CrossRef489
K OKAMOTO, T NAKATANI, S YAMASHITA, S TAKABAYASHI, T TAKAHAGI. (2008) Development of surface-functionalized drug-eluting stent with diamond-like carbon nanocoated by using PECVD method. Surface and Coatings Technology 202:22-23, 5750-5752
CrossRef490
Probal Roy, Laurent Bonello, Axel de Labriolle, Teruo Okabe, Tina L. Pinto Slottow, Daniel H. Steinberg, Rebecca Torguson, Kimberly Smith, Zhenyi Xue, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Ron Waksman. (2008) Two-Year Outcome of Patients Treated With Sirolimus- Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry). The American Journal of Cardiology 102:3, 292-297
CrossRef491
Kae-Woei Liang, Sui-Chu Yin, Chih-Tai Ting, Shing-Jong Lin, Chi-Mei Hsueh, Chiu-Yuan Chen, Shih-Lan Hsu. (2008) Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells. European Journal of Pharmacology 590:1-3, 343-354
CrossRef492
KISHORE J. HARJAI, PAMELA ORSHAW, CHETAN SHENOY, SUBASIT ACHARJI, DANIEL SPORN, ALI ABOUFARES, DWIGHT STAPLETON. (2008) Clinical Outcomes Following Drug-Eluting versus Bare Metal Stent Implantation for Lesion Subsets Excluded from Pivotal Clinical Trials: Findings from the GHOST Study (Guthrie Health System Off-Label StenT Study). Journal of Interventional Cardiology 21:4, 315-324
CrossRef493
AMANDA SOUSA, J. RIBAMAR COSTA, Jr, ADRIANA C. MOREIRA, MANUEL CANO, GALO MALDONADO, RICARDO A. COSTA, RICARDO PAVANELLO, EDSON R. ROMANO, CANTIDIO CAMPOS, NAGIB HADDAD, ALEXANDRE ABIZAID, FAUSTO FERES, LUIZ ALBERTO MATTOS, RODOLFO STAICO, J. EDUARDO SOUSA. (2008) Long-Term Clinical Outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry. Journal of Interventional Cardiology 21:4, 307-314
CrossRef494
Anne Neubert, Katrin Sternberg, Stefan Nagel, Claus Harder, Klaus-Peter Schmitz, Heyo K. Kroemer, Werner Weitschies. (2008) Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents. Journal of Controlled Release 130:1, 2-8
CrossRef495
Michael J. Mack, Syma L. Prince, Morley Herbert, Phillip P. Brown, Marc Katz, George Palmer, James R. Edgerton, Eric Eichhorn, Mitchell J. Magee, Todd M. Dewey. (2008) Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting. The Annals of Thoracic Surgery 86:2, 496-503
CrossRef496
Lisa T. Newsome, Michael A. Kutcher, Roger L. Royster. (2008) Coronary Artery Stents: Part I. Evolution of Percutaneous Coronary Intervention. Anesthesia & Analgesia 107:2, 552-569
CrossRef497
Marco Valgimigli, Nicole Mittmann, David J. Cohen, Gianluca Campo, Pierre K. Isogai, Soo Jin Seung, Brian Dulisse, Chiara Arcozzi, Paolo Squasi, Gianfranco Percoco, Roberto Ferrari. (2008) A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. International Journal of Cardiology 128:1, 53-61
CrossRef498
C. M. Gross, S. Schmidt, M. Bergmann. (2008) Standortbestimmung der Drug-Eluting-Stents ein Jahr nach Beginn der Sicherheitsdiskussion. Clinical Research in Cardiology Supplements 3:1, 85-89
CrossRef499
Girish R. Mood, Anthony A. Bavry, Deepak L. Bhatt. (2008) Clopidogrel and coronary stents: Risks and benefits. Current Atherosclerosis Reports 10:4, 303-308
CrossRef500
K. O. Niemela. (2008) Biodegradable coating for drug-eluting stents--more than a facelift?. European Heart Journal 29:16, 1930-1931
CrossRef501
P. Roy, D. H. Steinberg, S. J. Sushinsky, T. Okabe, T. L. Pinto Slottow, K. Kaneshige, Z. Xue, L. F. Satler, K. M. Kent, W. O. Suddath, A. D. Pichard, N. J. Weissman, J. Lindsay, R. Waksman. (2008) The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. European Heart Journal 29:15, 1851-1857
CrossRef502
Anne Simmons, Ajay Devidas Padsalgikar, Lynn Marie Ferris, Laura Anne Poole-Warren. (2008) Biostability and biological performance of a PDMS-based polyurethane for controlled drug release. Biomaterials 29:20, 2987-2995
CrossRef503
Michael Maeng, Lisette O. Jensen, Anne Kaltoft, Hans H.T. Hansen, Morten Bøttcher, Jens F. Lassen, Per Thayssen, Lars R. Krusell, Klaus Rasmussen, Lars Pedersen, Henrik T. Sørensen, Søren P. Johnsen, Leif Thuesen. (2008) Comparison of Stent Thrombosis, Myocardial Infarction, and Mortality Following Drug-Eluting Versus Bare-Metal Stent Coronary Intervention in Patients With Diabetes Mellitus. The American Journal of Cardiology 102:2, 165-172
CrossRef504
David F. Kong, Eric L. Eisenstein, Robert A. Harrington. (2008) Late adverse events after drug-eluting stent implantation. Current Cardiology Reports 10:4, 253-262
CrossRef505
Roxana Mehran, Bruce Brodie, David A. Cox, Cindy L. Grines, Barry Rutherford, Deepak L. Bhatt, George Dangas, Fred Feit, E. Magnus Ohman, Helen Parise, Martin Fahy, Alexandra J. Lansky, Gregg W. Stone. (2008) The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale. American Heart Journal 156:1, 44-56
CrossRef506
Gregory J. Mishkel, Anna L. Moore, Steve Markwell, Marc E. Shelton. (2008) Correlates of late and very late thrombosis of drug eluting stents. American Heart Journal 156:1, 141-147
CrossRef507
Giuseppe Gioia, Alberto Benassi, Raghar Mohendra, Khaza Chowdhury, Iqbal Masood, William Matthai. (2008) Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Catheterization and Cardiovascular Interventions 72:1, 13-20
CrossRef508
Kishore Udipi, Mingfei Chen, Peiwen Cheng, Kevin Jiang, Diane Judd, Alejandra Caceres, Robert J. Melder, Josiah N. Wilcox. (2008) Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent. Journal of Biomedical Materials Research Part A 85A:4, 1064-1071
CrossRef509
S. G. Ellis, C. D. O'Shaughnessy, S. L. Martin, K. Kent, T. McGarry, M. A. Turco, D. J. Kereiakes, J. J. Popma, M. Friedman, J. Koglin, G. W. Stone, . (2008) Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. European Heart Journal 29:13, 1625-1634
CrossRef510
MOO HYUN KIM, SOON JUN HONG, KWANG SOO CHA, HUN SIK PARK, SHUNG CHULL CHAE, SEUNG HO HUR, HYEON CHEOL GWON, JANG HO BAE, DO-SUN LIM. (2008) Effect of Paclitaxel-Eluting Versus Sirolimus-Eluting Stents on Coronary Restenosis in Korean Diabetic Patients. Journal of Interventional Cardiology 21:3, 225-231
CrossRef511
Pablo del Saz-Saucedo, José Francisco Maestre-Moreno, Juan Francisco Arenillas-Lara. (2008) Ateromatosis intracraneal. Medicina Clínica 131:4, 141-152
CrossRef512
Somjot S. Brar, John Kim, Simerjeet K. Brar, Ray Zadegan, Michael Ree, In-Lu A. Liu, Prakash Mansukhani, Vicken Aharonian, Ric Hyett, Albert Yuh-Jer Shen. (2008) Long-Term Outcomes by Clopidogrel Duration and Stent Type in a Diabetic Population With De Novo Coronary Artery Lesions. Journal of the American College of Cardiology 51:23, 2220-2227
CrossRef513
Stephan Windecker, Peter Jüni. (2008) Safety of drug-eluting stents. Nature Clinical Practice Cardiovascular Medicine 5:6, 316-328
CrossRef514
Ehtisham Mahmud, Guilherme Bromberg-Marin, Vachaspathi Palakodeti, Lawrence Ang, Dana Creanga, Anthony N. DeMaria. (2008) Clinical Efficacy of Drug-Eluting Stents in Diabetic Patients. Journal of the American College of Cardiology 51:25, 2385-2395
CrossRef515
M. Todd Miller, Carl J. Lavie, Christopher J. White. (2008) Impact of Obesity on the Pathogenesis and Prognosis of Coronary Heart Disease. Journal of the CardioMetabolic Syndrome 3:3, 162-167
CrossRef516
L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, L. Thuesen. (2008) Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial. European Heart Journal 29:22, 2733-2741
CrossRef517
, J. Daemen, M. L. Simoons, W. Wijns, A. Bagust, G. Bos, J. M. Bowen, E. Braunwald, E. Camenzind, B. Chevalier, C. DiMario, J. Fajadet, A. Gitt, G. Guagliumi, H. L. Hillege, S. James, P. Juni, A. Kastrati, S. Kloth, S. D. Kristensen, M. Krucoff, V. Legrand, M. Pfisterer, M. Rothman, P. W. Serruys, S. Silber, P. G. Steg, I. Tariah, L. Wallentin, S. W. Windecker, , A. Aimonetti, D. Allocco, A. Baczynska, A. Bagust, M. Berenger, G. Bos, A. Boam, J.M. Bowen, E. Braunwald, J.P. Calle, E. Camenzind, G. Campo, S. Carlier, B. Chevalier, J. Daemen, J. de Schepper, G. Di Bisceglie, C. DiMario, H. Dobbels, J. Fajadet, A. Farb, J.C. Ghislain, A. Gitt, G. Guagliumi, S. Hellbardt, H.L. Hillege, R. ten Hoedt, C. Isaia, S. James, P. de Jong, P. Juni, A. Kastrati, E. Klasen, S. Kloth, S.D. Kristensen, M. Krucoff, V. Legrand, M. Lekehal, L. LeNarz, F. Ni Mhullain, H. Nagai, A. Patteet, D. Paunovic, M. Pfisterer, A. Potgieter, I. Purdy, C. Raveau-Landon, M. Rothman, P.W. Serruys, S. Silber, M.L. Simoons, P.G. Steg, I. Tariah, S. Ternstrom, J. Van Wuytswinkel, M. Waliszewski, L. Wallentin, W. Wijns, S.W. Windecker. (2008) Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. European Heart Journal 30:2, 152-161
CrossRef518
Giuseppe De Luca, Harry Suryapranata, Gregg W. Stone, David Antoniucci, Giuseppe Biondi-Zoccai, Adnan Kastrati, Massimo Chiariello, Paolo Marino. (2008) Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials. International Journal of Cardiology 126:1, 37-44
CrossRef519
Ioannis Iakovou. (2008) Thrombosis after stent implantation: how much of a problem is there?. Future Cardiology 4:3, 261-267
CrossRef520
Mamas Mamas, Douglas Fraser, Farzin Fath-Ordoubadi. (2008) The role of thrombectomy and distal protection devices during percutaneous coronary interventions. EuroIntervention 4:1, 115-123
CrossRef521
Masashi Kimura, Gary S. Mintz, Neil J. Weissman, Keith D. Dawkins, Eberhard Grube, Stephen G. Ellis, Louis A. Cannon, Zaki Masud, Lazar Mandinov, Donald Baim, Gregg W. Stone. (2008) Meta-analysis of the Effects of Paclitaxel-Eluting Stents Versus Bare Metal Stents on Volumetric Intravascular Ultrasound in Patients With Versus Without Diabetes Mellitus††Conflict of interest: Drs. Weissman, Dawkins, Grube, Ellis, and Cannon have received research grants from Boston Scientific Corporation. Drs. Mintz, Ellis, and Cannon are on the speaker's bureau of and have received honoraria from Boston Scientific Corporation. Drs. Ellis, Cannon, and Stone are consultants for and are on the advisory board of Boston Scientific Corporation. Drs. Mandinov and Baim have ownership interest or stock in and are employed at Boston Scientific Corporation.. The American Journal of Cardiology 101:9, 1263-1268
CrossRef522
Abid Assali, Yael Raz, Hana Vaknin-Assa, Itsik Ben-Dor, David Brosh, Igal Teplitsky, Shmuel Fuchs, Ran Kornowski. (2008) Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions. EuroIntervention 4:1, 108-114
CrossRef523
Fernando Rivero, Raúl Moreno, Laura Barreales, Guillermo Galeote, Angel Sánchez-Recalde, Luis Calvo, Santiago Jimenez-Valero, Alexis Villate, Mauricio Vanegas, José-Luis López-Sendón. (2008) Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents. EuroIntervention 4:1, 124-132
CrossRef524
Henning Kelbæk, Lene Kløvgaard, Steffen Helqvist, Jens F. Lassen, Lars R. Krusell, Thomas Engstrøm, Hans E. Bøtker, Erik Jørgensen, Kari Saunamäki, Samir Aljabbari, Per Thayssen, Anders Galløe, Gunnar V.H. Jensen, Leif Thuesen. (2008) Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions. Journal of the American College of Cardiology 51:21, 2011-2016
CrossRef525
Maurits Dirksen, Maarten Vink, Maarten Suttorp, Jan Tijssen, Mark Patterson, Ton Slagboom, Ferdinand Kiemeneij, Gerrit Laarman. (2008) Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study. EuroIntervention 4:1, 64-70
CrossRef526
Eberhard Grube, Horst Sievert, Karl-Eugen Hauptmann, Ralf Mueller, Ulrich Gerckens, Lutz Buellesfeld, Junya Ako, Takao Shimohama, Marco Costa, Peter Fitzgerald. (2008) Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results. EuroIntervention 4:1, 71-76
CrossRef527
Ashesh N. Buch, Aamir Javaid, Daniel H. Steinberg, Probal Roy, Tina L. Pinto Slottow, Zhenyi Xue, Kimberly Smith, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman. (2008) Outcomes After Sirolimus- and Paclitaxel-Eluting Stent Implantation in Patients With Insulin-Treated Diabetes Mellitus. The American Journal of Cardiology 101:9, 1253-1258
CrossRef528
Pallav Garg, David J. Cohen, Thomas Gaziano, Laura Mauri. (2008) Balancing the Risks of Restenosis and Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents. Journal of the American College of Cardiology 51:19, 1844-1853
CrossRef529
Mitchell W. Krucoff, Dean J. Kereiakes, John L. Petersen, Roxana Mehran, Vic Hasselblad, Alexandra J. Lansky, Peter J. Fitzgerald, Jyotsna Garg, Mark A. Turco, Charles A. Simonton, Stefan Verheye, Christophe L. Dubois, Roger Gammon, Wayne B. Batchelor, Charles D. O'Shaughnessy, James B. Hermiller, Joachim Schofer, Maurice Buchbinder, William Wijns. (2008) A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease. Journal of the American College of Cardiology 51:16, 1543-1552
CrossRef530
Antonio J. Domínguez Franco, Juan H. Alonso Briales, Manuel F. Jiménez Navarro, Jose M. Hernández García, José M. García Pinilla, Margarita Pérez Caravante, Eduardo De Teresa Galván. (2008) Clinical Impact of Drug-eluting Stents in an Unselected Population of Diabetic Patients. Clinical Cardiology 31:4, 165-171
CrossRef531
David Tanous, Neil Hime, Roland Stocker. (2008) Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds. Redox Report 13:2, 48-59
CrossRef532
Stephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, Ivan Horvath, Matyas Keltai, Jean-Paul R Herrman, Frans Van de Werf, William E Downey, Benjamin M Scirica, Sabina A Murphy, Elliott M Antman. (2008) Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. The Lancet 371:9621, 1353-1363
CrossRef533
Barry Reicher, Robert S. Poston, Mandeep R. Mehra, Ashish Joshi, Patrick Odonkor, Zachary Kon, Peter A. Reyes, David A. Zimrin. (2008) Simultaneous “hybrid” percutaneous coronary intervention and minimally invasive surgical bypass grafting: Feasibility, safety, and clinical outcomes. American Heart Journal 155:4, 661-667
CrossRef534
Luigi Vignali, Francesco Saia, Antonio Manari, Andrea Santarelli, Andrea Rubboli, Elisabetta Varani, Giancarlo Piovaccari, Alberto Menozzi, Gianfranco Percoco, Alberto Benassi, Guido Rusticali, Paolo Marzaroli, Paolo Guastaroba, Roberto Grilli, Aleardo Maresta, Antonio Marzocchi. (2008) Long-Term Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease (Results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry). The American Journal of Cardiology 101:7, 947-952
CrossRef535
Jiro Aoki, Gary S. Mintz, Neil J. Weissman, J. Tift Mann, Louis Cannon, Joel Greenberg, Eberhard Grube, A.R. Zaki Masud, Joerg Koglin, Lazar Mandinov, Gregg W. Stone. (2008) Chronic Arterial Responses to Overlapping Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions 1:2, 161-167
CrossRef536
Giuseppe Tarantini, Enrico Favaretto, Arianna Gardin, Massimo Napodano, Gianbattista Isabella, Marco Panfili, Gino Gerosa, Sabino Iliceto, Angelo Ramondo. (2008) Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes. Journal of Cardiovascular Medicine 9:4, 396-402
CrossRef537
Fareed Shaikh, Rajesh Maddikunta, Mohamed Djelmami-Hani, Joaquin Solis, Suhail Allaqaband, Tanvir Bajwa. (2008) Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?. Catheterization and Cardiovascular Interventions 71:5, 614-618
CrossRef538
John A. Ormiston, Ehtisham Mahmud, Mark A. Turco, Jeffrey J. Popma, Neil Weissman, Louis A. Cannon, Tift Mann, Michael J. Lucca, Soo-Teik Lim, Jack J. Hall, Dougal McClean, David Dobies, Lazar Mandinov, Donald S. Baim. (2008) Direct Stenting With the TAXUS Liberté Drug-Eluting Stent. JACC: Cardiovascular Interventions 1:2, 150-160
CrossRef539
Christopher J. Lockhart, Paul K. Hamilton, Katherine A. McVeigh, Gary E. McVeigh. (2008) A cardiologist view of vascular disease in diabetes. Diabetes, Obesity and Metabolism 10:4, 279-292
CrossRef540
Nestor Mercado, Simon R. Dixon, William W. O'Neill. 2008. Primary Percutaneous Coronary Intervention. , 91-117.
CrossRef541
Michael S. Lee, Raymond Zimmer, Antonio Pessegueiro, Daniel Jurewitz, Jonathan Tobis. (2008) Outcomes of nonagenarians who undergo percutaneous coronary intervention with drug-eluting stents. Catheterization and Cardiovascular Interventions 71:4, 526-530
CrossRef542
Dietmar Trenk, Franz-Josef Neumann. (2008) Drug-eluting coronary stents: as safe as bare-metal stents, but optimized antiplatelet therapy may further improve clinical outcome. European Journal of Clinical Pharmacology 64:3, 227-232
CrossRef543
Nihat Ozer, Burak Tangurek, Fatih Firat, Songul Ozer, Zeynep Tartan, Recep Ozturk, Batuhan Ozay, Figen Ciloglu, Hale Yilmaz, Nese Cam. (2008) Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart and Vessels 23:2, 75-82
CrossRef544
John A Ormiston, Patrick W Serruys, Evelyn Regar, Dariusz Dudek, Leif Thuesen, Mark WI Webster, Yoshinobu Onuma, Hector M Garcia-Garcia, Robert McGreevy, Susan Veldhof. (2008) A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. The Lancet 371:9616, 899-907
CrossRef545
Harvey S. Hecht, Maja Zaric, Vladimir Jelnin, Lev Lubarsky, Manish Prakash, Gary Roubin. (2008) Usefulness of 64-Detector Computed Tomographic Angiography for Diagnosing In-Stent Restenosis in Native Coronary Arteries. The American Journal of Cardiology 101:6, 820-824
CrossRef546
Giuseppe De Luca, Harry Suryapranata, Paolo Marino. (2008) Reperfusion Strategies in Acute ST-Elevation Myocardial Infarction: An Overview of Current Status. Progress in Cardiovascular Diseases 50:5, 352-382
CrossRef547
Miodrag Ostojic, Dragan Sagic, Branko Beleslin, Robert Jung, Zoran Perisic, Nikola Jagic, Milan Nedeljkovic, Ljupco Mangovski, Bratislav Milosavljevic, Sinisa Stojkovic, Dejan Orlic, Zelimir Antonic, Vladimir Miloradovic, Dragan Topic, Dragica Paunovic. (2008) First clinical comparison of Nobori –Biolimus A9 eluting stents with Cypher– Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes. EuroIntervention 3:5, 574-579
CrossRef548
Ahmed Khattab, Gert Richardt, Vitali Verin, Henning Kelbaek, Carlos Macaya, Jacques Berland, Karine Miquel-Hebert, Cécile Dorange, Patrick Serruys. (2008) Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial. EuroIntervention 3:5, 566-573
CrossRef549
Patrick Ohlmann, Gary S. Mintz, Sang-Wook Kim, Augusto D. Pichard, Lowel F. Satler, Kenneth M. Kent, William O. Suddath, Ron Waksman, Neil J. Weissman. (2008) Intravascular ultrasound findings in patients with restenosis of sirolimus- and paclitaxel-eluting stents. International Journal of Cardiology 125:1, 11-15
CrossRef550
Jaspal S Taggar, Gregory YH Lip, Aravinda Nanjundappa, Robert S Dieter, Sangeeta Mandapaka, Pranab Das, Shakeel Ahmad. (2008) Idraparinux for the prevention of thromboembolism in patients with atrial fibrillation. Therapy 5:2, 139-144
CrossRef551
Amir Kraitzer, Lia Ofek, Reut Schreiber, Meital Zilberman. (2008) Long-term in vitro study of paclitaxel-eluting bioresorbable core/shell fiber structures. Journal of Controlled Release 126:2, 139-148
CrossRef552
Johannes Ruef, Hans Störger, Franz Schwarz, Jürgen Haase. (2008) Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions. Catheterization and Cardiovascular Interventions 71:3, 333-339
CrossRef553
Kevin E. Kip, Kim Hollabaugh, Oscar C. Marroquin, David O. Williams. (2008) The Problem With Composite End Points in Cardiovascular Studies. Journal of the American College of Cardiology 51:7, 701-707
CrossRef554
Meital Zilberman, Amir Kraitzer. (2008) Paclitaxel-eluting composite fibers: Drug release and tensile mechanical properties. Journal of Biomedical Materials Research Part A 84A:2, 313-323
CrossRef555
Henry H. Ting, Matthew T. Roe, Bernard J. Gersh, John A. Spertus, John S. Rumsfeld, Fang-Shu Ou, John Kao, Kirsten Hall Long, David R. Holmes, Eric D. Peterson. (2008) Factors Associated With Off-Label Use of Drug-Eluting Stents in Patients With ST-Elevation Myocardial Infarction. The American Journal of Cardiology 101:3, 286-292
CrossRef556
Ajay J. Kirtane, Stephen G. Ellis, Keith D. Dawkins, Antonio Colombo, Eberhard Grube, Jeffrey J. Popma, Martin Fahy, Martin B. Leon, Jeffrey W. Moses, Roxana Mehran, Gregg W. Stone. (2008) Paclitaxel-Eluting Coronary Stents in Patients With Diabetes Mellitus. Journal of the American College of Cardiology 51:7, 708-715
CrossRef557
Bas L. van der Hoeven, Su-San Liem, J. Wouter Jukema, Navin Suraphakdee, Hein Putter, Jouke Dijkstra, Douwe E. Atsma, Marianne Bootsma, Katja Zeppenfeld, Pranobe V. Oemrawsingh, Ernst E. van der Wall, Martin J. Schalij. (2008) Sirolimus-Eluting Stents Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction: 9-Month Angiographic and Intravascular Ultrasound Results and 12-Month Clinical Outcome. Journal of the American College of Cardiology 51:6, 618-626
CrossRef558
Ren Kawaguchi, Manel Sabate, Dominick J. Angiolillo, Pilar Jimenez-Quevedo, Nobuaki Suzuki, Cecilia Corros, Hideki Futamatsu, Fernando Alfonso, Rosana Hernandez-Antolin, Carlos Macaya, Theodore A. Bass, Marco A. Costa. (2008) Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus. The International Journal of Cardiovascular Imaging 24:2, 125-132
CrossRef559
M. Kitoga, A. Pasquet, V. Preumont, J. Kefer, M.-P. Hermans, J.-L. Vanoverschelde, M. Buysschaert. (2008) Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents. Diabetes & Metabolism 34:1, 62-67
CrossRef560
Jack P. Chen. (2008) Safety and Efficacy of the Drug-Eluting Stent: A Double-Edged Sword?. Southern Medical Journal 101:2, 174-178
CrossRef561
Probal Roy, Ashesh N. Buch, Aamir Javaid, Teruo Okabe, Vikram Raya, Tina L. Pinto Slottow, Daniel H. Steinberg, Kimberly Smith, Zhenyi Xue, Natalie Gevorkian, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Joseph Lindsay, Ron Waksman. (2008) Impact of “Off-Label” Utilization of Drug-Eluting Stents on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology 101:3, 293-299
CrossRef562
Carrozza, Joseph P. Jr., . (2008) Drug-Eluting Stents — Pushing the Envelope beyond the Labels?. New England Journal of Medicine 358:4, 405-407
Full Text563
Marroquin, Oscar C., Selzer, Faith, Mulukutla, Suresh R., Williams, David O., Vlachos, Helen A., Wilensky, Robert L., Tanguay, Jean-François, Holper, Elizabeth M., Abbott, J. Dawn, Lee, Joon S., Smith, Conrad, Anderson, William D., Kelsey, Sheryl F., Kip, Kevin E., . (2008) A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications. New England Journal of Medicine 358:4, 342-352
Full Text564
Sahin Kaplan, Peter Barlis, Sahin Kaplan, Peter Barlis, Abdulkadir Kiris, Konstantinos Dimopoulos, Sukru Celik, Carlo Di Mario. (2008) Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions. Acute Cardiac Care 10:2, 88-92
CrossRef565
R. Kornowski, H. Vaknin-Assa, E. Lev, I. Ben-Dor, I. Teplitsky, E. Rechavia, D. Brosh, S. Fuchs, A. Assali. (2008) Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction. Acute Cardiac Care 10:3, 167-172
CrossRef566
A.G. Grant, C.J. White, T.J. Collins, J.S. Jenkins, J.P. Reilly, S.R. Ramee,. (2008) Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheterization and Cardiovascular Interventions 71:1, 108-111
CrossRef567
Jae-Hwan Lee, Hyun-Sook Kim, Seung-Whan Lee, Jae-Hyeong Park, Si-Wan Choi, Jin-Ok Jeong, Yoonhaeng Cho, Naehee Lee, Kyoung-Suk Rhee, Jae-Ki Ko, In-Whan Seong. (2008) Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction. Catheterization and Cardiovascular Interventions
CrossRef568
Hyeon Gook Lee, Kook Jin Chun, Kyoung Im Cho, Dong Won Lee, Jun Hyuk Oh, Byung Jae Ahn, Seong Ho Kim, Joon Sang Lee, Moo Young Kim, Woo Hyung Bae, Woo Seog Ko, Joon Hoon Jeong, Tae Ik Kim, Han Cheol Lee, Jun Kim, June Hong Kim, Taek Jong Hong, Yung Woo Shin. (2008) Impact of Drug-Eluting Stents on Clinical Outcomes in Patients With Diffuse Coronary Lesions. Korean Circulation Journal 38:11, 612
CrossRef569
Dingsong Feng, Tomoya Higashihara, Rudolf Faust. (2008) Facile synthesis of diphenylethylene end-functional polyisobutylene and its applications for the synthesis of block copolymers containing poly(methacrylate)s. Polymer 49:2, 386-393
CrossRef570
Tolga Kocum, Mustafa Yurtdas, Turkay Ozcan, Burak Akcay, Tansel Erol, Ahmet Camsari, Oben Doven. (2008) Direct Stenting Versus Predilatation and Stenting Technique When Using Paclitaxel-Eluting Stents. International Heart Journal 49:5, 545-552
CrossRef571
SOPHIA VAINA, ANDREW T.L. ONG, PATRICK W. SERRUYS. 2008. Drug-eluting stents. , 83-99.
CrossRef572
Julio R. Gaspar, Jun Qu, Ninfa L. Straubinger, Robert M. Straubinger. (2008) Highly selective and sensitive assay for paclitaxel accumulation by tumor cells based on selective solid phase extraction and micro-flow liquid chromatography coupled to mass spectrometry. The Analyst 133:12, 1742
CrossRef573
Stuart J. Pocock, Alexandra J. Lansky, Roxana Mehran, Jeffrey J. Popma, Martin P. Fahy, Yingbo Na, George Dangas, Jeffrey W. Moses, Tereza Pucelikova, David E. Kandzari, Stephen G. Ellis, Martin B. Leon, Gregg W. Stone. (2008) Angiographic Surrogate End Points in Drug-Eluting Stent Trials. Journal of the American College of Cardiology 51:1, 23-32
CrossRef574
Masami Nishino, Shiro Hoshida, Hiroyasu Kato, Yasuyuki Egami, Ryu Shutta, Hitoshi Yamaguchi, Kenjiro Tanaka, Jun Tanouchi, Masatsugu Hori, Yoshio Yamada. (2008) Preprocedural Statin Administration can Reduce Thrombotic Reaction After Stent Implantation. Circulation Journal 72:2, 232-237
CrossRef575
Bon-Kwon Koo, Peter J. Fitzgerald. (2008) Novel Coronary Stent Platforms. Korean Circulation Journal 38:8, 393
CrossRef576
Jing Lu, Masaru P. Rao, Noel C. MacDonald, Dongwoo Khang, Thomas J. Webster. (2008) Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomaterialia 4:1, 192-201
CrossRef577
Leonardo De Luca, Gennaro Sardella, Giovanni De Persio, Alessandro Petrolini, Francesco Fedele. (2008) Impact of abciximab on coronary restenosis in diabetic patients undergoing elective paclitaxel-eluting stent implantation. A prospective, randomized, placebo-controlled study. Acute Cardiac Care 10:2, 93-99
CrossRef578
Paweł Buszman, Stanisław Trznadel, Krzysztof Milewski, Janusz Rzeźniczak, Tadeusz Przewłocki, Maciej Kośmider, Jaroslaw Wójcik, Jacek Janczak, Aleksander Żurakowski, Marek Kondys, Marek Król, Leszek Kinasz, Andrzej Jaklik, Łukasz Rzeszutko, Grzegorz L. Kałuża, Stephan Kiesz, Robert Gil. (2008) Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: A prospective multicenter registry. Catheterization and Cardiovascular Interventions 71:1, 51-57
CrossRef579
Jiro Aoki, Ajay J. Kirtane, George D. Dangas, Alexandra J. Lansky, Andy Morales, Masashi Kimura, Young-Hak Kim, Issam Moussa, Giora Weisz, Edward M. Kreps, Michael Collins, Theresa Frankin-Bond, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, Roxana Mehran. (2008) Clinical Outcomes After Heterogeneous Overlap Stenting With Drug-Eluting Stents and Bare-Metal Stents for de Novo Coronary Artery Narrowings. The American Journal of Cardiology 101:1, 58-62
CrossRef580
Seung-Jung Park, Duk-Woo Park. (2008) Drug-Eluting Stents for Left Main Coronary Artery Stenosis: Case Selection and Technical Issues. The American Heart Hospital Journal 6:1, 21-29
CrossRef581
Tina L. Pinto Slottow, Daniel H. Steinberg, Probal Roy, Aamir Javaid, Ashesh N. Buch, Teruo Okabe, Zhenyi Xue, Kimberly Smith, Rebecca Torguson, Augusto D. Pichard, Lowell F. Satler, William O. Suddath, Kenneth M. Kent, Ron Waksman. (2008) Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovascular Revascularization Medicine 9:1, 24-28
CrossRef582
Ran Kornowski, Stephen Fort, Yaron Almagor, Sigmund Silber, Basil S. Lewis, on behalf of the NIRTOP investigato. (2008) Impact of vessel size, lesion length and diabetes mellitus on angiographic restenosis outcomes: Insights from the NIRTOP study. Acute Cardiac Care 10:2, 104-110
CrossRef583
Masao Yamasaki, Junya Ako, Yasuhiro Honda, Ali Hassan, Bon Koo, Alexandre Abizaid, Peter Fitzgerald, Robert Whitbourn. (2008) Novel guidewire-based stent delivery system. Catheterization and Cardiovascular Interventions
CrossRef584
Woong Chol Kang, Kyu Jin Oh, Seung Hwan Han, Tae Hoon Ahn, Wook-Jin Chung, Mi Seung Shin, Kwang Kon Koh, In Suck Choi, Eak Kyun Shin. (2007) Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: Comparison with same drug-eluting overlapping stents. International Journal of Cardiology 123:1, 12-17
CrossRef585
JEFFREY J. POPMA, BONNIE WEINER, MICHAEL J. COWLEY, CHARLES SIMONTON, DAN McCORMICK, TED FELDMAN. (2007) FDA Advisory Panel on the Safety and Efficacy of Drug-Eluting Stents: Summary of Findings and Recommendations. Journal of Interventional Cardiology 20:6, 425-446
CrossRef586
Christodoulos Stefanadis, Konstantinos Toutouzas, Elli Stefanadi, Andreas Lazaris, Efstratios Patsouris, Nicholas Kipshidze. (2007) Inhibition of plaque neovascularization and intimal hyperplasia by specific targeting vascular endothelial growth factor with bevacizumab-eluting stent: An experimental study. Atherosclerosis 195:2, 269-276
CrossRef587
Peter Braun, . (2007) Prospective randomized study of the restenotic process in small coronary arteries using a Carbofilm™ coated stent in comparison with plain old balloon angioplasty:. Catheterization and Cardiovascular Interventions 70:7, 920-927
CrossRef588
Giuseppina Novo, Maniglia Deborha, Corrado Egle, Muratori Ida, Sutera Fiorella, Evola Salvatore, Ferrara Filippo, Hoffmann Enrico, Novo Salvatore. (2007) Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention. Coronary Artery Disease 18:8, 627-631
CrossRef589
Alexandre Abizaid, Jeffrey J. Popma, Luis F. Tanajura, Kyoko Hattori, Brad Solberg, Cristina Larracas, Fausto Feres, José de Ribamar Costa, Lewis B. Schwartz. (2007) Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: The TriMaxx trial. Catheterization and Cardiovascular Interventions 70:7, 914-919
CrossRef590
Woong Chol Kang, Kyu Jin Oh, Seung Hwan Han, Tae Hoon Ahn, Wook-Jin Chung, Mi-Seung Shin, Kwang Kon Koh, In Suck Choi, Eak Kyun Shin. (2007) Effect of preinterventional arterial remodeling on intimal hyperplasia after implantation of a polymer-based paclitaxel-eluting stent: Angiographic and IVUS study. International Journal of Cardiology 123:1, 50-54
CrossRef591
Konstantinos Toutouzas, Chrysoula Patsa, Sophia Vaina, Eleftherios Tsiamis, Manolis Vavuranakis, Elli Stefanadi, Anastasios Spanos, Dimitiros Iliopoulos, Mathaios Panagiotou, Ioannis Chlorogiannis, Eustratios Pattakos, Christodoulos Stefanadis. (2007) Drug eluting stents versus coronary artery bypass surgery in patients with isolated proximal lesion in left anterior descending artery suffering from chronic stable angina. Catheterization and Cardiovascular Interventions 70:6, 832-837
CrossRef592
Ryan Berg, Joseph Aragon, Vladimir Royter, John F. Shanley, Greg Cogert, Renu Vermani, Saibal Kar, Neal Eigler, Frank Litvack. (2007) Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model. Catheterization and Cardiovascular Interventions 70:6, 871-879
CrossRef593
Rainer Hoffmann, Christian Hamm, Christoph A. Nienaber, Benny Levenson, Tassilo Bonzel, Georg Sabin, Jochen Senges, Ralf Zahn, Ulrich Tebbe, Thomas Pfannebecker, Hans Gert Richardt, Steffen Schneider, Malte Kelm. (2007) Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels. Coronary Artery Disease 18:7, 559-564
CrossRef594
Karl F. von Tiehl, Matthew J. Price, Rafael Valencia, Katherine J. Ludington, Paul S. Teirstein, Ronald A. Simon. (2007) Clopidogrel Desensitization After Drug-Eluting Stent Placement. Journal of the American College of Cardiology 50:21, 2039-2043
CrossRef595
Pavel Červinka, Jozef Jakabčin, Jiři Jäger, Josef Veselka, Petr Kala, Jaroslav Maly. (2007) Long-term health outcome and mortality evaluation after invasive coronary treatment using drug-eluting stents: HOME DES registry. Coronary Artery Disease 18:7, 577-581
CrossRef596
Héctor M. García-García, Joost Daemen, Neville Kukreja, Shuzou Tanimoto, Carlos A.G. van Mieghem, Martin van der Ent, Ron T. van Domburg, Patrick W. Serruys. (2007) Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: Insights from the rapamycin-eluting stent evaluated at rotterdam cardiology hospital—(RESEARCH) registry. Catheterization and Cardiovascular Interventions 70:5, 635-639
CrossRef597
Joost Daemen, Christian Spaulding, Sophie Jacob, Eric Boersma, Olivier Varenne, Patrick Serruys. (2007) A pooled safety analysis of data comparing paclitaxel-eluting stents with bare-metal stents. EuroIntervention 3:3, 392-399
CrossRef598
Steven E. Nissen. (2007) Late thrombosis with drug-eluting stents: Anatomy of a controversy and lessons learned. Current Cardiology Reports 9:6, 429-431
CrossRef599
Martin Unverdorben, Ralf Degenhardt, Marcus Wiemer, Dieter Horstkotte, Henrik Schneider, Christoph Nienaber, Wolfgang Bocksch, Michael Gross, Michael Boxberger, Christian Vallbracht, . (2007) The Paclitaxel-Eluting Coroflex™ Please Stent Pilot Study (PECOPS I). Clinical Research in Cardiology 96:11, 803-811
CrossRef600
Steffen Helqvist, Henning Kelbæk, Leif Thuesen, Lene Kløvgaard, Lars Krusell, Erik Jørgensen, Hans Bøtker, Gunnar Jensen, Jens Lassen, Per Thayssen, Anders Galløe, Kari Saunamäki. (2007) Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial. EuroIntervention 3:3, 309-314
CrossRef601
Raúl Moreno, Christian Spaulding, Gert Jan Laarman, Ilkka Tierala, Christoph Kaiser, Jose-Luis Lopez-Sendon. (2007) Effectiveness and safety of paclitaxel-eluting stents in patients with ST-segment elevation acute myocardial infarction. EuroIntervention 3:3, 386-391
CrossRef602
Pallav Garg, Laura Mauri. (2007) The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Current Opinion in Cardiology 22:6, 565-571
CrossRef603
Jason Ryan, Donald E. Cutlip, David J. Cohen, Duane S. Pinto. (2007) Drug eluting stents for ST-elevation myocardial infarction: risk and benefit. Journal of Thrombosis and Thrombolysis 24:3, 293-299
CrossRef604
Shuzou Tanimoto, Patrick W. Serruys, Leif Thuesen, Dariusz Dudek, Bernard de Bruyne, Bernard Chevalier, John A. Ormiston. (2007) Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials. Catheterization and Cardiovascular Interventions 70:4, 515-523
CrossRef605
Jeffrey W. Moses, Giora Weisz, Gregory Mishkel, Ronald Caputo, Charles O'Shaughnessey, S. Chiu Wong, Tim A. Fischell, Michael Mooney, David O. Williams, Jeffrey J. Popma, Peter Fitzgerald, Sidney Smith, Richard E. Kuntz, Michael Collins, Sidney A. Cohen, Martin B. Leon. (2007) The SIRIUS-DIRECT trial: A multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions. Catheterization and Cardiovascular Interventions 70:4, 505-512
CrossRef606
Dean J. Kereiakes, Paul S. Teirstein, Ian J. Sarembock, David R. Holmes, Mitchell W. Krucoff, William W. O’Neill, Ron Waksman, David O. Williams, Jeffrey J. Popma, Maurice Buchbinder, Roxana Mehran, Ian T. Meredith, Jeffrey W. Moses, Gregg W. Stone. (2007) The Truth and Consequences of the COURAGE Trial. Journal of the American College of Cardiology 50:16, 1598-1603
CrossRef607
Daniel H. Steinberg, Tina L. Pinto Slottow, Ashesh N. Buch, Aamir Javaid, Probal K. Roy, Shaila Garg, Teruo Okabe, Rebecca Torguson, Kimberly A. Smith, Zhenyi Xue, William O. Suddath, Kenneth M. Kent, Lowell F. Satler, Augusto D. Pichard, Joseph Lindsay, Ron Waksman. (2007) Impact of In-Stent Restenosis on Death and Myocardial Infarction. The American Journal of Cardiology 100:7, 1109-1113
CrossRef608
Santiago Jimenez-Valero, Belen Santos, Fernando Pajin, Tomas Canton, Esther Lazaro, Jose Moreu, Gonzalo Hernandez, Luis Rodriguez Padial. (2007) Clinical outcomes of dexamethasone-eluting stent implantation in ST-elevation acute myocardial infarction. Catheterization and Cardiovascular Interventions 70:4, 492-497
CrossRef609
Paul S. Seifert, Barbara A. Huibregtse, Jason Polovick, Bradley Poff. (2007) Early vascular response to overlapped paclitaxel-eluting stents in swine coronary arteries. Cardiovascular Revascularization Medicine 8:4, 251-258
CrossRef610
S. Ekqvist, C. Svedman, H. Möller, M. Kehler, C.M. Pripp, J. Björk, B. Gruvberger, E. Holmström, C.G. Gustavsson, M. Bruze. (2007) High frequency of contact allergy to gold in patients with endovascular coronary stents. British Journal of Dermatology 157:4, 730-738
CrossRef611
Dean J. Kereiakes. (2007) The Emperor’s New Clothes. Journal of the American College of Cardiology 50:14, 1381-1385
CrossRef612
Antonio Manari, Elena Costa, Alessandro Scivales, Patrizia Ponzi, Francesca Di Stasi, Vincenzo Guiducci, Gianluca Pignatelli, Paola Giacometti. (2007) Economic appraisal of the angioplasty procedures performed in 2004 in a high-volume diagnostic and interventional cardiology unit. Journal of Cardiovascular Medicine 8:10, 792-798
CrossRef613
Alaide Chieffo, Azeem Latib, Antonio Colombo. (2007) Drug-eluting stents: What is the balance of risks and benefits?. Current Cardiovascular Risk Reports 1:4, 279-283
CrossRef614
Rishi Sukhija, Wilbert S. Aronow, Ravi Sureddi, Sumith Aleti, Behzad Molavi, Rajesh Sachdeva, Jawahar L. Mehta. (2007) Predictors of In-stent Restenosis and Patient Outcome After Percutaneous Coronary Intervention in Patients With Diabetes Mellitus. The American Journal of Cardiology 100:5, 777-780
CrossRef615
Christoph Stettler, Simon Wandel, Sabin Allemann, Adnan Kastrati, Marie Claude Morice, Albert Schömig, Matthias E Pfisterer, Gregg W Stone, Martin B Leon, José Suarez de Lezo, Jean-Jacques Goy, Seung-Jung Park, Manel Sabaté, Maarten J Suttorp, Henning Kelbaek, Christian Spaulding, Maurizio Menichelli, Paul Vermeersch, Maurits T Dirksen, Pavel Cervinka, Anna Sonia Petronio, Alain J Nordmann, Peter Diem, Bernhard Meier, Marcel Zwahlen, Stephan Reichenbach, Sven Trelle, Stephan Windecker, Peter Jüni. (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. The Lancet 370:9591, 937-948
CrossRef616
E.-K. Choi, B.-K. Koo, H.-S. Kim, Y.-M. Cho, H.-J. Kang, Y.-S. Cho, W.-Y. Chung, I.-H. Chae, D.-J. Choi, B.-H. Oh, Y.-B. Park, Y.-S. Choi. (2007) Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy. Diabetic Medicine 24:9, 1003-1011
CrossRef617
Charles A. Simonton, Bruce Brodie, Barrett Cheek, Fred Krainin, Chris Metzger, James Hermiller, Stanley Juk, Peter Duffy, Angela Humphrey, Marcy Nussbaum, Sherry Laurent. (2007) Comparative Clinical Outcomes of Paclitaxel- and Sirolimus-Eluting Stents. Journal of the American College of Cardiology 50:13, 1214-1222
CrossRef618
Chang-Bum Park, Myeong-ki Hong, Young-Hak Kim, Duk-Woo Park, Ki-Hoon Han, Cheol Whan Lee, Duck-Hyun Kang, Jae-Kwan Song, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2007) Comparison of angiographic patterns of in-stent restenosis between sirolimus- and paclitaxel-eluting stent. International Journal of Cardiology 120:3, 387-390
CrossRef619
Probal Roy, Teruo Okabe, Tina L. Pinto Slottow, Daniel H. Steinberg, Kimberly Smith, Rebecca Torguson, Zhenyi Xue, Natalie Gevorkian, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Ron Waksman. (2007) Correlates of Clinical Restenosis Following Intracoronary Implantation of Drug-Eluting Stents. The American Journal of Cardiology 100:6, 965-969
CrossRef620
S. Manzo-Silberman, O. Varenne, C. Spaulding. (2007) Limites des stents actifs. Annales de Cardiologie et d'Angéiologie 56, S48-S52
CrossRef621
Rahul Bose, Gaurav Gupta, Paul A. Grayburn, Emily A. Laible, Mi Jung Kang, James W. Choi. (2007) Safety of Drug-Eluting Stents in the Coronary Artery in ST-Elevation Myocardial Infarction at a Single High-Volume Medical Center. The American Journal of Cardiology 100:6, 949-952
CrossRef622
Ryota Sakurai, Yoichiro Hongo, Masao Yamasaki, Yasuhiro Honda, Heidi N. Bonneau, Paul G. Yock, Donald Cutlip, Jeffrey J. Popma, Peter Zimetbaum, Jean Fajadet, Richard E. Kuntz, William Wijns, Peter J. Fitzgerald. (2007) Detailed Intravascular Ultrasound Analysis of Zotarolimus-Eluting Phosphorylcholine-Coated Cobalt-Chromium Alloy Stent in de Novo Coronary Lesions (Results from the ENDEAVOR II Trial). The American Journal of Cardiology 100:5, 818-823
CrossRef623
Gregory Ducrocq, Victor Serebruany, Jean-Francois Tanguay. (2007) Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives. Expert Review of Cardiovascular Therapy 5:5, 939-953
CrossRef624
Daniela Trabattoni, Franco Fabbiocchi, Piero Montorsi, Paolo Ravagnani, Stefano Galli, Giovanni Teruzzi, Giuseppe Calligaris, Stefano De Martini, Antonio L. Bartorelli. (2007) Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: Analysis of a single center registry. Catheterization and Cardiovascular Interventions 70:3, 415-421
CrossRef625
Ralf Zahn, C. W. Hamm, S. Schneider, U. Zeymer, G. Richardt, M. Kelm, B. Levenson, T. Bonzel, U. Tebbe, G. Sabin, C. A. Nienaber, Thomas Pfannebecker, J. Senges, . (2007) The Sirolimus-eluting coronary stent in daily routine practice in Germany:. Clinical Research in Cardiology 96:8, 548-556
CrossRef626
Andrew E. Ajani, Bryan P. Yan, David J. Clark, David Eccleston, Anthony Walton, Robert Lew, Adam Meehan, Angela Brennan, Chris Reid, Stephen J. Duffy. (2007) Contemporary Treatment of In-Stent Restenosis and the Incidence of Recurrent In-Stent Restenosis in the Era of Drug-Eluting Stents. Heart, Lung and Circulation 16:4, 269-273
CrossRef627
Imad Sheiban, Gian Paolo Ballari, Claudio Moretti, Walter Grosso Marra, Emanuele Meliga, Pierluigi Omedè, Filippo Sciuto, Gian Paolo Trevi. (2007) Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results. Journal of Cardiovascular Medicine 8:8, 582-588
CrossRef628
TANIA CHECHI, GUIDO VITTORI, GIUSEPPE G.L. BIONDI ZOCCAI, SABINE VECCHIO, ELENA FALCHETTI, GAIA SPAZIANI, GIORGIO BALDERESCHI, CRISTINA GIGLIOLI, SERAFINA VALENTE, MASSIMO MARGHERI. (2007) Single-Center Randomized Evaluation of Paclitaxel-Eluting Versus Conventional Stent in Acute Myocardial Infarction (SELECTION). Journal of Interventional Cardiology 20:4, 282-291
CrossRef629
Probal Roy, Rebecca Torguson, Teruo Okabe, Tina L. Pinto Slottow, Daniel H. Steinberg, Kimberly Smith, Zhenyi Xue, Natalie Gevorkian, Lowell L. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Ron Waksman. (2007) Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheterization and Cardiovascular Interventions 70:2, 167-172
CrossRef630
Michael Jonas, Frederic S. Resnic, Andrew D. Levin, Nipun Arora, Campbell David Rogers. (2007) Transition from bare metal to drug eluting stenting in contemporary US practice: Effect on incidence and predictors of clinically driven target lesion revascularization. Catheterization and Cardiovascular Interventions 70:2, 175-183
CrossRef631
Marcel Beijk, Franz-Josef Neumann, Marcus Wiemer, Eberhard Grube, Jürgen Haase, Leif Thuesen, Christian Hamm, Susan Veldhof, Cecile Dorange, Patrick Serruys, Jan Piek. (2007) Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial). EuroIntervention 3:2, 206-212
CrossRef632
Keith Dawkins, Eberhard Grube, Giulio Guagliumi, Adrian Banning, Krzysztof Zmudka, Antonio Colombo, Leif Thuesen, Karl Hauptman, Jean Marco, William Wijns, Jeffrey Popma, Neil Weissman, Joerg Koglin, Mary Russell. (2007) Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents. EuroIntervention 3:2, 213-221
CrossRef633
Didier Blanchard, Gian Danzi, Philip Urban, Morris Moseri, Craig Juergens, Philip Guyon, Bernd Nowak, Damras Tresucosol, Maarten Suttorp, Ahmad Farshid, Ran Kornowski, Eulogio Garcia, Richard Yeend, Hirofumi Nagai, Dragica Paunovic. (2007) A novel ultra-thin bare metal stent (BMS): results from a worldwide registry. EuroIntervention 3:2, 249-255
CrossRef634
Arturo R. Quizhpe, Fausto Feres, José de Ribamar Costa, Alexandre Abizaid, Galo Maldonado, Ricardo Costa, Andrea Abizaid, Manuel Cano, Adriana C. Moreira, Rodolfo Staico, Luiz Alberto Mattos, Luiz Fernando Tanajura, Aurea Chaves, Marinella Centemero, Amanda M.R. Sousa, J. Eduardo M.R. Sousa. (2007) Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels. American Heart Journal 154:2, 373-378
CrossRef635
S. Silber, M. Borggrefe, M. Böhm, H.M. Hoffmeister, R. Dietz, G. Ertl, G. Heusch. (2007) Positionspapier der DGK zur Wirksamkeit und Sicherheit von Medikamente freisetzenden Koronarstents (DES). Der Kardiologe 1:2, 84-111
CrossRef636
Alexandre Berger, Jean-Christophe Stauffer, Charles Seydoux, Manon Siegenthaler, Alain Benoît, Jean-Jacques Goy. (2007) Three-year follow-up of the first prospective randomized comparison between paclitaxel and sirolimus stents: The TAXi-LATE trial. Catheterization and Cardiovascular Interventions 70:2, 163-166
CrossRef637
Genshan Ma, Shu Ding, Yi Feng, Chengxing Shen, Lijuan Chen, Zhong Chen. (2007) Tetramethylpyrazine-Eluting Stents Prevented In-Stent Restenosis in a Porcine Model. Journal of Cardiovascular Pharmacology 50:2, 201-205
CrossRef638
Esteban Escolar, Gary S. Mintz, Jeffrey Popma, Aleksandra Michalek, Sang Wook Kim, Lazar Mandinov, Joerg Koglin, Gregg Stone, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins, Neil J. Weissman. (2007) Meta-Analysis of Angiographic Versus Intravascular Ultrasound Parameters of Drug-Eluting Stent Efficacy (from TAXUS IV, V, and VI). The American Journal of Cardiology 100:4, 621-626
CrossRef639
Diane E. Head, Joshua J. Sebranek, Cameron Zahed, Douglas B. Coursin, Richard C. Prielipp. (2007) A tale of two stents: perioperative management of patients with drug-eluting coronary stents. Journal of Clinical Anesthesia 19:5, 386-396
CrossRef640
Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon. (2007) Left Main Drug-Eluting Stents. Journal of the American College of Cardiology 50:6, 498-500
CrossRef641
Gennaro Sardella, Chiara Bucciarelli-Ducci, Massimo Mancone, Riccardo Colantonio, Giuseppe Massimo Sangiorgi, Francesco Fedele. (2007) Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention. Journal of Cardiovascular Medicine 8:8, 625-628
CrossRef642
Ryota Sakurai, Junya Ako, Ali H.M. Hassan, Heidi N. Bonneau, Franz-Josef Neumann, Walter Desmet, David R. Holmes, Paul G. Yock, Peter J. Fitzgerald, Yasuhiro Honda. (2007) Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: A quantitative intravascular ultrasound analysis. American Heart Journal 154:2, 361-365
CrossRef643
Shaila Garg, Kimberly Smith, Rebecca Torguson, Teruo Okabe, Tina L. Pinto Slottow, Daniel H. Steinberg, Probal Roy, Zhenyi Xue, Natalie Gevorkian, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Ron Waksman. (2007) Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheterization and Cardiovascular Interventions 70:1, 9-14
CrossRef644
Lisette Okkels Jensen, Michael Maeng, Anne Kaltoft, Per Thayssen, Hans Henrik Tilsted Hansen, Morten Bottcher, Jens Flensted Lassen, Lars Romer Krussel, Klaus Rasmussen, Knud Noerregaard Hansen, Lars Pedersen, Soeren Paaske Johnsen, Henrik Toft Soerensen, Leif Thuesen. (2007) Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions. Journal of the American College of Cardiology 50:5, 463-470
CrossRef645
Marco Valgimigli, Gianluca Campo, Chiara Arcozzi, Patrizia Malagutti, Roberto Carletti, Fabrizio Ferrari, Dario Barbieri, Giovanni Parrinello, Gianfranco Percoco, Roberto Ferrari. (2007) Two-Year Clinical Follow-Up After Sirolimus-Eluting Versus Bare-Metal Stent Implantation Assisted by Systematic Glycoprotein IIb/IIIa Inhibitor Infusion in Patients With Myocardial Infarction. Journal of the American College of Cardiology 50:2, 138-145
CrossRef646
Giuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, Arnoud W.J. van't Hof, Jan C.A. Hoorntje, Jan-Henk Dambrink, A.T. Marcel Gosselink, Menko-Jan de Boer. (2007) Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. International Journal of Cardiology 119:3, 306-309
CrossRef647
Giuseppe Gioia, William Matthai, Karen Gillin, James Dralle, Alberto Benassi, Maria Francesca Gioia, Jacqueline White. (2007) Revascularization in severe left ventricular dysfunction: Outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting. Catheterization and Cardiovascular Interventions 70:1, 26-33
CrossRef648
Subbu Venkatraman, Freddy Boey. (2007) Release profiles in drug-eluting stents: Issues and uncertainties. Journal of Controlled Release 120:3, 149-160
CrossRef649
Ron Waksman. (2007) Late stent thrombosis—The “vulnerable” stent. Catheterization and Cardiovascular Interventions 70:1, 54-56
CrossRef650
L. Iri Kupferwasser, Allen M. Amorn, Nikhil Kapoor, Michael S. Lee, Saibal Kar, Bojan Cercek, Suhail Dohad, James Mirocha, James S. Forrester, Prediman K. Shah, Raj R. Makkar. (2007) Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Catheterization and Cardiovascular Interventions 70:1, 1-8
CrossRef651
Pál Kárpáti. (2007) Mérföldkövek a kardiológia fejlődésének útján. Orvosi Hetilap 148:28, 1335-1338
CrossRef652
Aloke V. Finn, Gaku Nakazawa, Frank D. Kolodgie, Renu Virmani. (2007) Controversies Surrounding the Use of Drug-Eluting Stents. The American Heart Hospital Journal 5:3, 141-145
CrossRef653
Grayson G. Geary. (2007) The Vascular Therapist. Heart, Lung and Circulation 16:3, 193-199
CrossRef654
Mark G. Rabbat, Anthony A. Bavry, Deepak L. Bhatt. (2007) Drug-Eluting Stents: Can We Move Beyond Stent Thrombosis?. The American Heart Hospital Journal 5:3, 155-158
CrossRef655
Daniel H. Steinberg, Ron Waksman. (2007) Drug-Eluting Stent Thrombosis vs Bare Metal Stent Restenosis: Finding the Lesser of Two Evils. The American Heart Hospital Journal 5:3, 151-154
CrossRef656
FLAVIO RIBICHINI, VALERIA FERRERO, MAURO FEOLA, ANDREA ROGNONI, SANDRA BRUNELLESCHI, GIOVANNI VACCA, CORRADO VASSANELLI. (2007) Neutropenia in Patients Treated With Thienopyridines and High-Dose Oral Prednisone after Percutaneous Coronary Interventions. Journal of Interventional Cardiology 20:3, 209-213
CrossRef657
F. Cademartiri, A. Palumbo, E. Maffei, L. Grutta, G. Runza, F. Pugliese, M. Midiri, N. R. A. Mollet, W. B. Meijboom, A. Menozzi, L. Vignali, C. Reverberi, D. Ardissino, G. P. Krestin. (2007) Diagnostic accuracy of 64-slice CT in the assessment of coronary stents. La radiologia medica 112:4, 526-537
CrossRef658
Filippo Cademartiri, Joanne D. Schuijf, Francesca Pugliese, Nico R. Mollet, J. Wouter Jukema, Erica Maffei, Lucia J. Kroft, Alessandro Palumbo, Diego Ardissino, Patrick W. Serruys, Gabriel P. Krestin, Ernst E. Van der Wall, Pim J. de Feyter, Jeroen J. Bax. (2007) Usefulness of 64-Slice Multislice Computed Tomography Coronary Angiography to Assess In-Stent Restenosis. Journal of the American College of Cardiology 49:22, 2204-2210
CrossRef659
John Cosgrave, Gloria Melzi, Simon Corbett, Giuseppe G.L. Biondi-Zoccai, Pierfrancesco Agostoni, Rade Babic, Flavio Airoldi, Alaide Chieffo, Giuseppe M. Sangiorgi, Matteo Montorfano, Iassen Michev, Mauro Carlino, Antonio Colombo. (2007) Comparable Clinical Outcomes With Paclitaxel- and Sirolimus-Eluting Stents in Unrestricted Contemporary Practice. Journal of the American College of Cardiology 49:24, 2320-2328
CrossRef660
Emmanouil S. Brilakis, Subhash Banerjee, Peter B. Berger. (2007) Perioperative Management of Patients With Coronary Stents. Journal of the American College of Cardiology 49:22, 2145-2150
CrossRef661
Anderson Mehrle, Thomas Skelton, Alexandra Almonacid. (2007) Stent fracture: An unusual cause of late restenosis after sirolimus-eluting stent placement. Catheterization and Cardiovascular Interventions 69:7, 988-991
CrossRef662
Marko Remmel, Franz Hartmann, Lars C. Harland, Heribert Schunkert, Peter W. Radke. (2007) Rational Use of Drug-Eluting Stents. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 6:2, 85-89
CrossRef663
Chi-Hang Lee, Adrian Low, Jimmy Lim, Hwee-Bee Wong, Yean-Teng Lim, Huay-Cheem Tan. (2007) CYPHER versus TAXUS stent for bifurcation lesions beyond 30 days—long-term follow-up results. International Journal of Cardiology 117:3, 422-424
CrossRef664
Giuseppe G.L. Biondi-Zoccai, Giuseppe M. Sangiorgi, David Antoniucci, Eberhard Grube, Carlo Di Mario, Bernard Reimers, Corrado Tamburino, Pierfrancesco Agostoni, John Cosgrave, Antonio Colombo. (2007) Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients. International Journal of Cardiology 117:3, 349-354
CrossRef665
Alexandre Abizaid, Alexandra J. Lansky, Peter J. Fitzgerald, Luis Fernando Tanajura, Fausto Feres, Rodolfo Staico, Luiz Mattos, Andrea Abizaid, Aurea Chaves, Marinella Centemero, Amanda G.M.R. Sousa, J. Eduardo Sousa, Margo J. Zaugg, Lewis B. Schwartz. (2007) Percutaneous Coronary Revascularization Using a Trilayer Metal Phosphorylcholine-Coated Zotarolimus-Eluting Stent. The American Journal of Cardiology 99:10, 1403-1408
CrossRef666
Tracy Y. Wang, Vic Hasselblad, John L. Peterson, William Wijns, Azin Parhizgar, Dean J. Kereiakes, Mitchell W. Krucoff. (2007) The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) Trial study design: Advancing the active-control evaluation of second-generation drug-eluting stents. American Heart Journal 153:5, 743-748
CrossRef667
Nico H.J. Pijls, Pepijn van Schaardenburgh, Ganesh Manoharan, Eric Boersma, Jan-Willem Bech, Marcel van’t Veer, Frits Bär, Jan Hoorntje, Jacques Koolen, William Wijns, Bernard de Bruyne. (2007) Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis. Journal of the American College of Cardiology 49:21, 2105-2111
CrossRef668
H. Vernon Anderson, Richard W. Smalling, Timothy D. Henry. (2007) Drug-Eluting Stents for Acute Myocardial Infarction
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 49:19, 1931-1933
CrossRef669
Duncan G. de Souza, Victor C. Baum, Natalie M. Ballert. (2007) Late Thrombosis of a Drug-eluting Stent Presenting in the Perioperative Period. Anesthesiology 106:5, 1057-1059
CrossRef670
Ted R. Kohler, Philip M. Toleikis, David M. Gravett, Rui L. Avelar. (2007) Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap
CrossRef671
Ichizo Tsujino, Junya Ako, Yasuhiro Honda, Peter J Fitzgerald. (2007) Drug delivery via nano-, micro and macroporous coronary stent surfaces. Expert Opinion on Drug Delivery 4:3, 287-295
CrossRef672
Ge Zhang, Laura J. Suggs. (2007) Matrices and scaffolds for drug delivery in vascular tissue engineering. Advanced Drug Delivery Reviews 59:4-5, 360-373
CrossRef673
Gautam Kedia, Michael S. Lee. (2007) Stent thrombosis with drug-eluting stents: A re-examination of the evidence. Catheterization and Cardiovascular Interventions 69:6, 782-789
CrossRef674
Paolo Ortolani, Antonio Marzocchi, Cinzia Marrozzini, Tullio Palmerini, Francesco Saia, Nevio Taglieri, Matteo Aquilina, Federica Baldazzi, Simona Silenzi, Robin M.T. Cooke, Maria-Letizia Bacchi Reggiani, Angelo Branzi. (2007) Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization. Catheterization and Cardiovascular Interventions 69:6, 790-798
CrossRef675
James Margolis, John McDonald, Richard Heuser, Peter Klinke, Ron Waksman, Renu Virmani, Neil Desai, David Hilton. (2007) Systemic Nanoparticle Paclitaxel (nab-Paclitaxel) for In-stent Restenosis I (SNAPIST-I): A First-in-Human Safety and Dose-finding Study. Clinical Cardiology 30:4, 165-170
CrossRef676
Mark A. Turco, John A. Ormiston, Jeffrey J. Popma, Lazar Mandinov, Charles D. O’Shaughnessy, Tift Mann, Thomas F. McGarry, Chiung-Jen Wu, Charles Chan, Mark W.I. Webster, Jack J. Hall, Gregory J. Mishkel, Louis A. Cannon, Donald S. Baim, Joerg Koglin. (2007) Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions. Journal of the American College of Cardiology 49:16, 1676-1683
CrossRef677
Ajay J. Kirtane, Jeffrey W. Moses. (2007) Revascularization in Heart Failure: The Role of Percutaneous Coronary Intervention. Heart Failure Clinics 3:2, 229-235
CrossRef678
AHMED A. KHATTAB, ANDREAS OTTO, MATTHIAS HOCHADEL, RALPH TOELG, VOLKER GEIST, GERT RICHARDT. (2007) Drug-Eluting Stents Versus Bare Metal Stents Following Rotational Atherectomy for Heavily Calcified Coronary Lesions: Late Angiographic and Clinical Follow-Up Results. Journal of Interventional Cardiology 20:2, 100-106
CrossRef679
FLAVIO RIBICHINI, VALERIA FERRERO, ANDREA ROGNONI, PAOLO MARINO, SANDRA BRUNELLESCHI, CORRADO VASSANELLI. (2007) Percutaneous Treatment of Coronary Bifurcations: Lesion Preparation Before Provisional Bare Metal Stenting and Subsequent Immunosuppression with Oral Prednisone. The IMPRESS-Y Study. Journal of Interventional Cardiology 20:2, 114-121
CrossRef680
Giuseppe De Luca, Giannignazio Carbone, AntonGiulio Maione, Giovanni Gregorio. (2007) In-stent thrombosis after discontinuation of antiplatelet therapy 2 years after DES implantation: A case report. International Journal of Cardiology 116:3, 399-400
CrossRef681
Peter Barlis, Mark Horrigan, Safari Elis, Robert Chan, Michael Wong, Omar Farouque, George Proimos, Andrew E. Ajani, David J. Clark. (2007) Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting. Cardiovascular Revascularization Medicine 8:2, 84-89
CrossRef682
Matteo Cassin, Marzia De Biasio, Franco Macor, Claudio Burelli, Fauzia Vendrametto, Mauro Driussi, Gian Luigi Nicolosi. (2007) Late coronary thrombosis in paclitaxel-eluting stents. Case reports. Journal of Cardiovascular Medicine 8:4, 284-288
CrossRef683
Jung-Won Suh, Jin-Shik Park, Hyun-Jai Cho, Min-Seok Kim, Hyun-Jae Kang, Young-Seok Cho, Bon-Kwon Koo, Woo-Young Chung, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi, Hyo-Soo Kim, Dae-Won Sohn, Byung-Hee Oh, Young-Bae Park. (2007) Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans. International Journal of Cardiology 117:1, 31-36
CrossRef684
Stone, Gregg W., Moses, Jeffrey W., Ellis, Stephen G., Schofer, Joachim, Dawkins, Keith D., Morice, Marie-Claude, Colombo, Antonio, Schampaert, Erick, Grube, Eberhard, Kirtane, Ajay J., Cutlip, Donald E., Fahy, Martin, Pocock, Stuart J., Mehran, Roxana, Leon, Martin B., . (2007) Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents. New England Journal of Medicine 356:10, 998-1008
Full Text685
Mauri, Laura, Hsieh, Wen-hua, Massaro, Joseph M., Ho, Kalon K.L., D'Agostino, Ralph, Cutlip, Donald E., . (2007) Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents. New England Journal of Medicine 356:10, 1020-1029
Full Text686
Lagerqvist, Bo, James, Stefan K., Stenestrand, Ulf, Lindbäck, Johan, Nilsson, Tage, Wallentin, Lars, . (2007) Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden. New England Journal of Medicine 356:10, 1009-1019
Full Text687
Daniel H. Steinberg, Sundeep Mishra, Aamir Javaid, Tina L. Pinto Slottow, Ashesh N. Buch, Probal Roy, Teruo Okabe, Kimberly A. Smith, Rebecca Torguson, Zhenyi Xue, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Ron Waksman. (2007) Comparison of Effectiveness of Bare Metal Stents Versus Drug-Eluting Stents in Large (≥3.5 mm) Coronary Arteries. The American Journal of Cardiology 99:5, 599-602
CrossRef688
Nadine Gauthier, Michel R Le May. (2007) Percutaneous coronary intervention for left main coronary artery disease. Expert Review of Cardiovascular Therapy 5:2, 213-220
CrossRef689
Waqar Habib Ahmed. (2007) Review of the TAXUS® Liberté™ SR paclitaxel-eluting coronary stent. Expert Review of Medical Devices 4:2, 117-120
CrossRef690
Daniel Bainbridge, Davy Cheng, Janet Martin, Richard Novick. (2007) Does off-pump or minimally invasive coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with percutaneous coronary intervention? A meta-analysis of randomized trials. The Journal of Thoracic and Cardiovascular Surgery 133:3, 623-631
CrossRef691
Giora Weisz, Jeffrey W Moses. (2007) New percutaneous approaches for chronic total occlusion of coronary arteries. Expert Review of Cardiovascular Therapy 5:2, 231-241
CrossRef692
Stephen G. Ellis, Antonio Colombo, Eberhard Grube, Jeffrey Popma, Joerg Koglin, Keith D. Dawkins, Gregg W. Stone. (2007) Incidence, Timing, and Correlates of Stent Thrombosis With the Polymeric Paclitaxel Drug-Eluting Stent. Journal of the American College of Cardiology 49:10, 1043-1051
CrossRef693
Ayman A. El-Menyar, Jassim Al Suwaidi, David R. Holmes. (2007) Left Main Coronary Artery Stenosis: State-of-the-Art. Current Problems in Cardiology 32:3, 103-193
CrossRef694
Mimi Q. Le, Craig R. Narins. (2007) Mycotic pseudoaneurysm of the left circumflex coronary artery: A fatal complication following drug-eluting stent implantation. Catheterization and Cardiovascular Interventions 69:4, 508-512
CrossRef695
Mátyás Keltai. (2007) A gyógyszerkibocsátó coronariastentek alkalmazásának hatásai. Orvosi Hetilap 148:10, 443-450
CrossRef696
Victor Legrand. (2007) Therapy Insight: diabetes and drug-eluting stents. Nature Clinical Practice Cardiovascular Medicine 4:3, 143-150
CrossRef697
John Cosgrave, Gloria Melzi, Simon Corbett, Giuseppe G.L. Biondi-Zoccai, Rade Babic, Flavio Airoldi, Alaide Chieffo, Giuseppe M. Sangiorgi, Matteo Montorfano, Iassen Michev, Mauro Carlino, Antonio Colombo. (2007) Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent. American Heart Journal 153:3, 354-359
CrossRef698
Michael S. Lee, Daniel Jurewitz, Joseph Aragon, James Forrester, Raj R. Makkar, Saibal Kar. (2007) Stent fracture associated with drug-eluting stents: Clinical characteristics and implications. Catheterization and Cardiovascular Interventions 69:3, 387-394
CrossRef699
Susanne S. Pedersen, Johan Denollet, Andrew T.L. Ong, Karel Sonnenschein, Ruud A.M. Erdman, Patrick W. Serruys, Ron T. van Domburg. (2007) Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality. European Journal of Cardiovascular Prevention & Rehabilitation 14:1, 135-140
CrossRef700
ZHEN KUN YANG, WEI FENG SHEN, RUI YAN ZHANG, YE KONG, JIAN SHENG ZHANG, JIAN HU, QI ZHANG, FENG HUA DING. (2007) Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention with Drug-Eluting Stent Implantation in Patients with Multivessel Coronary Disease. Journal of Interventional Cardiology 20:1, 10-16
CrossRef701
Jose de Ribamar Costa, Gary S. Mintz, Stéphane G. Carlier, Kenichi Fujii, Koichi Sano, Masashi Kimura, Kaoru Tanaka, Ricardo A. Costa, Joanna Lui, Yingbo Na, Celia Castellanos, Sinan Biro, Issam Moussa, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon. (2007) Intravascular ultrasound assessment of drug-eluting stent expansion. American Heart Journal 153:2, 297-303
CrossRef702
Philip Urban, Edoardo De Benedetti. (2007) Thrombosis: the last frontier of coronary stenting?. The Lancet 369:9562, 619-621
CrossRef703
Julio García-Tejada, Hipólito Gutiérrez, Agustín Albarrán, Felipe Hernández, Teresa Velázquez, Sergio Rodríguez, Iván Gómez, Juan Tascón. (2007) Carbo-stent liberador de tacrolimus Janus®. Resultados inmediatos y seguimiento clínico a medio plazo. Revista Española de Cardiología 60:2, 197-200
CrossRef704
Ashesh N. Buch, Ron Waksman. (2007) Cypher Versus Taxus: All Smoke and No Fire: Lessons for Future Comparative Drug-Eluting Stent Trials in Interventional Cardiology. The American Journal of Cardiology 99:3, 424-427
CrossRef705
Joost Daemen, Peter Wenaweser, Keiichi Tsuchida, Linda Abrecht, Sophia Vaina, Cyrill Morger, Neville Kukreja, Peter Jüni, Georgios Sianos, Gerrit Hellige, Ron T van Domburg, Otto M Hess, Eric Boersma, Bernhard Meier, Stephan Windecker, Patrick W Serruys. (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. The Lancet 369:9562, 667-678
CrossRef706
Gurpreet Sandhu, Brendan Doyle, Ripudamanjit Singh, Malcolm Bell, John Bresnahan, Verghese Mathew, David Holmes, Amir Lerman, Charanjit Rihal. (2007) Frequency, Etiology, Treatment, and Outcomes of Drug-Eluting Stent Thrombosis During One Year of Follow-Up. The American Journal of Cardiology 99:4, 465-469
CrossRef707
Eugenia Nikolsky, Gregg W. Stone. (2007) Utility of drug-eluting stents in complex lesions and high-risk patients. Current Treatment Options in Cardiovascular Medicine 9:1, 11-28
CrossRef708
Robert J. Applegate, Matthew T. Sacrinty, Michael A. Kutcher, Talal T. Baki, Sanjay K. Gandhi, Renato M. Santos, William C. Little. (2007) Comparison of Drug-Eluting Versus Bare Metal Stents on Later Frequency of Acute Myocardial Infarction and Death. The American Journal of Cardiology 99:3, 333-338
CrossRef709
Marco A. Costa, Manel Sabate, Rodolfo Staico, Fernando Alfonso, Ana C. Seixas, Mariano Albertal, Arthur Crossman, Dominick J. Angiolillo, Martin Zenni, J. Eduardo Sousa, Carlos Macaya, Theodore A. Bass. (2007) Anatomical and physiologic assessments in patients with small coronary artery disease: Final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial. American Heart Journal 153:2, 296.e1-296.e7
CrossRef710
F. Unger, U. Westedt, P. Hanefeld, R. Wombacher, S. Zimmermann, A. Greiner, M. Ausborn, T. Kissel. (2007) Poly(ethylene carbonate): A thermoelastic and biodegradable biomaterial for drug eluting stent coatings?. Journal of Controlled Release 117:3, 312-321
CrossRef711
Juan Sánchez-Rubio Lezcano, José Gabriel Galache Osuna, Isabel Calvo Cebollero, Antonela Lukic, José Antonio Diarte de Miguel, Luis Javier Placer Peralta. (2007) Resultados a largo plazo del empleo de stents recubiertos de fármacos en la práctica clínica habitual. Comparación entre los stents liberadores de rapamicina y los stents liberadores de paclitaxol. Medicina Clínica 128:6, 211-213
CrossRef712
K.H. Chan, J. Armstrong, S. Withers, N. Malik, D.C. Cumberland, J. Gunn, C.M. Holt. (2007) Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents. Biomaterials 28:6, 1218-1224
CrossRef713
Jochen Wöhrle, Thorsten Nusser, Hans A. Kestler, Matthias Kochs, Vinzenz Hombach. (2007) Comparison of the slow-release polymerbased paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions. Clinical Research in Cardiology 96:2, 70-76
CrossRef714
PETER W. GROENEVELD, JANICE J. SUH, MARY ANNE MATTA. (2007) The Costs and Quality-of-Life Outcomes of Drug-Eluting Coronary Stents: A Systematic Review. Journal of Interventional Cardiology 20:1, 1-9
CrossRef715
Valentin Fuster, Javier Sanz. (2007) Gene therapy and stem cell therapy for cardiovascular diseases today: a model for translational research. Nature Clinical Practice Cardiovascular Medicine 4, S1-S8
CrossRef716
Alban Dibra, Adnan Kastrati, Fernando Alfonso, Melchior Seyfarth, Maria-José Pérez-Vizcayno, Julinda Mehilli, Albert Schömig. (2007) Effectiveness of Drug-Eluting Stents in Patients With Bare-Metal In-Stent Restenosis. Journal of the American College of Cardiology 49:5, 616-623
CrossRef717
Joost Daemen, Patrick W Serruys. (2007) Optimal revascularization strategies for multivessel coronary artery disease. Current Opinion in Internal Medicine 6:1, 19-25
CrossRef718
Joseph Dubin, Donald E Cutlip. (2007) Current issues in coronary artery stenting in the elderly. Aging Health 3:1, 105-114
CrossRef719
Yukio Ozaki, Tetsu Yamaguchi, Takahiko Suzuki, Masato Nakamura, Michihiko Kitayama, Hideo Nishikawa, Teruo Inoue, Kazuhiro Hara, Fumihiko Usuba, Masami Sakurada, Kojiro Awano, Hitoshi Matsuo, Sugao Ishiwata, Tatsuya Yasukawa, Tevfik F. Ismail, Hitoshi Hishida, Osamu Kato. (2007) Impact of Cutting Balloon Angioplasty (CBA) Prior to Bare Metal Stenting on Restenosis. Circulation Journal 71:1, 1-8
CrossRef720
Simon J. Corbett, John Cosgrave, Antonio Colombo. (2007) Concurrent implantation of sirolimus- and paclitaxel-eluting stents in the same vessel. Catheterization and Cardiovascular Interventions 69:1, 109-114
CrossRef721
Shuzou Tanimoto, Joost Daemen, Keiichi Tsuchida, Héctor M. García-García, Peter de Jaegere, Ron T. van Domburg, Patrick W. Serruys. (2007) Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: Insight into the RESEARCH and T-SEARCH registries. Catheterization and Cardiovascular Interventions 69:1, 94-103
CrossRef722
Seong-Man Kim, Doo-Il Kim, Hwan-Jin Cho, Sang-Hoon Seol, Dae-Kyeong Kim, Tae-Hyun Yang, Dong-Soo Kim. (2007) Effects of Cilostazol on the Drug-Eluting Stent in Native Coronary Arteries. Korean Circulation Journal 37:7, 304
CrossRef723
Susanne S. Pedersen, Johan Denollet, Andrew T.L. Ong, Patrick W. Serruys, Ruud A.M. Erdman, Ron T. van Domburg. (2007) Impaired health status in Type D patients following PCI in the drug-eluting stent era. International Journal of Cardiology 114:3, 358-365
CrossRef724
Leo Slavin, Ankush Chhabra, Jonathan M. Tobis. (2007) Drug-Eluting Stents. Cardiology in Review 15:1, 1-12
CrossRef725
Dong Won Lee, Jae Kyung Ha, Sung Gyu An, Jae-Hoon Choi, Tae Kun Lee, Han Cheol Lee, Jun Kim, June Hong Kim, Kook-Jin Chun, Taek Jong Hong, Yung Woo Shin. (2007) Comparison of the Clinical and Angiographic Outcomes of Compromised Side Branches (Stent Jail) after Percutaneous Coronary Intervention between Sirolimus-Eluting Stents and Paclitaxel-Eluting Stents. Korean Circulation Journal 37:12, 630
CrossRef726
Jacob M. Mishell, Kalpesh T. Vakharia, Thomas A. Ports, Yerem Yeghiazarians, Andrew D. Michaels. (2007) Determination of adequate coronary stent expansion using StentBoost, a novel fluoroscopic image processing technique. Catheterization and Cardiovascular Interventions 69:1, 84-93
CrossRef727
Masanori Okumura, Yukio Ozaki, Junichi Ishii, Shino Kan, Hiroyuki Naruse, Shigeru Matsui, Makoto Ishikawa, Kousuke Hattori, Tomoko Gochi, Tadashi Nakano, Akira Yamada, Shigeru Kato, Sadako Motoyama, Masayoshi Sarai, Yasushi Takagi, Tevfik F. Ismail, Masanori Nomura, Hitoshi Hishida. (2007) Restenosis and Stent Fracture Following Sirolimus-Eluting Stent (SES) Implantation. Circulation Journal 71:11, 1669-1677
CrossRef728
Corrado Tamburino, Gian Paolo Ussia, Marco Zimarino, Alfredo R. Galassi, Raffaele De Caterina. (2007) Early restenosis after drug-eluting stent implantation: A putative role for platelet activation. Canadian Journal of Cardiology 23:1, 57-59
CrossRef729
Saravanan Balamuthusamy, Rohit Arora. (2007) Hematologic Adverse Effects of Clopidogrel. American Journal of Therapeutics 14:1, 106-112
CrossRef730
Chi-Hang Lee, Mark Y. Chan. (2007) Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus. International Journal of Cardiology 114:3, E107-E108
CrossRef731
Pil-Ki Min, Jae-Hun Jung, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Won-Heum Shim. (2007) Effect of Cilostazol on In-Stent Neointimal Hyperplasia After Coronary Artery Stenting. Circulation Journal 71:11, 1685-1690
CrossRef732
Sou-Tung Chiu-Tsao, Dennis R. Schaart, Christopher G. Soares, Ravinder Nath. (2007) Dose calculation formalisms and consensus dosimetry parameters for intravascular brachytherapy dosimetry: Recommendations of the AAPM Therapy Physics Committee Task Group No. 149. Medical Physics 34:11, 4126
CrossRef733
Pascal Meier, Rainer Zbinden, Mario Togni, Peter Wenaweser, Stephan Windecker, Bernhard Meier, Christian Seiler. (2007) Coronary Collateral Function Long After Drug-Eluting Stent Implantation. Journal of the American College of Cardiology 49:1, 15-20
CrossRef734
Jae-Youn Moon, Myung Ho Jeong, In Soo Kim, Chung Hwan Jun, Jung Sun Cho, Jong Won Chung, Doosun Sim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang. (2007) The Frequency, Treatment and Clinical Outcomes of Stent Thrombosis after Use of TAXUS??Stent. Korean Circulation Journal 37:12, 641
CrossRef735
Julio García-Tejada, Hipólito Gutiérrez, Agustín Albarrán, Felipe Hernández, Teresa Velázquez, Sergio Rodríguez, Iván Gómez, Juan Tascón. (2007) Janus® Tacrolimus-Eluting Carbostent. Immediate and Medium-Term Clinical Results. Revista Española de Cardiología (English Edition) 60:2, 197-200
CrossRef736
Soon Jun Hong, Moo Hyun Kim, Tae Hoon Ahn, Wan Joo Shim, Seong Mi Park, Jong Il Choi, Hyung Joon Joo, Seung Yong Shin, Sang Yup Lim, Do-Sun Lim. (2007) Comparison of the Predictors of Coronary Restenosis after Drug-Eluting Stent Implantation in Diabetic and Nondiabetic Patients. Korean Circulation Journal 37:11, 530
CrossRef737
Jang-Young Kim, Junghan Yoon. (2007) Aspirin and Clopidogrel Resistance in Drug Eluting Stent Era. Korean Circulation Journal 37:4, 135
CrossRef738
Turkay Ozcan, V. Gokhan Cin, Mustafa Yurtdas, Burak Akcay, Sabri Seyis, Armagan Acele, Dilek Cicek, Ahmet Camsari, Necdet Akkus, Oben Doven. (2007) Angiographic and Clinical Outcome Following Sirolimus-Eluting Stent (Cypher) Implantation. International Heart Journal 48:1, 11-23
CrossRef739
John J. Mahmarian, Habib A. Dakik, Neil G. Filipchuk, Leslee J. Shaw, Sherif S. Iskander, Terrence D. Ruddy, Felix Keng, Milena J. Henzlova, Adel Allam, Lemuel A. Moyé, Craig M. Pratt. (2006) An Initial Strategy of Intensive Medical Therapy Is Comparable to That of Coronary Revascularization for Suppression of Scintigraphic Ischemia in High-Risk But Stable Survivors of Acute Myocardial Infarction. Journal of the American College of Cardiology 48:12, 2458-2467
CrossRef740
Matthias Pfisterer, Hans Peter Brunner-La Rocca, Peter T. Buser, Peter Rickenbacher, Patrick Hunziker, Christian Mueller, Raban Jeger, Franziska Bader, Stefan Osswald, Christoph Kaiser. (2006) Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents. Journal of the American College of Cardiology 48:12, 2584-2591
CrossRef741
Srihari Thanigaraj, Jason R. Wollmuth, Alan Zajarias, Jacob Chemmalakuzhy, John M. Lasala. (2006) From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents. Coronary Artery Disease 17:8, 673-679
CrossRef742
Harold L. Dauerman. (2006) Drug Eluting Stents. Coronary Artery Disease 17:8, 657-659
CrossRef743
Duk-Woo Park, Myeong-Ki Hong, Gary S. Mintz, Cheol Whan Lee, Jong-Min Song, Ki-Hoon Han, Duk-Hyun Kang, Sang-Sig Cheong, Jae-Kwan Song, Jae-Joong Kim, Neil J. Weissman, Seong-Wook Park, Seung-Jung Park. (2006) Two-Year Follow-Up of the Quantitative Angiographic and Volumetric Intravascular Ultrasound Analysis After Nonpolymeric Paclitaxel-Eluting Stent Implantation. Journal of the American College of Cardiology 48:12, 2432-2439
CrossRef744
SIGMUND SILBER. (2006) A New and Rapid Scoring System to Assess the Scientific Evidence from Clinical Trials. Journal of Interventional Cardiology 19:6, 485-492
CrossRef745
David E. Kandzari, Martin B. Leon, Jeffrey J. Popma, Peter J. Fitzgerald, Charles O’Shaughnessy, Michael W. Ball, Mark Turco, Robert J. Applegate, Paul A. Gurbel, Mark G. Midei, Sejal S. Badre, Laura Mauri, Kweli P. Thompson, LeRoy A. LeNarz, Richard E. Kuntz. (2006) Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease. Journal of the American College of Cardiology 48:12, 2440-2447
CrossRef746
Donald E. Cutlip. (2006) Drug-eluting stent era: will we improve 5-year outcomes?. Coronary Artery Disease 17:8, 681-684
CrossRef747
David Tanous, Jan Hinrich Bräsen, Katherine Choy, Ben J. Wu, Krishna Kathir, Antony Lau, David S. Celermajer, Roland Stocker. (2006) Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis 189:2, 342-349
CrossRef748
Mark H. Wernick, Allen Jeremias, Joseph P. Carrozza. (2006) Drug-eluting stents and stent thrombosis: a cause for concern?. Coronary Artery Disease 17:8, 661-665
CrossRef749
Huyen Tran, Shamir R Mehta, John W Eikelboom. (2006) Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI). Vascular Health and Risk Management 2:4, 379-387
CrossRef750
Henry W. Huang, Bruce N. Brent, Richard E. Shaw. (2006) Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era—a report from the American College of Cardiology-National Cardiovascular data registry (ACC-NCDR). Catheterization and Cardiovascular Interventions 68:6, 867-872
CrossRef751
Robert A. Harrington, Robert M. Califf. (2006) Late Ischemic Events After Clopidogrel Cessation Following Drug-Eluting Stenting. Journal of the American College of Cardiology 48:12, 2592-2595
CrossRef752
Duane S. Pinto, Jason Ryan, David J. Cohen. (2006) Drug-eluting stents for stent thrombosis elevation acute myocardial infarction: do we need randomized trials?. Coronary Artery Disease 17:8, 667-671
CrossRef753
Leonardo C. Clavijo, Daniel H. Steinberg, Rebecca Torguson, Pramod K. Kuchulakanti, William W. Chu, Jana Fournadjiev, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Ron Waksman, Augusto D. Pichard. (2006) Sirolimus-eluting stents and calcified coronary lesions: Clinical outcomes of patients treated with and without rotational atherectomy. Catheterization and Cardiovascular Interventions 68:6, 873-878
CrossRef754
ELLIOT J. SMITH, AJAY K. JAIN, MARTIN T. ROTHMAN. (2006) New Developments in Coronary Stent Technology. Journal of Interventional Cardiology 19:6, 493-499
CrossRef755
Scheller, Bruno, Hehrlein, Christoph, Bocksch, Wolfgang, Rutsch, Wolfgang, Haghi, Dariush, Dietz, Ulrich, Böhm, Michael, Speck, Ulrich, . (2006) Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter. New England Journal of Medicine 355:20, 2113-2124
Full Text756
S. Kumar, V. Suresh, B.D. Prendergast, N.H. Brooks, P. Wicks, R.D. Levy, S.G. Ray, D.H. Bennett, H.S. Lee. (2006) Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID)—A single-center study comparing Cypher™ sirolimus-eluting with Taxus™ paclitaxel-eluting stents. Catheterization and Cardiovascular Interventions 68:5, 663-668
CrossRef757
Robert D. Ecker, Elad I. Levy, Eric Sauvageau, Ricardo A. Hanel, L Nelson Hopkins. (2006) Current Concepts in the Management of Intracranial Atherosclerotic Disease. Neurosurgery 59:SUPPLEMENT, S3-210-S3-218
CrossRef758
Shahzad G. Raja, Gilles D. Dreyfus. (2006) Efficacy and Safety of Drug-Eluting Stents: Current Best Available Evidence. Journal of Cardiac Surgery 21:6, 605-612
CrossRef759
Glen E Cooke, Pascal J Goldschmidt-Clermont. (2006) The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease. Expert Opinion on Drug Safety 5:6, 815-826
CrossRef760
Yanai Ben-Gal, Yaron Moshkovitz, Nachum Nesher, Gideon Uretzky, Rony Braunstein, Alberto Hendler, Einat Zivi, Itzhak Herz, Rephael Mohr. (2006) Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus. The Annals of Thoracic Surgery 82:5, 1692-1697
CrossRef761
D Charytan, R E Kuntz. (2006) The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney International
CrossRef762
Ray M. Lee, Takahisa Masaki, Hung-Sheng Yang, Jihua Liu, Jun Chen, Li Li, Donald K. Blumenthal, Alfred K. Cheung. (2006) Different signaling responses to anti-proliferative agents in human aortic and venous smooth muscle cells. Journal of Cellular Biochemistry 99:3, 835-844
CrossRef763
2006. Acute Coronary Syndrome: NSTEMI. .
CrossRef764
S Misra, R Bonan, T Pflederer, P Roy-Chaudhury. (2006) BRAVO I: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney International
CrossRef765
DAVID E. KANDZARI, MARTIN B. LEON. (2006) Overview of Pharmacology and Clinical Trials Program with the Zotarolimus-Eluting Endeavor Stent. Journal of Interventional Cardiology 19:5, 405-413
CrossRef766
Y.H. Lin, Y.C. Liu, W.Y.I. Tseng, J.M. Juang, C.S. Hung, J.W. Lin, J.S. Jeng, P.K. Yip, H.L. Kao. (2006) The Impact of Lesion Length on Angiographic Restenosis after Vertebral Artery Origin Stenting. European Journal of Vascular and Endovascular Surgery 32:4, 379-385
CrossRef767
Shpend Elezi, Alban Dibra, Julinda Mehilli, Jürgen Pache, Rainer Wessely, Albert Schömig, Adnan Kastrati. (2006) Vessel Size and Outcome After Coronary Drug-Eluting Stent Placement. Journal of the American College of Cardiology 48:7, 1304-1309
CrossRef768
MATTHEW J. PRICE. (2006) Unprotected Left Main Coronary Intervention with Drug-Eluting Stents. Journal of Interventional Cardiology 19:s5, S21-S26
CrossRef769
JOHN M. LASALA, GREGG W. STONE, KEITH D. DAWKINS, PATRICK W. SERRUYS, ANTONIO COLOMBO, EBERHARD GRUBE, JOERG KOGLIN, STEPHEN ELLIS. (2006) An Overview of the TAXUS
CrossRef770
MICHAEL J. COWLEY. (2006) Drug-Eluting Stent Restenosis: Incidence, Predictors, Mechanisms, and Treatment. Journal of Interventional Cardiology 19:s5, S47-S53
CrossRef771
MARY E. RUSSELL, MARK I. FRIEDMAN, STEPHEN R. MASCIOLI, LESLIE E. STOLZ. (2006) Off-Label Use: An Industry Perspective on Expanding Use Beyond Approved Indications. Journal of Interventional Cardiology 19:5, 432-438
CrossRef772
Jae-Hun Jung, Pil-Ki Min, Jong-Youn Kim, Sungha Park, Eui-Young Choi, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Won-Heum Shim, Seung-Yun Cho. (2006) Systemic immunosuppressive therapy inhibits in-stent restenosis in patients with renal allograft. Catheterization and Cardiovascular Interventions 68:4, 567-573
CrossRef773
Francesco Saia, Giancarlo Piovaccari, Antonio Manari, Andrea Santarelli, Alberto Benassi, Enrico Aurier, Pietro Sangiorgio, Fabio Tarantino, Giuseppe Geraci, Giuseppe Vecchi, Paolo Guastaroba, Roberto Grilli, Antonio Marzocchi. (2006) Clinical Outcomes for Sirolimus-Eluting Stents and Polymer-Coated Paclitaxel-Eluting Stents in Daily Practice. Journal of the American College of Cardiology 48:7, 1312-1318
CrossRef774
Van de Werf, Frans, . (2006) Drug-Eluting Stents in Acute Myocardial Infarction. New England Journal of Medicine 355:11, 1169-1170
Full Text775
Laarman, Gerrit J., Suttorp, Maarten J., Dirksen, Maurits T., van Heerebeek, Loek, Kiemeneij, Ferdinand, Slagboom, Ton, van der Wieken, L. Ron, Tijssen, Jan G.P., Rensing, Benno J., Patterson, Mark, . (2006) Paclitaxel-Eluting versus Uncoated Stents in Primary Percutaneous Coronary Intervention. New England Journal of Medicine 355:11, 1105-1113
Full Text776
Richard G Bach. (2006) The early invasive strategy revisited: FRISC II at 5 years. The Lancet 368:9540, 966-969
CrossRef777
Victor Y. Lim, Lutz Buellesfeld, Ulrich Gerckens, Ralf Mueller, Thomas Schmidt, Eberhard Grube. (2006) Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: Results of clinical and angiographic follow-up at six months in a single-center registry. Catheterization and Cardiovascular Interventions 68:3, 343-348
CrossRef778
Giuseppe Gioia, William Matthai, Alberto Benassi, Hamza Rana, Howard A. Levite, Lannae G. Ewing. (2006) Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction. Catheterization and Cardiovascular Interventions 68:3, 392-398
CrossRef779
Hideki Futamatsu, Manel Sabaté, Dominick J. Angiolillo, Pilar Jimenez-Quevedo, Cecilia Corros, Kino Morikawa-Futamatsu, Fernando Alfonso, Julie Jiang, Pavel Cervinka, Rosana Hernandez-Antolin, Carlos Macaya, Theodore A. Bass, Marco A. Costa. (2006) Characterization of Plaque Prolapse After Drug-Eluting Stent Implantation in Diabetic Patients. Journal of the American College of Cardiology 48:6, 1139-1145
CrossRef780
Stephen Russell, Fernando Antoñanzas, Vicente Mainar. (2006) Impacto económico del stent coronario Taxus: implicaciones para el sistema sanitario español. Revista Española de Cardiología 59:9, 889-896
CrossRef781
MARCO L. ROSSI, GUIDO BELLI, DENNIS ZAVALLONI PARENTI, MELANIA SCATTURIN, PAOLO PAGNOTTA, GABRIELE GASPARINI, PATRIZIA PRESBITERO. (2006) "Do Least Harm" Philosophy May Suffice for Percutaneous Coronary Intervention in Octogenarians. Journal of Interventional Cardiology 19:4, 313-318
CrossRef782
Meital Zilberman, Robert C. Eberhart. (2006) DRUG-ELUTING BIORESORBABLE STENTS FOR VARIOUS APPLICATIONS. Annual Review of Biomedical Engineering 8:1, 153-180
CrossRef783
Alfredo Rodriguez, Carlos Fernández-Pereira, Máximo Rodriguez-Alemparte. (2006) Oral Sirolimus after bare metal stent implantation. Catheterization and Cardiovascular Interventions 68:2, 334-335
CrossRef784
Nicolas Benard, Robert Perrault, Damien Coisne. (2006) Computational Approach to Estimating the Effects of Blood Properties on Changes in Intra-stent Flow. Annals of Biomedical Engineering 34:8, 1259-1271
CrossRef785
Andrew J. Carter, Anastasia Brodeur, Robin Collingwood, Sarah Ross, Lori Gibson, Chi-An Wang, Scott Haller, Leslie Coleman, Renu Virmani. (2006) Experimental efficacy of an everolimus eluting cobalt chromium stent. Catheterization and Cardiovascular Interventions 68:1, 97-103
CrossRef786
Ameet Bakhai, Gregg W. Stone, Elizabeth Mahoney, Tara A. Lavelle, Chunxue Shi, Ronna H. Berezin, Betsy J. Lahue, Mary Ann Clark, Michael J. Lacey, Mary E. Russell, Stephen G. Ellis, James B. Hermiller, David A. Cox, David J. Cohen. (2006) Cost Effectiveness of Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization. Journal of the American College of Cardiology 48:2, 253-261
CrossRef787
Bryan P. Yan, Ronen Gurvitch, Andrew E. Ajani. (2006) Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Cardiovascular Revascularization Medicine 7:3, 155-158
CrossRef788
Simon J. Corbett, Rade Babic, John Cosgrave, Giuseppe M. Sangiorgi, Antonio Colombo. (2006) Is sirolimus better than paclitaxel? A review of the comparative data on drug-eluting stents. Cardiovascular Revascularization Medicine 7:3, 159-164
CrossRef789
Fausto Feres, J. Ribamar Costa, Alexandre Abizaid. (2006) Very late thrombosis after drug-eluting stents. Catheterization and Cardiovascular Interventions 68:1, 83-88
CrossRef790
Shpend Elezi, Alban Dibra, Ulrike Folkerts, Julinda Mehilli, Sylvia Heigl, Albert Schömig, Adnan Kastrati. (2006) Cost Analysis From Two Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in High-Risk Patients With Coronary Artery Disease. Journal of the American College of Cardiology 48:2, 262-267
CrossRef791
Kunal Sarkar, Samin K Sharma, Rajesh Sachdeva, Francesco Romeo, Luis Garza, Jawahar L Mehta. (2006) Coronary artery restenosis: vascular biology and emerging therapeutic strategies. Expert Review of Cardiovascular Therapy 4:4, 543-556
CrossRef792
William W. Chu, Pramod K. Kuchulakanti, Rebecca Torguson, Betty Wang, Leonardo C. Clavijo, William O. Suddath, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Ron Waksman. (2006) Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 68:1, 62-66
CrossRef793
Alanna Coolong, Laura Mauri. (2006) Clopidogrel treatment surrounding percutaneous coronary intervention: When should it be started and stopped?. Current Cardiology Reports 8:4, 267-271
CrossRef794
Eli I. Lev, Nawar Tayyan, Albert E. Raizner, Stuart L. Solomon, Donna Simmons, Neal S. Kleiman. (2006) Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention. Coronary Artery Disease 17:4, 379-384
CrossRef795
Jeffrey W. Moses, Gregg W. Stone, Eugenia Nikolsky, Gary S. Mintz, George Dangas, Eberhard Grube, Stephen G. Ellis, Alexandra J. Lansky, Giora Weisz, Martin Fahy, Yingbo Na, Mary E. Russell, Dennis Donohoe, Martin B. Leon, Roxana Mehran. (2006) Drug-Eluting Stents in the Treatment of Intermediate Lesions. Journal of the American College of Cardiology 47:11, 2164-2171
CrossRef796
Pavel Červinka, Marco A. Costa, Dominick J. Angiolillo, Radim Špaček, Marian Bystroň, Martin Kvašňák, Josef Veselka, Hitesh Nanda, Hideki Futamatsu, Kino Futamatsu. (2006) “Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study”. Catheterization and Cardiovascular Interventions 67:6, 846-851
CrossRef797
Einat Cohen-Sela, Ohad Rosenzweig, Jianchuan Gao, Hila Epstein, Irith Gati, Reuven Reich, Haim D. Danenberg, Gershon Golomb. (2006) Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis. Journal of Controlled Release 113:1, 23-30
CrossRef798
David R. Holmes, Charanjit Rihal. (2006) The 5-Year Projection on the Future of Interventional Cardiology. The American Heart Hospital Journal 4:3, 195-201
CrossRef799
Hidehiko Hara, Masato Nakamura, Julio C. Palmaz, Robert S. Schwartz. (2006) Role of stent design and coatings on restenosis and thrombosis. Advanced Drug Delivery Reviews 58:3, 377-386
CrossRef800
John Cosgrave, Gloria Melzi, Giuseppe G.L. Biondi-Zoccai, Flavio Airoldi, Alaide Chieffo, Giuseppe M. Sangiorgi, Matteo Montorfano, Iassen Michev, Mauro Carlino, Erminio Bonizzoni, Antonio Colombo. (2006) Drug-Eluting Stent Restenosis. Journal of the American College of Cardiology 47:12, 2399-2404
CrossRef801
Joseph Jagur-Grodzinski. (2006) Polymers for tissue engineering, medical devices, and regenerative medicine. Concise general review of recent studies. Polymers for Advanced Technologies 17:6, 395-418
CrossRef802
JENNIFER WHITE. (2006) Proceedings of the TCT: Questions Surround Antithrombotic Therapy in Coronary DES Implantation. Journal of Interventional Cardiology 19:3, 232-235
CrossRef803
Kalpana R. Kamath, James J. Barry, Kathleen M. Miller. (2006) The Taxus™ drug-eluting stent: A new paradigm in controlled drug delivery. Advanced Drug Delivery Reviews 58:3, 412-436
CrossRef804
Georgios Sianos, Sofia Vaina, Angela Hoye, Patrick W. Serruys. (2006) Bifurcation stenting with drug eluting stents: Illustration of the crush technique. Catheterization and Cardiovascular Interventions 67:6, 839-845
CrossRef805
Sandra E. Burke, Richard E. Kuntz, Lewis B. Schwartz. (2006) Zotarolimus (ABT-578) eluting stents. Advanced Drug Delivery Reviews 58:3, 437-446
CrossRef806
David J. Clark, Sara Lessio, Margaret O’Donoghue, Con Tsalamandris, Robert Schainfeld, Kenneth Rosenfield. (2006) Mechanisms and Predictors of Carotid Artery Stent Restenosis. Journal of the American College of Cardiology 47:12, 2390-2396
CrossRef807
A.D. DeHennis, K.D. Wise. (2006) A Fully Integrated Multisite Pressure Sensor for Wireless Arterial Flow Characterization. Journal of Microelectromechanical Systems 15:3, 678-685
CrossRef808
STEFAN BETGE, ANDREAS KRACK, HANS R. FIGULLA, GERALD S. WERNER. (2006) Analysis of Location and Pattern of Target Vessel Failure in Chronic Total Occlusions after Stent Implantation and Its Potential for the Efficient Use of Drug-Eluting Stents. Journal of Interventional Cardiology 19:3, 226-231
CrossRef809
Angela Hoye, Ioannis Iakovou, Lei Ge, Carlos A.G. van Mieghem, Andrew T.L. Ong, John Cosgrave, Giuseppe M. Sangiorgi, Flavio Airoldi, Matteo Montorfano, Iassen Michev, Alaide Chieffo, Mauro Carlino, Nicola Corvaja, Jiro Aoki, Gaston A. Rodriguez Granillo, Marco Valgimigli, Georgios Sianos, Willem J. van der Giessen, Pim J. de Feyter, Ron T. van Domburg, Patrick W. Serruys, Antonio Colombo. (2006) Long-Term Outcomes After Stenting of Bifurcation Lesions With the “Crush” Technique. Journal of the American College of Cardiology 47:10, 1949-1958
CrossRef810
Chang-Bum Park, Cheol Whan Lee, Bong-Ki Lee, Young-Hak Kim, Myeong-Ki Hong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2006) Safety and efficacy with drug-eluting stent in st-segment elevation and non-ST-segment elevation myocardial infarction. Clinical Cardiology 29:5, 199-203
CrossRef811
Donald E. Cutlip. (2006) Drug-eluting stent era: will we improve 5-year outcomes?. Coronary Artery Disease 17:3, 289-292
CrossRef812
Martin Unverdorben, Ralf Degenhardt, Christian Vallbracht, Marcus Wiemer, Dieter Horstkotte, Henrik Schneider, Christoph Nienaber, Wolfgang Bocksch, Michael Gross, Michael Boxberger, . (2006) The paclitaxel-eluting Coroflex™ please stent pilot study (PECOPS I): Acute and 6-month clinical and angiographic follow-up. Catheterization and Cardiovascular Interventions 67:5, 703-710
CrossRef813
Patrick W. Serruys. (2006) Fourth Annual American College of Cardiology International Lecture. Journal of the American College of Cardiology 47:9, 1754-1768
CrossRef814
Luis S. Díaz de la Llera, Sara M. Ballesteros, Agustín Guisado, Almudena Aguilera, Ana Campos, Ángel Sánchez, Manuel Villa, Gabriel Retegui. (2006) Tratamiento de las lesiones bifurcadas mediante técnica de crush T stenting: resultados inmediatos y a medio plazo. Revista Española de Cardiología 59:5, 458-464
CrossRef815
G. W. Stone, H. D. Aronow. (2006) Long-term Care After Percutaneous Coronary Intervention: Focus on the Role of Antiplatelet Therapy. Mayo Clinic Proceedings 81:5, 641-652
CrossRef816
C. Lally, D.J. Kelly, P.J. Prendergast. 2006. Stents. .
CrossRef817
Giora Weisz, Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Mel R. Clark, Barry M. Cohen, Stephen G. Ellis, Patrick Coleman, Carolyn Hill, Chunxue Shi, Donald E. Cutlip, Richard E. Kuntz, Jeffrey W. Moses. (2006) Two-Year Outcomes After Sirolimus-Eluting Stent Implantation. Journal of the American College of Cardiology 47:7, 1350-1355
CrossRef818
William W. Chu, Pramod K. Kuchulakanti, Rebecca Torguson, Betty Wang, Leonardo C. Clavijo, William O. Suddath, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, Ron Waksman. (2006) Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 67:4, 595-599
CrossRef819
Albrecht Elsässer, Helge Möllmann, Holger M. Nef, Christian W. Hamm. (2006) How to revascularize patients with diabetes mellitus—. Clinical Research in Cardiology 95:4, 195-203
CrossRef820
Peng Wu, David W. Grainger. (2006) Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27:11, 2450-2467
CrossRef821
Alfredo E. Rodriguez, Juan F. Granada, Máximo Rodriguez-Alemparte, Cesar F. Vigo, Juan Delgado, Carlos Fernandez-Pereira, Antonio Pocovi, Alfredo M. Rodriguez-Granillo, Daryl Schulz, Albert E. Raizner, Igor Palacios, William O’Neill, Grzegorz L. Kaluza, Gregg Stone. (2006) Oral Rapamycin After Coronary Bare-Metal Stent Implantation to Prevent Restenosis. Journal of the American College of Cardiology 47:8, 1522-1529
CrossRef822
Tony Y. Eng, M.K. Boersma, C.D. Fuller, J.Y. Luh, A. Siddiqi, S. Wang, C.R. Thomas. (2006) The Role of Radiation Therapy in Benign Diseases. Hematology/Oncology Clinics of North America 20:2, 523-557
CrossRef823
Kyoung-Ha Park, Seong-Wook Park, Myeong-Ki Hong, Young-Hak Kim, Bong-Ki Lee, Duk-Woo Park, Bong-Ryong Choi, Mi-Jeong Kim, Kyoung-Min Park, Cheol Whan Lee, Sang-Sig Cheong, Jae-Joong Kim, Seung-Jung Park. (2006) Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions. Catheterization and Cardiovascular Interventions 67:4, 589-594
CrossRef824
Feras M. Bader, Abdallah G. Kfoury, Edward M. Gilbert, William H. Barry, Naeem Humayun, Mary E. Hagan, Heidi Thomas, Dale Renlund. (2006) Percutaneous Coronary Interventions With Stents in Cardiac Transplant Recipients. The Journal of Heart and Lung Transplantation 25:3, 298-301
CrossRef825
Kathryn J. A. Gruchalla, James J. Nawarskas. (2006) The Paclitaxel-Eluting Stent in Percutaneous Coronary Intervention. Cardiology in Review 14:2, 88-98
CrossRef826
Shahzad G. Raja. (2006) Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction. The Annals of Thoracic Surgery 81:3, 1162-1171
CrossRef827
Angela Migliorini, Guia Moschi, Ruben Vergara, Guido Parodi, Nazario Carrabba, David Antoniucci. (2006) Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheterization and Cardiovascular Interventions 67:3, 344-348
CrossRef828
Gemma Conn, Asmeret G Kidane, Geoffrey Punshon, Ruben Y Kannan, George Hamilton, Alexander M Seifalian. (2006) Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?. Expert Review of Medical Devices 3:2, 245-261
CrossRef829
Hideyuki Eto, Masaaki Miyata, Noriaki Kume, Manabu Minami, Hiroyuki Itabe, Koji Orihara, Shuichi Hamasaki, Sadatoshi Biro, Yutaka Otsuji, Toru Kita, Chuwa Tei. (2006) Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury. Biochemical and Biophysical Research Communications 341:2, 591-598
CrossRef830
Serruys, Patrick W., Kutryk, Michael J.B., Ong, Andrew T.L., . (2006) Coronary-Artery Stents. New England Journal of Medicine 354:5, 483-495
Full Text831
Satya Reddy Atmakuri, Eli I. Lev, Carlos Alviar, Edward Ibarra, Albert E. Raizner, Stuart L. Solomon, Neal S. Kleiman. (2006) Initial Experience With a Magnetic Navigation System for Percutaneous Coronary Intervention in Complex Coronary Artery Lesions. Journal of the American College of Cardiology 47:3, 515-521
CrossRef832
William S. Weintraub. (2006) The vascular effects of cilostazol. Canadian Journal of Cardiology 22, 56B-60B
CrossRef833
Keita Kikuchi, Haruo Makuuchi, Hiroshi Murakami, Takamaro Suzuki, Makoto Oono, Kiyoshi Chiba. (2006) Use of an audible ultrasonic flowmeter to locate deeply buried coronary arteries for off-pump coronary artery bypass grafting. The Japanese Journal of Thoracic and Cardiovascular Surgery 54:2, 75-77
CrossRef834
Young-Hak Kim, Seong-Wook Park, Cheol Whan Lee, Myeong-Ki Hong, Hyeon-Cheol Gwon, Yangsoo Jang, Myoung Mook Lee, Bon Kwon Koo, Dong Joo Oh, Ki Bae Seung, Seung-Jae Tahk, Junghan Yoon, Seung-Jung Park. (2006) Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions. Catheterization and Cardiovascular Interventions 67:2, 181-187
CrossRef835
Donald S. Baim, Laura Mauri, Donald C. Cutlip. (2006) Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease. Journal of the American College of Cardiology 47:4, 878-881
CrossRef836
Sheila A Doggrell. (2006) Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation. Expert Opinion on Pharmacotherapy 7:2, 225-228
CrossRef837
BRUCE R. BRODIE. (2006) Adjunctive Balloon Postdilatation after Stent Deployment: Is It Still Necessary with Drug-Eluting Stents?. Journal of Interventional Cardiology 19:1, 43-50
CrossRef838
Manel Sabaté. (2006) Insulinodependencia, ¿rapamicina-resistencia?. Revista Española de Cardiología 59:2, 91-93
CrossRef839
Thierry Charron, Nafiseh Nili, Bradley H. Strauss. (2006) The cell cycle: A critical therapeutic target to prevent vascular proliferative disease. Canadian Journal of Cardiology 22, 41B-55B
CrossRef840
Rainer Wessely, Albert Schömig, Adnan Kastrati. (2006) Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting Stents. Journal of the American College of Cardiology 47:4, 708-714
CrossRef841
B.J. Gersh. (2006) Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents. Yearbook of Cardiology 2006, 260-261
CrossRef842
Babak Azarbal, Jesse W. Currier. (2006) Allergic Reactions After the Implantation of Drug-Eluting Stents. Journal of the American College of Cardiology 47:1, 182-183
CrossRef843
Alfredo E. Rodriguez, Juan Mieres, Carlos Fernandez-Pereira, Cesar F. Vigo, Maximo Rodriguez-Alemparte, Daniel Berrocal, Liliana Grinfeld, Igor Palacios. (2006) Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial. Journal of the American College of Cardiology 47:1, 205-207
CrossRef844
Jianmin Yang, Ningfu Wang, Xingwei Zhang, Jian Xu, Feng Ling, Liang Zhou, Xianhua Ye. (2006) Late Angiographic Stent Thrombosis in a Drug-Eluting Stent That Occurred 20 Months After Premature Discontinuation of Clopidogrel Administration. International Heart Journal 47:5, 707-713
CrossRef845
Mayte Pozo, Virginia Castilla, Cristina Gutierrez, Rosario de Nicolás, Jesús Egido, Jesús González-Cabrero. (2006) Ursolic acid inhibits neointima formation in the rat carotid artery injury model. Atherosclerosis 184:1, 53-62
CrossRef846
Gerald S. Werner, Gero Schwarz, Dirk Prochnau, Michael Fritzenwanger, Andreas Krack, Stefan Betge, Hans R. Figulla. (2006) Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: A strategy of extensive lesion coverage with drug-eluting stents. Catheterization and Cardiovascular Interventions 67:1, 1-9
CrossRef847
Mattias Ekman, Iwar Sjögren, Stefan James. (2006) Cost-effectiveness of the Taxus paclitaxel-eluting stent in the Swedish healthcare system. Scandinavian Cardiovascular Journal 40:1, 17-24
CrossRef848
W. Motz, R. Kaiser. (2006) Stenttherapie bei diabeteskranken Koronarpatienten. Clinical Research in Cardiology 95:S1, i27-i30
CrossRef849
Sidney C. Smith, Ted E. Feldman, John W. Hirshfeld, Alice K. Jacobs, Morton J. Kern, Spencer B. King, Douglass A. Morrison, William W. O’Neill, Hartzell V. Schaff, Patrick L. Whitlow, David O. Williams, Elliott M. Antman, Sidney C. Smith, Cynthia D. Adams, Jeffrey L. Anderson, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon Ann Hunt, Alice K. Jacobs, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2006) ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. Journal of the American College of Cardiology 47:1, e1-e121
CrossRef850
Henning Kelbæk, Leif Thuesen, Steffen Helqvist, Lene Kløvgaard, Erik Jørgensen, Samir Aljabbari, Kari Saunamäki, Lars R. Krusell, Gunnar V.H. Jensen, Hans E. Bøtker, Jens F. Lassen, Henning R. Andersen, Per Thayssen, Anders Galløe, Anton van Weert. (2006) The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial. Journal of the American College of Cardiology 47:2, 449-455
CrossRef851
Edo Kaluski, Alberto Hendler, Nir Uriel, Olga Milo‐Cotter, Zvi Vered, Ricardo Krakover, Gad Cotter. (2006) Adjunctive pharmacotherapy for coronary interventions—time to read the writing on the wall. Acute Cardiac Care 8:4, 186-195
CrossRef852
W FRISHMAN. (2006) Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationWindecker S, Remondino A, Eberli FR, et al (Univ Hosp Bern, Switzerland; Univ Hosp Zurich; Univ of Bristol, England) N Engl J Med 353:653–662, 2005§. Yearbook of Medicine 2006, 331-333
CrossRef853
(2005) Drug-Eluting Coronary Stents. New England Journal of Medicine 353:22, 2404-2408
Full Text854
PAUL VERMEERSCH, PIERFRANCESCO AGOSTONI. (2005) Should Degenerated Saphenous Vein Grafts Routinely Be Sealed with Drug-Eluting Stents?. Journal of Interventional Cardiology 18:6, 467-473
CrossRef855
Andrew TL Ong, Patrick W Serruys. (2005) Technology Insight: an overview of research in drug-eluting stents. Nature Clinical Practice Cardiovascular Medicine 2:12, 647-658
CrossRef856
Arkadiusz Derkacz, Marcin Protasiewicz, Nicholas Kipshidze, Dariusz Biały, Rafał Poręba, Elżbieta Bereś-Pawlik, Krzysztof Abramski, Andwalentyna Mazurek. (2005) Endoluminal Phototherapy for Prevention of Restenosis: Preliminary Results at 6-Month Follow-Up. Photomedicine and Laser Surgery 23:6, 536-542
CrossRef857
Michael S. Lee, Atman P. Shah, Joseph Aragon, Aamer Jamali, Suhail Dohad, Saibal Kar, Raj R. Makkar. (2005) Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheterization and Cardiovascular Interventions 66:4, 507-511
CrossRef858
On-Hing Kwok, Wing-Hing Chow, Tin-Chu Law, Alex Chiu, William Ng, Wai-Fat Lam, Mun K. Hong, Jeffrey J. Popma. (2005) First human experience with angiopeptin-eluting stent: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Catheterization and Cardiovascular Interventions 66:4, 541-546
CrossRef859
Chun-Ming Shih, Chun-Che Shih, Yea-Yang Su, Nen-Chung Chang, Shing-Jong Lin. (2005) In vitro study of drug loading on polymer-free oxide films of metallic implants. Journal of Biomedical Materials Research Part A 75A:3, 519-529
CrossRef860
SIGMUND SILBER. (2005) Cypher Versus Taxus: Are There Differences?. Journal of Interventional Cardiology 18:6, 441-446
CrossRef861
Áurea J. Chaves, Amanda G.M.R. Sousa, Luiz A. Mattos, Alexandre Abizaid, Fausto Feres, Rodolfo Staico, Marinella Centemero, Luiz F. Tanajura, Andrea C. Abizaid, Arilson Rodrigues, Ângela Paes, Gary S. Mintz, J. Eduardo Sousa. (2005) Pilot study with an intensified oral sirolimus regimen for the prevention of in-stent restenosis in de novo lesions: A serial intravascular ultrasound study. Catheterization and Cardiovascular Interventions 66:4, 535-540
CrossRef862
JUN TANIGAWA, NILESH SUTARIA, OMER GOKTEKIN, CARLO DI MARIO. (2005) Treatment of Unprotected Left Main Coronary Artery Stenosis in the Drug-Eluting Stent Era. Journal of Interventional Cardiology 18:6, 455-465
CrossRef863
Jian-Zhong Chen, Shrirang V. Ranade, Xiang-Qun Xie. (2005) NMR characterization of paclitaxel/poly (styrene-isobutylene-styrene) formulations. International Journal of Pharmaceutics 305:1-2, 129-144
CrossRef864
Hideaki Kaneda, Junya Ako, Yasuhiro Honda, Mitsuyasu Terashima, Yoshihiro Morino, Paul G. Yock, Jeffrey J. Popma, Martin B. Leon, Jeffrey W. Moses, Peter J. Fitzgerald. (2005) Impact of Asymmetric Stent Expansion on Neointimal Hyperplasia Following Sirolimus-Eluting Stent Implantation. The American Journal of Cardiology 96:10, 1404-1407
CrossRef865
Catherine Cagiannos, Omran R. Abul-Khoudoud, Waldemar DeRijk, Daniel H. Shell, Lisa K. Jennings, Elizabeth A. Tolley, Charles R. Handorf, Timothy C. Fabian. (2005) Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. Journal of Vascular Surgery 42:5, 980-988
CrossRef866
Tae-Hyun Yang, Seong-Wook Park, Myeong-Ki Hong, Duk-Woo Park, Kyoung-Min Park, Young-Hak Kim, Ki-Hoon Han, Cheol Whan Lee, Sang-Sig Cheong, Jae-Joong Kim, Seung-Jung Park. (2005) Impact of Diabetes Mellitus on Angiographic and Clinical Outcomes in the Drug-Eluting Stents Era. The American Journal of Cardiology 96:10, 1389-1392
CrossRef867
P. Couppié, F. De Poli, C. Thalouarn, F. Fellinger, M. Hanssen, MC. Dickelé. (2005) Le stent « actif » en 2005 : remplit-il ses promesses ?. Annales de Cardiologie et d'Angéiologie 54:6, 325-331
CrossRef868
Kok-Meng Yee, Christopher E. Buller, Diane Catellier, Eric A. Cohen, Ronald C. Carere, Todd Anderson, Peter Berger, Jeffrey R. Burton, Gerald Barbeau, Koon K. Teo, Vladimir Dzavik, . (2005) Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: A report from the total occlusion study of Canada (TOSCA). Catheterization and Cardiovascular Interventions 66:2, 178-184
CrossRef869
Lutz Buellesfeld, Ulrich Gerckens, Ralf Mueller, Thomas Schmidt, Eberhard Grube. (2005) Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: Results of a Taxus CTO registry. Catheterization and Cardiovascular Interventions 66:2, 173-177
CrossRef870
L. Buellesfeld, V. Lim, U. Gerckens, R. Mueller, E. Grube. (2005) Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography. Zeitschrift für Kardiologie 94:10, 690-694
CrossRef871
S. Eckert, D. Tschöpe. (2005) Glukosestoffwechsel. Zeitschrift für Kardiologie 94:S3, iii88-iii91
CrossRef872
Gregg W. Stone, Antonio Colombo, Paul S. Teirstein, Jeffrey W. Moses, Martin B. Leon, Nicolaus J. Reifart, Gary S. Mintz, Angela Hoye, David A. Cox, Donald S. Baim, Bradley H. Strauss, Matthew Selmon, Issam Moussa, Takahiko Suzuki, Hideo Tamai, Osamu Katoh, Kazuaki Mitsudo, Eberhard Grube, Louis A. Cannon, David E. Kandzari, Mark Reisman, Robert S. Schwartz, Steven Bailey, George Dangas, Roxana Mehran, Alexander Abizaid, Patrick W. Serruys. (2005) Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results. Catheterization and Cardiovascular Interventions 66:2, 217-236
CrossRef873
Rainer Wessely, Jurgen Pache, Albert Schomig. (2005) Recurrence of in-stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus-eluting stent. Transplant International 18:9, 1113-1115
CrossRef874
Christoph Kaiser, Hans Peter Brunner-La Rocca, Peter T Buser, Piero O Bonetti, Stefan Osswald, André Linka, Alain Bernheim, Andreas Zutter, Michael Zellweger, Leticia Grize, Matthias E Pfisterer. (2005) Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET). The Lancet 366:9489, 921-929
CrossRef875
Junya Ako, Yoshihiro Morino, Yasuhiro Honda, Ali Hassan, Shinjo Sonoda, Paul G. Yock, Martin B. Leon, Jeffrey W. Moses, Heidi N. Bonneau, Peter J. Fitzgerald. (2005) Late Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation. Journal of the American College of Cardiology 46:6, 1002-1005
CrossRef876
Daniel C Bezerra, Julien Bogousslavky. (2005) Clopidogrel: cardiologists’ panacea or neurologists’ headache?. Future Cardiology 1:5, 579-590
CrossRef877
Nicholas N Kipshidze, Mykola V Tsapenko, Martin B Leon, Gregg W Stone, Jeffrey W Moses. (2005) Update on drug-eluting coronary stents. Expert Review of Cardiovascular Therapy 3:5, 953-968
CrossRef878
Dibra, Alban, Kastrati, Adnan, Mehilli, Julinda, Pache, Jürgen, Schühlen, Helmut, von Beckerath, Nicolas, Ulm, Kurt, Wessely, Rainer, Dirschinger, Josef, Schömig, Albert, . (2005) Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients. New England Journal of Medicine 353:7, 663-670
Full Text879
Windecker, Stephan, Remondino, Andrea, Eberli, Franz R., Jüni, Peter, Räber, Lorenz, Wenaweser, Peter, Togni, Mario, Billinger, Michael, Tüller, David, Seiler, Christian, Roffi, Marco, Corti, Roberto, Sütsch, Gabor, Maier, Willibald, Lüscher, Thomas, Hess, Otto M., Egger, Matthias, Meier, Bernhard, . (2005) Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization. New England Journal of Medicine 353:7, 653-662
Full Text880
Patrick W. Serruys, Andrew T.L. Ong, Lex A. van Herwerden, J. Eduardo Sousa, Adib Jatene, Johannes J.R.M. Bonnier, Jacques P.M.A. Schönberger, Nigel Buller, Robert Bonser, Clemens Disco, Bianca Backx, Paul G. Hugenholtz, Brian G. Firth, Felix Unger. (2005) Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease. Journal of the American College of Cardiology 46:4, 575-581
CrossRef881
Jorge A. Belardi, Fernando Cura, Mariano Albertal, Lucio Padilla, German Solioz, Pablo Perez Balino, Julio A. Pascua, Carlos Fava, Daniel Berrocal, Oscar Mendiz, Liliana Grinfeld. (2005) Use of drug-eluting stents for the treatment of in-stent restenosis in routine clinical practice. Coronary Artery Disease 16:5, 327-330
CrossRef882
Lei Ge, Flavio Airoldi, Ioannis Iakovou, John Cosgrave, Iassen Michev, Giuseppe M. Sangiorgi, Matteo Montorfano, Alaide Chieffo, Mauro Carlino, Nicola Corvaja, Antonio Colombo. (2005) Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique. Journal of the American College of Cardiology 46:4, 613-620
CrossRef883
Bon-Kwon Koo, Hyun-Jai Kang, Tae-Jin Youn, In-Ho Chae, Dong-Joo Choi, Hyo-Soo Kim, Dae-Won Sohn, Byung-Hee Oh, Myoung-Mook Lee, Young-Bae Park, Yun-Shik Choi, Seung-Jae Tahk. (2005) Physiologic Assessment of Jailed Side Branch Lesions Using Fractional Flow Reserve. Journal of the American College of Cardiology 46:4, 633-637
CrossRef884
Jiro Aoki, Gastón A. Rodríguez-Granillo, Patrick W. Serruys. (2005) Estrategias emergentes en cardiología intervencionista. Revista Española de Cardiología 58:8, 962-973
CrossRef885
Alaide Chieffo, Antonio Colombo. (2005) Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?. Nature Clinical Practice Cardiovascular Medicine 2:8, 396-400
CrossRef886
B. Scheller, A. Grandt, S. Wnendt, G. Lorenz, M. Böhm, G. Nickenig. (2005) Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model. Zeitschrift für Kardiologie 94:7, 445-452
CrossRef887
Patrick W. Serruys, Georgios Sianos, Alexandre Abizaid, Jiro Aoki, Peter den Heijer, Hans Bonnier, Pieter Smits, Dougal McClean, Stefan Verheye, Jorge Belardi, Jose Condado, Michel Pieper, Louise Gambone, Marco Bressers, Janette Symons, Eduardo Sousa, Frank Litvack. (2005) The Effect of Variable Dose and Release Kinetics on Neointimal Hyperplasia Using a Novel Paclitaxel-Eluting Stent Platform. Journal of the American College of Cardiology 46:2, 253-260
CrossRef888
Pilar Jiménez-Quevedo, Manel Sabaté. (2005) Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents. Expert Review of Cardiovascular Therapy 3:4, 635-646
CrossRef889
Raúl Moreno. (2005) Stents recubiertos y otros dispositivos antirreestenosis. Revista Española de Cardiología 58:7, 842-862
CrossRef890
(2005) Guías de Práctica Clínica sobre intervencionismo coronario percutáneo. Revista Española de Cardiología 58:6, 679-728
CrossRef891
Floyd D. Loop. (2005) Coronary Artery Surgery. The Annals of Thoracic Surgery 79:6, S2221-S2227
CrossRef892
PAOLO ORTOLANI, ANTONIO MARZOCCHI, MATTEO AQUILINA, WILLIAM GAIBA, STEFANO NERI, CINZIA MARROZZINI, TULLIO PALMERINI, NEVIO TAGLIERI, A. BRANZI. (2005) 32P Brachytherapy in the Treatment of Complex Cypher In-Stent Restenosis. Journal of Interventional Cardiology 18:3, 205-211
CrossRef893
Begoña Benito, Mónica Masotti, Amadeo Betriu. (2005) Avances en el tratamiento farmacológico coadyuvante en la intervención coronaria. Revista Española de Cardiología 58:6, 729-743
CrossRef894
Myeong-Ki Hong, Cheol Whan Lee, Young-Hak Kim, Bong-Ki Lee, Min-Kyu Kim, Tae-Hyun Yang, Jong-Min Song, Ki-Hoon Han, Duk-Hyun Kang, Jae-Kwan Song, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park. (2005) Two-year follow-up intravascular ultrasound analysis after bare metal stent implantation in 120 lesions. Catheterization and Cardiovascular Interventions 65:2, 247-253
CrossRef895
Michael Schlüter, Joachim Schofer. (2005) Direct Stenting With Sirolimus-Eluting Stents. The American Heart Hospital Journal 3:3, 182-192
CrossRef896
Ralf Zahn, Christian W. Hamm, Steffen Schneider, Uwe Zeymer, Christoph A. Nienaber, Gert Richardt, Malte Kelm, Benny Levenson, Tassilo Bonzel, Ulrich Tebbe, Georg Sabin, Jochen Senges. (2005) Incidence and Predictors of Target Vessel Revascularization and Clinical Event Rates of the Sirolimus-Eluting Coronary Stent (Results from the Prospective Multicenter German Cypher Stent Registry). The American Journal of Cardiology 95:11, 1302-1308
CrossRef897
Robin Collingwood, Lori Gibson, Souad Sedlik, Renu Virmani, Andrew J. Carter. (2005) Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Catheterization and Cardiovascular Interventions 65:2, 227-232
CrossRef898
Eulogio García. (2005) Intervencionismo en el contexto del infarto de miocardio. Conceptos actuales. Revista Española de Cardiología 58:5, 567-584
CrossRef899
Jiro Aoki, Patrick W. Serruys, Heleen van Beusekom, Andrew T.L. Ong, Eugene P. McFadden, Georgios Sianos, Willem J. van der Giessen, Evelyn Regar, Pim J. de Feyter, H. Richard Davis, Stephen Rowland, Michael J.B. Kutryk. (2005) Endothelial Progenitor Cell Capture by Stents Coated With Antibody Against CD34. Journal of the American College of Cardiology 45:10, 1574-1579
CrossRef900
George Dangas, Stephen G. Ellis, Richard Shlofmitz, Stanley Katz, David Fish, Steven Martin, Roxana Mehran, Mary E. Russell, Gregg W. Stone. (2005) Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. Journal of the American College of Cardiology 45:8, 1186-1192
CrossRef901
Alexandra J. Lansky, Ricardo A. Costa, Michael Mooney, Mark G. Midei, Henry K. Lui, Warren Strickland, Roxana Mehran, Martin B. Leon, Mary E. Russell, Stephen G. Ellis, Gregg W. Stone. (2005) Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. Journal of the American College of Cardiology 45:8, 1180-1185
CrossRef902
Stephen G. Ellis, Jeffrey J. Popma, John M. Lasala, Joerg J. Koglin, David A. Cox, James Hermiller, Charles O’Shaughnessy, James Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Joel Greenberg, Gregg W. Stone. (2005) Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation. Journal of the American College of Cardiology 45:8, 1193-1200
CrossRef903
Jeffrey W. Moses, Roxana Mehran, Eugenia Nikolsky, John M. Lasala, Woodrow Corey, Glenn Albin, Cary Hirsch, Martin B. Leon, Mary E. Russell, Stephen G. Ellis, Gregg W. Stone. (2005) Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes. Journal of the American College of Cardiology 45:8, 1165-1171
CrossRef904
James B. Hermiller, Albert Raizner, Louis Cannon, Paul A. Gurbel, Michael A. Kutcher, S. Chiu Wong, Mary E. Russell, Stephen G. Ellis, Roxana Mehran, Gregg W. Stone. (2005) Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus. Journal of the American College of Cardiology 45:8, 1172-1179
CrossRef905
Dean J. Kereiakes, Richard E. Kuntz, Laura Mauri, Mitchell W. Krucoff. (2005) Surrogates, substudies, and real clinical end points in trials of drug-eluting stents**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 45:8, 1206-1212
CrossRef906
Javier Zueco Gil. (2005) Importancia de los factores clínicos y anatómicos en el intervencionismo coronario. Revista Española de Cardiología 58:4, 430-441
CrossRef907
Prospero B. Gogo, David J. Schneider, Matthew W. Watkins, Edward F. Terrien, Burton E. Sobel, Harold L. Dauerman. (2005) Systemic Inflammation After Drug-Eluting Stent Placement. Journal of Thrombosis and Thrombolysis 19:2, 87-92
CrossRef908
Neil J. Weissman, Joerg Koglin, David A. Cox, James Hermiller, Charles O’Shaughnessy, James Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Joel Greenberg, Michael Kutcher, S. Chiu Wong, Warren Strickland, Michael Mooney, Mary E. Russell, Stephen G. Ellis, Gregg W. Stone. (2005) Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation. Journal of the American College of Cardiology 45:8, 1201-1205
CrossRef909
Raúl Moreno, Cristina Fernández, Rosana Hernández, Fernando Alfonso, Dominick J. Angiolillo, Manel Sabaté, Javier Escaned, Camino Bañuelos, Antonio Fernández-Ortiz, Carlos Macaya. (2005) Drug-eluting stent thrombosis. Journal of the American College of Cardiology 45:6, 954-959
CrossRef910
Ioannis Iakovou, Thomas Schmidt, Lei Ge, Giuseppe M. Sangiorgi, Goran Stankovic, Flavio Airoldi, Alaide Chieffo, Matteo Montorfano, Mauro Carlino, Iassen Michev, Nicola Corvaja, John Cosgrave, Ulrich Gerckens, Eberhard Grube, Antonio Colombo. (2005) Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. Journal of the American College of Cardiology 45:5, 805-806
CrossRef911
Andrew T.L. Ong, Angela Hoye, Jiro Aoki, Carlos A.G. van Mieghem, Gaston A. Rodriguez Granillo, Karel Sonnenschein, Evelyn Regar, Eugene P. McFadden, Georgios Sianos, Willem J. van der Giessen, Peter P.T. de Jaegere, Pim de Feyter, Ron T. van Domburg, Patrick W. Serruys. (2005) Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. Journal of the American College of Cardiology 45:6, 947-953
CrossRef912
José M. de La Torre Hernández, Fermín Sainz Laso, Cristina Ruisánchez, Javier Zueco, Álvaro Figueroa, Thierry Colman. (2005) Tratamiento de lesiones con alto riesgo de reestenosis. Estudio comparativo en 300 pacientes del stent liberador de rapamicina, el stent con polímero liberador de paclitaxel y el stent convencional. Revista Española de Cardiología 58:3, 262-269
CrossRef913
Jonathan Eddinger, Mylan C. Cohen. (2005) Advances in nuclear imaging for preoperative risk assessment. Current Cardiology Reports 7:2, 143-147
CrossRef914
Ehtisham Mahmud, Babek Pezeshki, Ali Salami, Shahin Keramati. (2005) Highlights of the 2004 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting: Clinical implications. Journal of the American College of Cardiology 45:5, 796-801
CrossRef915
Anthony A. Bavry, Dharam J. Kumbhani, Thomas J. Helton, Deepak L. Bhatt. (2005) What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?. Journal of the American College of Cardiology 45:6, 941-946
CrossRef916
Anita Wokhlu, James G. (2005) Dollars and Stents: The Economics of Drug-Eluting Stents. The American Heart Hospital Journal 3:2, 94-104
CrossRef917
JIRO AOKI, ANGELA HOYE, ANTON V. STAFEROV, BAGRAT G. ALEKYAN, PATRICK W. SERRUYS. (2005) Sirolimus-Eluting Stent Implantation for Chronic Total Occlusion of the Left Main Coronary Artery. Journal of Interventional Cardiology 18:1, 65-69
CrossRef918
Pierre-Frédéric Keller, Reda Ibrahim, Jean-Claude Tardif. (2005) The drug-based pipeline against restenosis. Expert Opinion on Emerging Drugs 10:1, 67-86
CrossRef919
J. F. VILES-GONZALEZ, V. FUSTER. (2005) Looking for the culprit of coronary in-stent restenosis: debatable role for the fibrinolytic system?. Journal of Thrombosis and Haemostasis 3:2, 230-232
CrossRef920
SAMUEL O. JONES, ROBERT E. ECKART, ERIC A. SHRY, DANIEL E. SIMPSON. (2005) Review of Subacute Stent Thrombosis Following Percutaneous Coronary Intervention at a Low-Volume Catheterization Laboratory. Journal of Interventional Cardiology 18:1, 11-15
CrossRef921
Aloke V. Finn, Igor F. Palacios, Adnan Kastrati, Herman K. Gold. (2005) Drug-eluting stents for diabetes mellitus. Journal of the American College of Cardiology 45:4, 479-483
CrossRef922
Elad I. Levy, Ricardo A. Hanel, Tsz Lau, Christopher J. Koebbe, Naveh Levy, David J. Padalino, Kim Marie Malicki, Lee R. Guterman, L. Nelson Hopkins. (2005) Frequency and management of recurrent stenosis after carotid artery stent implantation. Journal of Neurosurgery 102:1, 29-37
CrossRef923
Daniel W. Isenbarger, Jon R. Resar. (2005) Drug‐eluting versus third‐generation bare metal stents: The US strategy. Acute Cardiac Care 7:4, 171-175
CrossRef924
Mark A Moyad. (2005) Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part I. Current Opinion in Urology 15:1, 1-6
CrossRef925
Antonio Colombo, Ioannis Iakovou. (2005) Plaque sealing—a concept waiting for support. Acute Cardiac Care 7:2, 72-74
CrossRef926
William W. Chu, Ron Waksman. (2005) Contemporary use of drug-eluting stents. Current Treatment Options in Cardiovascular Medicine 7:1, 35-46
CrossRef927
James B Hermiller. (2005) Drug-Eluting Stents in the Management of Coronary Artery Disease. Disease Management & Health Outcomes 13:1, 1-7
CrossRef928
Dahlia T Lainer, Ernest Brahn. (2005) New antiangiogenic strategies for the treatment of proliferative synovitis. Expert Opinion on Investigational Drugs 14:1, 1-17
CrossRef929
Soon Jun Hong, Do-Sun Lim, Hong Seog Seo, Young-Hoon Kim, Wan Joo Shim, Chang Gyu Park, Dong Joo Oh, Young Moo Ro. (2005) Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis. Catheterization and Cardiovascular Interventions 64:1, 75-81
CrossRef930
Marco Zimarino, Giulia Renda, Raffaele De Caterina. (2005) Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents. Drugs 65:6, 725-732
CrossRef931
Zachary K. Baldwin, Amito Chandiwal, Viji Balasubramanian, Benjamin J. Pearce, Michael A. Curi, Christopher L. Skelly, Wendy W. Huang, James E. Vosicky, Bernard Roizman, Ralph R. Weichselbaum, Lewis B. Schwartz. (2005) Modulation of vascular remodeling induced by a brief intraluminal exposure to the recombinant R7020 strain of Herpes simplex-1. Journal of Vascular Surgery 41:1, 115-121
CrossRef932
Bryan PY Yan, David J Clark, Andrew E Ajani. (2005) Oral antiplatelet therapy and percutaneous coronary intervention. Expert Opinion on Pharmacotherapy 6:1, 3-12
CrossRef933
Prabir Roy-Chaudhury, Burnett S. Kelly, Murad Melhem, Jianhua Zhang, Jinsong Li, Pankaj Desai, Rino Munda, Sue C. Heffelfinger. (2005) Novel Therapies for Hemodialysis Vascular Access Dysfunction: Fact or Fiction!. Blood Purification 23:1, 29-35
CrossRef934
Abdallah G Rebeiz, Joseph Adams, Robert A Harrington. (2005) Interventional Cardiovascular Pharmacotherapy. American Journal of Cardiovascular Drugs 5:2, 93-102
CrossRef935
Randi Selmer, Sigrun Halvorsen, Kurt I. Myhre, Torbjørn F. Wisløff, Ivar Sønbø Kristiansen. (2005) Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction. Scandinavian Cardiovascular Journal 39:5, 276-285
CrossRef936
Flavio Ribichini, Valeria Ferrero, Andrea Rognoni, Giovanni Vacca, Corrado Vassanelli. (2005) Angiotensin Antagonism in Coronary Artery Disease. Drugs 65:8, 1073-1096
CrossRef937
Angela Hoye, Carlos A. G. van Mieghem, Andrew T. L. Ong, Jiro Aoki, Gaston A. Rodriguez Granillo, Marco Valgimigli, Keiichi Tsuchida, Georgios Sianos, Eugene P. Mcfadden, Willem J. van der Giessen, Pim J. de Feyter, Ron T. van Domburg, Patrick W. Serruys. (2005) Percutaneous therapy of bifurcation lesions with drug‐eluting stent implantation: the Culotte technique revisited. Acute Cardiac Care 7:1, 36-40
CrossRef938
Shrirang V. Ranade, Robert E. Richard, Michael N. Helmus. (2005) Styrenic block copolymers for biomaterial and drug delivery applications. Acta Biomaterialia 1:1, 137-144
CrossRef939
Shrirang V. Ranade, Kathleen M. Miller, Robert E. Richard, A. Ken Chan, Michael J. Allen, Michael N. Helmus. (2004) Physical characterization of controlled release of paclitaxel from the TAXUS? Express2? drug-eluting stent. Journal of Biomedical Materials Research 71A:4, 625-634
CrossRef940
Gerald S. Werner, Andreas Krack, Gero Schwarz, Dirk Prochnau, Stefan Betge, Hans R. Figulla. (2004) Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. Journal of the American College of Cardiology 44:12, 2301-2306
CrossRef941
SIGMUND SILBER. (2004) Which Parameter Should Be Chosen as Primary Endpoint for Randomized Drug-Eluting Stent Studies?. Journal of Interventional Cardiology 17:6, 375-385
CrossRef942
Donald S Baim. (2004) New devices for percutaneous coronary intervention are rapidly making bypass surgery obsolete. Current Opinion in Cardiology 19:6, 593-597
CrossRef943
Steven R Bailey. (2004) Drug-eluting stents have made brachytherapy obsolete. Current Opinion in Cardiology 19:6, 598-600
CrossRef944
Sheila A Doggrell. (2004) Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis. Expert Opinion on Pharmacotherapy 5:11, 2209-2220
CrossRef945
Paul P. Dobesh, Zachary A. Stacy, Alexander J. Ansara, Jason M. Enders. (2004) Drug-Eluting Stents: A Mechanical and Pharmacologic Approach to Coronary Artery Disease. Pharmacotherapy 24:11, 1554-1577
CrossRef946
J. Hausleiter, A. Kastrati, J. Mehilli, H. Schuhlen, J. Pache, F. Dotzer, C. Glatthor, S. Siebert, J. Dirschinger, A. Schomig, . (2004) A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. Journal of Internal Medicine 256:5, 388-397
CrossRef947
Mark A. Moyad. (2004) Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: Part II. Urologic Oncology: Seminars and Original Investigations 22:6, 472-477
CrossRef948
Thomas M Schiele, Florian Krötz, Volker Klauss. (2004) Vascular restenosis – striving for therapy. Expert Opinion on Pharmacotherapy 5:11, 2221-2232
CrossRef949
Grzegorz L Kaluza, Albert E Raizner. (2004) Brachytherapy for restenosis after stenting for coronary artery disease: its role in the drug-eluting stent era. Current Opinion in Cardiology 19:6, 601-607
CrossRef950
Adnan Kastrati. (2004) Drug-eluting stents for secondary prevention of restenosis. Catheterization and Cardiovascular Interventions 63:3, 265-266
CrossRef951
Raisuke Iijima, Yuji Ikari, Masamichi Wada, Masanori Shiba, Masato Nakamura, Kazuhiro Hara. (2004) Cutting balloon angioplasty is superior to balloon angioplasty or stent implantation for small coronary artery disease. Coronary Artery Disease 15:7, 435-440
CrossRef952
Robert S. Schwartz, Nicolas A. Chronos, Renu Virmani. (2004) Preclinical restenosis models and drug-eluting stents. Journal of the American College of Cardiology 44:7, 1373-1385
CrossRef953
Mark J Eisenberg. (2004) Drug-eluting stents: some bare facts. The Lancet 364:9444, 1466-1467
CrossRef954
Santhi K Ganesh, Kimberly A Skelding, Laxmi Mehta, Kathleen O’Neill, Jungnam Joo, Gang Zheng, James Goldstein, Robert Simari, Eric Billings, Nancy L Geller, David Holmes, William W O’Neill, Elizabeth G Nabel. (2004) Rationale and study design of the CardioGene Study: genomics of in-stent restenosis. Pharmacogenomics 5:7, 949-1004
CrossRef955
Eberhard Grube, Alexandra Lansky, Karl Eugen Hauptmann, Carlo Di Mario, Germano Di Sciascio, Antonio Colombo, Sigmund Silber, Juergen Stumpf, Nicolaus Reifart, Jean Fajadet, Antonio Marzocchi, Joachim Schofer, Pierre Dumas, Rainer Hoffmann, Giulio Guagliumi, Mark Pitney, Mary E. Russell. (2004) High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization. Journal of the American College of Cardiology 44:7, 1368-1372
CrossRef956
Richard V. Aghababian. (2004) Emergency Department Evaluation and Treatment of Patients With ST-Segment Elevation Myocardial Infarction. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 3:3, 110-113
CrossRef957
Sheila A Doggrell. (2004) Clinical trials in restenosis with 7-hexanoyltaxol and paclitaxel-eluting stents. Expert Review of Cardiovascular Therapy 2:5, 745-752
CrossRef958
Ganesan Karthikeyan, Balram Bhargava. (2004) Prevention of restenosis after coronary angioplasty. Current Opinion in Cardiology 19:5, 500-509
CrossRef959
O. Barthélémy. (2004) Quelles leçons tirer des grandes études et registres concernant l'utilisation des stents actifs ?. Annales de Cardiologie et d'Angéiologie 53:5, 229-233
CrossRef960
Harold L Dauerman. (2004) Approaches to restenosis: mechanical and pharmacological strategies. Coronary Artery Disease 15:6, 303-305
CrossRef961
Alexander Levitzki. (2004) PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases. Cytokine & Growth Factor Reviews 15:4, 229-235
CrossRef962
Mohan N Babapulle, Lawrence Joseph, Patrick Bélisle, James M Brophy, Mark J Eisenberg. (2004) A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. The Lancet 364:9434, 583-591
CrossRef963
Ron Waksman. (2004) Vascular brachytherapy vs. drug-eluting stents for the treatment of in-stent restenosis: The jury's still out. Catheterization and Cardiovascular Interventions 62:3, 290-291
CrossRef964
Herrmann, Howard C., . (2004) Prevention of Cardiovascular Events after Percutaneous Coronary Intervention. New England Journal of Medicine 350:26, 2708-2710
Full Text965
Sheila A Doggrell. (2004) Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery. Expert Opinion on Pharmacotherapy 5:6, 1431-1434
CrossRef966
Richard E. Kuntz, John C. Wang, Laura Mauri, David J. Cohen. (2004) An Evidence-Based Approach to the Use of Drug-Eluting Stents in Clinical Practice. The American Heart Hospital Journal 2:3, 132-141
CrossRef967
Raúl Moreno, Cristina Fernández, Fernando Alfonso, Rosana Hernández, Maria J. Pérez-Vizcayno, Javier Escaned, Manel Sabaté, Camino Bañuelos, Dominick J. Angiolillo, Luis Azcona, Carlos Macaya. (2004) Coronary stenting versus balloon angioplasty in small vessels. Journal of the American College of Cardiology 43:11, 1964-1972
CrossRef968
(2004) Paclitaxel-Eluting Coronary Stents. New England Journal of Medicine 350:20, 2099-2100
Full Text969
J Marco. (2004) Les endoprothèses
actives
délivrant in situ une drogue antimitotique ou cytostatique: une révolution qui ne dispense pas de la réflexion. Annales de Cardiologie et d'Angéiologie 53, S50-S52
CrossRef970
Mark A Moyad, Markus Sonnleithner. (2004) Prostate cancer and coronary heart disease: correlation or coincidence?. Urologic Clinics of North America 31:2, 207-212
CrossRef971
P Urban, A.H Gerschlick, G Guagliumi, P Guyon, C Lotan, J Schofer, A Seth, J.E Sousa, W Wijns. (2004) Le registre e-Cypher : objectifs et organisation. Annales de Cardiologie et d'Angéiologie 53, S18-S21
CrossRef972
Nicholas N. Kipshidze, Patrick Iversen, Han-Soo Kim, Hamid Yiazdi, George Dangas, Rufus Seaborn, Gishel New, Fermin Tio, Ron Waksman, Roxana Mehran, Mykola Tsapenko, Gregg W. Stone, Gary S. Roubin, Sriram Iyer, Martin B. Leon, Jeffrey W. Moses. (2004) Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model. Catheterization and Cardiovascular Interventions 61:4, 518-527
CrossRef973
Renu Virmani, Frank D. Kolodgie, Andrew Farb. (2004) Drug-Eluting Stents: Are They Really Safe?. The American Heart Hospital Journal 2:2, 85-88
CrossRef974
Lee, Thomas H., . (2004) “Me-Too” Products — Friend or Foe?. New England Journal of Medicine 350:3, 211-212
Full Text975
Eberhard Grube, Lutz Buellesfeld. (2004) Paclitaxel-Eluting Stents. American Journal of Cardiovascular Drugs 4:6, 355-360
CrossRef976
Harald Vik‐Mo, Rune Wiseth, Knut Hegbom. (2004) Coronary aneurysm after implantation of a paclitaxel‐eluting stent. Scandinavian Cardiovascular Journal 38:6, 349-352
CrossRef977
Cynthia A. Yock, Paul G. Yock. (2004) The Drug-Eluting Stent Information Gap. The American Heart Hospital Journal 2:1, 21-25
CrossRef
- Letters
